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PART – I 
ANTI­MICROBIAL ACTIVITY OF 
ILAVU VER 
CHOORANAM 
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1. INTRODUCTION 
           
          World’s first originated medicine is our traditional siddha system of 
medicine. This system of medicine was founded by siddhars. In the Siddha 
pharmacopeia, the Sidddars have used 4 typs of crud drugs which is crude drugs of plant 
origin, animal origin, mineral origin and metal origin for preparing medicines. Herbs are 
extensive used for the preparation of medicine in siddha system of medicine. 
                   “Ver paaru thazhai paaru minjinakkal mella mella 
                     Parpa chenduram paaru” . 
          Roots, leaves, flowers, fruits, seeds of plants are being used to alleviate the 
diseases. If the herbal drugs cannot control the severity of the disease, the next step is to 
use the drugs of mineral & metal origin as parpam and chenduram. It is the line of 
treatment in this system. 
                    Roots are rich in phytochemicals. To illustrate the importance of roots, 
“Pathartha guna chinthamani” classified roots as Dasamoolam and panchamoolam.  
         The basic theory of siddha system is that the human body is made up of   96  
thathuvas. The human body functions mainly by the three uyir thaathus (3 Humors ) are 
named under mukkutram and these are related to arusuvaigal (6 Tastes ) and pancha 
boodhangal (5 Basic elements). 
        Disease occurs in the human by means of decrease or increase in quantities 
of uyir thaathus. 
                   Siddhars classified the total diseases in human body according to the 
literature “Agathiyar  rathina churukka naadi” as 4448 disease. 
                  Vellai noi is one of the “Neer rogam” under these  classification. The 
aetiology,types and clinical features of vellai noi are mentioned in “Yugi chinthamani”. 
                  In modern aspect the vellai noi is compared to that of Leucorrhoea. Abnormal 
vaginal discharge (Leucorrhoea) is quite a frequent complaint of women in day to day 
life. It could be painful (dragging pain in abdomen, lumbar region pain) cause lot of 
discomfort (Intense itching, irritability),stress and even affect the sexual life and 
libido(Obstetrics and Gynecology for post graduates -S.S.Ratnam). 
                  Commonly fungal, parasitic, bacterial and sexually transmitted diseases are 
the prim causative factors. Other causes are hormonal imbalance, improper lifestyle and 
surroundings, anemia, diabetes, etc.., 
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The survey conducted all over the world indicates that 75% of women will have 
at least one episode of candidal vaginitis during their life time and 40% -50% of women 
may experience a recurrence(Sobel J.D,1985). 90% of patients caused by candida 
albicans, trichomonas vaginalis, gardnerella vaginalis (Clayton et al., 1985).  
The development of the nation partially depends on the development of the 
women who constitute half of its population. But woman is more prone to disease 
regarding her situation to come across various explanatory changes of life like puberty, 
menstruation, child bearing, lactation and menopause. If woman is healthy, she will give 
her ‘Best’ for the health and development of her child, family, society and nation. 
So I have decided to choose one of the most common complaints of women “The 
vaginal discharge” as my dissertation topic ”Vellai noi”. 
Herbal medicine also called as phytomedicine, and it has a long tradition of use. It 
has a high value in treating and preventing diseases. The WHO estimated that 80% of 
people worldwide rely on herbal medicine for health care. 
Current treatments for leucorrhoea include Metronidazole, Itrconazole, Imidazole, 
Ecanozole. The advers effect of these drugs are Neuropathy, Epileptiform seizures, 
Leucopenia, CNS & GI disturbances,Urticaria,Angioedema, Menstural irregularities, 
Increase in liver enzymes, Dark urine. So I have decided to take the herbal medicine 
“Ilavu ver (Bombax ceiba) since it will be less toxic and will not produce the adverse 
effects like the modern medicines. 
In the siddha literature “GUNAPADAM – MOOLIGAI VAGUPPU” the drug 
“Ilavu ver chooranam”(Bombax ceiba)is indicated for leucorrhoea. So the drug has been 
selected for the dissertation work in treating the disease leucorrhoea. 
The root of Bombax ceiba is a modified root for the special function of 
supporting and it is named as ROOT  BUTTRESSES. This tree is widely distributed in 
tropical regions. It grows in alluvial sand near the banks of rivers and rainfall is well 
distributed throughout the year. 
Since the above said conditions are conducive for the plantation of bombax ceiba. 
So it is widely cultivated in the Theni district which lies in the hilly regions of western 
ghats. If the plant well growing in this alluvial soil, this root contains rich 
phytochemicals. Roots are abundant in quantity in root buttresses. 
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So this root can be used as a cost effective medicine for the treatment of 
leucorrhoea, which in turn provides curing low economic status women. 
Similar to the exploration of the underground gold to ornamental ones, I have 
decided to use the roots of Bombax ceiba in an effective manner to cure the ailment and 
thereby creating a healthy womanhood.       
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2. AIM AND OBJECTIVES 
 
AIM:  
 Herbal medicines also called phytomedicine. It has long tradition of use for long 
life with better health. The value of herbal medicine in the treating and preventing 
disease. Root of Ilavu maram ( Bombax ceiba ) are very useful to treat a vellai noi ( 
Leucorrhoea ) which is mentioned in our literature. It will be less toxic and will not 
produce the adverse effects for leucorrhoea.     Leucorrhoea is one of the most common 
complaints of women. These roots are abundant in quantity in root buttresses. So this 
root can be used as a cost effective medicine for the treatment of leucorrhoea, which in 
turn  provides curing even for low economic status women.So I have decided to use the 
roots of Bombax ceiba in an effective manner to cure the ailment and thereby creating a 
healthy womenhood. 
 The ultimate aim of my dissertation work is to prove the ANTI – MICROBIAL  
ACTIVITY of   Ilavu ver chooranam 
OBJECTIVE: 
In this dissertation work, the “ILAVU VER CHOORANAM” is analyzed to 
assess the following aspects: 
K To collect the literature review 
K Get the authentication of the raw drug 
K Pharmacognostic study  for the raw drug  
K Phytochemical and Chemical analysis for the trial drug to identify the 
active components. 
K  Pharmacological study to evaluate the anti – microbial activity 
K Clinical study to assess the efficacy of the drug through open clinical trial 
of Leucorrhoea patients. 
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3. REVIEW OF LITERATURE 
3.1. Botanical aspect: 
Bentham & Hooker’s classification: 
Kingdom  -   Plantae 
Sub kingdom  -   Tracheabionta 
Super division  - Spermatophyta 
Division  -  Magnoliophyta  
Class   - Magnoliopsida 
Sub class  -  Dilleniidae 
Order   - Malvales 
Family   -  Bambacaceae 
Genus    -  Bombax 
Species   -  Bombax ceiba 
Vernacular names: 
English  - Cotton Tree , Red Silk-cotton Tree 
Tamil   - Ilavam , Ilavu , Mullilavu , Kongu , Pulai 
Sanskrit  - Kantakadruma , Raktapushpa , Bahuvirya , Pichhala ,                        
Mochani   - Tuliphala 
Hindi   - Kaantisenbal , Pagun , Rakatsenbal , Semul 
Bengal   - Pagun , Roktosimul , Simul , Tula 
Gujarat  - Sawar , Shimalo , Shimar , Shimul 
Kanadam  - Booruga , Kempubooruga , Mullilavau 
Marathi  - Kantesavar , Saur , Simalo , Tamari 
Malayalam  - Mullilabpoola , Mullilavau , Mocha , Unnamuriku , Purani 
Oriya   - Bouroh , Mochoroso , Salmali , Simuli 
Telugu              - Boorugachettu , Kondabooruga , Mundlaburaga ,  
Pinnaburaga 
Combodia  - Roka 
Chinese  - Mu Mien    
Burma   - Didu , Lepanbin , Letpan  
Ceylon     - Parutti 
French     - Bambax de Malabar , Cotonnier Mapou 
Indo China   - Gao , Sich moc mienthu 
Malaya   - Mook min , Simur 
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Distribution: 
A lofty, deciduous tree buttressed at the base, up to 40m in height and 6m or more 
in girth, with a clear bole of 24-30m. Widely distributed throughout India, including the 
Andamans, up to 1,500m or even higher. The trees, in full bloom, present a striking blaze 
of colour and are grown in avenues. In peninsular India, the tree is very common in the 
dry as well as moist, mixed deciduous forests; in West Bengal and Assam, it is found in 
the mixed evergreen forests as well. The tree grows sporadically in the mixed deciduous 
forests in the sub-Himalayan region and lower valleys, and is typical of the alluvial-
savannah-type forests, tending to be gregarious near the riverbanks 
Description of the plant: 
Branches horizontally spreading, more or less in whorls; young stems and 
branches covered with stout, hard prickles; bark pale ash to silver-grey, smooth in the 
early years, later becoming rough, with irregular vertical cracks. 
Leaves large, spreading, glabrous, digitate, leaflets 5-7, lanceolate, 10-20cm long. 
Flowers numerous, large, 10-13cm in diam, fleshy, bright crimson, yellow or 
orange, clustered at the end of branches, bisexual, very rarely unisexual. 
Capsules oblong-ovoid, woody, 10-19cm long; seeds many, obovoid, smooth,6-
9mm long, oily, with dense silky hairs. 
The buttresses are present only in trees of c30 years or more. The tree sometimes 
reaches very large dimensions, as much as 59m in height and 35m in girth around the 
buttress. It is eminently suited for afforestation of new ground and of grasslands in the 
riverain tracts. It is also useful in controlling soil erosion. 
The tree is natural habitat, excluding the hills, the absolute maximum shade-
temperature varies from 37.5 to 50, the absolute minimum from- 2.5 to 17.5, and the 
rainfall from 50 to 460cm or more; it thrives best in places where the rainfall is well 
distributed throughout the year. 
Phenology:                                                      
The tree commences to shed leaves in the beginning of December, becoming 
leafless by the end of the month. The new leaves appear in March-April. The flowers 
appear during Jan- Feb, and sometimes continue up to March. If the leaves are present, 
the flowers, as a rule, will be less. The tree starts fruiting at the age of about eight years; 
grafted stock, however, bears fruits after a year. The fruits ripen during April- May. The 
woody five-valved capsule usually opens when still on the tree.    The seeds are covered 
by masses of white, silky hairs and are easily dispersed by wind, to long distances. The 
7 
 
seeds are irregular, obovoid, dark brown, smooth with a brittle testa. The seeds are 
collected from mid- March to mid- May and are separated from the floss. The weight of 
100 dry fruits is c 2kg, of which the floss is c 600g and seeds c 500g, the rest being made 
up of the woody rind; 25,300-38,500 seeds weigh a kilogram. Although the seeds are 
oily, they remain viable for c 2 years, if properly stored. Fresh seeds show high 
germination percentage and are preferred for sowing. 
Part used: 
Root, Bark, Flower, Fruit, Gum 
Actions: 
Root   - Astringent, demulcent, tonic, aphrodisiac, cooling, slightly  
diuretic  
Bark   - Demulcent, diuretic, tonic, slightly astringent 
Flower   - Cooling, diuretic, astringent, tonic aphrodisiac, stimulant, 
expectorant,  alterative. 
Young fruits      -  Expectorant, stimulant, diuretic 
Gum     - Astringent, styptic, tonic aphrodisiac, demulcent. 
Chemical constituents: 
Leaves: 
Crud protein, 18.69; crud fiber, 11.42; total minerals, 6.96; reducing sugar, 1.2; 
total sugars, 4.94; and starch, 12.09%. 
Flowers: 
Calyces: 
Moisture, 85.66; crud protein, 1.38; ethwr extr, 0.44; carbohydrates, 11.95; and 
mineral matter,1.09; calcium, 92.25; phosphorus, 49.0; and magnesium, 54.24 mg|100g. 
Fresh petal: 
Orang-red anthocyanin, pelagonidin-5β-D-glucopyranoside (C21 H21 CIO10 m p, 
300◦) and cyaniding-7-methyl-ether-3 β-glucopyranoside (C22 H23 CIO11, m p 300◦) 
Alcoholic extract of flowers: 
Hentriacontane, hentriacontanol, β-sitosterol and its β-D-glucoside, quercetin, 
kaempferol and an essential oil. 
Stamens: 
A new polysaccharide consisting of D-galactose, L-arabinose and L-rhamnose in 
the molecular ratio of 5 5 3 . 
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Young roots: 
Moisture, 7.5; mineral matter, 2.1; pritein, 1.2; fat,0.9; starch, 71.2; pectic 
substances, 6.0; cellulose,2.0; phpsphatides(cephalin), 0.3; semul-red(a colouring 
matter), 0.5; tannins, 0.4; non-tannins, 0.1; and sugars(arabinose and galactose), 8.2%.  
The proportion of the constituents varies with the age of the roots ; younger roots 
contain more sugars, starch, and pectic substances than the older roots, but contain less 
oil, colouring matter and cellulose. 
Root bark: 
Lupeol,β-sitosterol,8-formyl-7-hydroxy-5-isopropyl-2-methoxy-3-methyl-1,4-
nsphthaquinone(C16 H16 O5 ,m p 82◦ ), isohemigossypol-1-methyl ether(C16 H18 O4,m p 
153◦),  
isohemigossypol-1, 2-dimethyl ether(C17 H20 O4,m p 101-02◦),  
7-hydroxycadalene (C15 H18O, m p 113-14◦) . 
Bark: 
Total water extr, 9.92; tannins, 3.01; and non-tannins, 6.91%. It also contains 
lupeol, β-sitosterol and its D-glucoside. 
Gum: 
           8.9% mineral matter and a considerable propotion of catechol tannin; on complete 
hydrolysis, it yiels a mixture of L-arabinose, D-galactose, D-galacturonic acid, and 
possibly rhamnose. The gum also contains tannic and gallic acids. 
Seeds: 
            Moisture, 6.2; crude protein, 28.51; pentosans, 8.9; and mucilage, 2.0%. The 
seeds also contain n-hexacosanol, palmitic, gallic and tannic acids, octyl palmitate, l-
galloyl-β-glucose, ethyl-gallate, α-, β- and γ-tocopherols, carotenoids, and an unidentified 
terpene.  
MEDICINAL USES: 
Leaves & Flowers: 
The paste of flowers, and also that of leaves, is employed as an application in 
cutaneous troubles. 
Flowers: 
These are good for haemorrhage, conjunctivitis, splenomegaly and haemorrhoids.  
Root: 
It is used in dysentery, gonorrhoea, impotence. 
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Bark:  
It’s aqueous extract mixed with curd is used to check blood- dysentery. Externally 
it is used as a styptic, and also for fomenting wounds. The paste of the bark is applied to 
skin eruptions. 
Gum: 
It is used for dysentery, haemoptysis in pulmonary tuberculosis, influenza and 
menorrhagia, burning sensation, strangury and haemorrhoids. 
The young fruits: 
These are considered beneficial in calculous affections, chronic inflammation and 
ulceration of the bladder and kidneys. 
Seeds: 
It is used in gonorrhoea, chronic cystitis and other catarrhal affection. The hot, 
aqueous extract of the seeds possesses moderate oxytocic activity.                           
 3.2. GUNAPADAM ASPECT : 
Part used: 
Leaves, Flower, Seed, Bark,Gum, Cotton, Root. 
Taste (suvai): 
          Sweet, Astringent, Bitter. 
Character(thanmai): 
Thatpam 
Classifaication(pirivu): 
           Inippu 
Gunam: 
          “  நƫக்கடுப்பு நெரrவு நண்ெடாழுகு ேமகமும்ேபாம் 
ஆƫக்கும்விந்து ேவாைடக்கு மாண்ைமயுறும்- பாƫக்குள் 
நிலவு மதிவதன ேநrைழேய ெவப்பாயம் 
இலவு மரத்தா லியம்பு” 
(AGATHIYAR GUNAVAGADAM) 
The bombax ceiba tree cures Burning micturation and Leucorrhoea.Its strengthens 
the Sukkilam and Rasa thadhu. 
The bark of Bombax ceiba is grainded and taken lemon size then mixed with 
pulitha neer nullifies the effect of Idumarunthu. 
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3.3. MODERN ASPECT OF DISEASE : 
 
LEUCORRHOEA : 
Physiology of vagina: 
It is a fibromuscular passage that connects the uterus to the introitus.The vaginal 
mucosa is lined by squamous epithelium which consists of a basal layer of cuboidal cells, 
a middle layer of prickle cells and a superficial layer of cornified cells. Vaginal secretion 
is small in amount in healthy women, and consists of white coagulated material. The 
vaginal contents are mostly derived from the squamous cells of the vaginal mucosa. 
Some contribution comes from endometrium.  
Patho physiology: 
The superficial cornified cells of the vaginal mucosa produce glycogen under 
oestrogen stimulation and are continuously desquamated. Subsequently, as a result of the 
breaking down of the cells, glycogen is liberated and ultimately converted into lactic 
acid.In the newborn, before the appearance of the Doderlein’s bacilli, glycogen is broken 
down into lactic acid and there is some evidence that the process is brought about by 
enzyme action. After the appearance of Doderlein’s bacilli, the production of the lactic 
acid is augmented by the action of bacilli on simple sugar.The vaginal secretion is acidic 
due to the precence of lactic acid and acidity inhibits the growth of pathogenic 
organisms. The pH of the vagina averages about 4.5 during reproductive life. The acidity, 
which is undoubtedly oestrogen dependent, falls after the menopause to neutral or even 
alkaline. Before puberty the pH is about 7. This high pH before puberty and after 
menopause explains the tendency for the development of mixed organism infections in 
these age groups. 
The components of vaginal secretion are from: 
The sweat and sebaceous glands of the vulva and the specialized racemose glands 
of Bartholin’s. The characteristic odour of the vaginal secretion is provided by the 
apocrine glands of the vulva. 
The transudate of the vaginal epithelium and the desquamated cells of the 
cornified layer. This is strongly acidic. 
The mucous secretion of the endocervical glands which is alkaline. 
The endometrial glandular secretion. 
          All these play a varying part at different times of the menstrual cycle, the last two 
being most active just before menstruation. 
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Causes of leucorrhoea: 
Pathalogical vaginal discharge: 
• Non infective                                  
• Infective 
• Neoplastic 
• Truama 
Non infective leucorrhoea: 
The term leucorrhoea should be restricted to those conditions when the normal 
vaginal secretion is increased in amount.  
Causes: 
i. Physiological  excess 
ii. Cervical  causes 
iii. Vaginal  causes 
Physiological excess: 
The normal secretion is expected to increase in conditions when the oestrogen 
levels become high. Such conditions are 
During puberty: 
Increased levels of endogenous oestrogen lead to marked overgrowth of the 
endocervical epithelium which may encroach onto the ectocervix producing congenital 
erosion  increased secretion. 
During menstrual cycle: 
Around ovulation peak rise of oestrogen increase in secretory activity of the 
cervical gland. 
Premenstrual pelvic congestion and increased mucus secretion from the 
hypertrophied endometrial glands. 
Pregnancy: 
There is hyperoestrinism with increased vascularity.This lead to increased vaginal 
transudate and cervical gland secretion. 
During sexual excitement: 
When there is abundant secretion from the Bartholin’s glands.    
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Cervical cause: 
Non infective cervical lesion may produce excessive secretion which pours out at 
the vulva. Such lesions are cervical erosion, chronic cervicitis, mucus polyp and 
ectropion (Cervical glands are exposed to the vagina). 
Vaginal causes: 
Increased vaginal transudation occurs in conditions associated with increased 
pelvic congestion. The lesions are uterine prolapse, acquired retroverted uterus, chronic 
pelvic inflammatory disease and even chronic constipation. 
Infections: 
Infection of the genital tract may cause muco-purulent or frankly purulent vaginal 
discharge. The amount, colour, and odour depend upon the type of infection. 
Types: 
• Specific vaginal infection 
• Non specific vaginal infection 
Specific vaginal infection: 
If the strict definition of accepted as an excessive vaginal secretion in which the 
primary cause is not infective,any vaginal discharge which is frankly purulent and 
contains pus cells and from which the causative organism can be isolated and cultured, 
should be considered as due to specific vaginal infection. 
Vulvo-vaginitis: 
• Non-specific organisms (Infancy and post-menopausal age groups). 
• Tricomonas vaginitis. 
• Candida albicans. 
• Gonococcal and other bacterial infections (Bartholinitis and Urethritis). 
Cervicitis: 
• Pyogenic infection due to non-specific organisms during puerperium 
and following abortion. 
• Gonococcal infection. 
Endometritis: 
• Non-specific infections during puerperium and post-menopausal age. 
• Tuberculous endometritis. 
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It is observed that50% vaginitis is due to bacterial vaginosis 
                         20-25% due to monilial infection 
 15-20% due to trichomonal infection 
Gardnerella (bacterial) vaginosis: 
Bacterial vaginosis is termed vaginosis rather than vaginitis, because it is 
associated with alteration in the normal vaginal flora rather than due to any specific 
infection. There is a considerable decrease in the number of lactobacilli in the vaginal 
discharge with 100-fold increase in growth of other anaerobic bacteria.Since lactobacilli 
release hydrogen peroxide toxic to other bacteria, reduction in their number allow other 
bacteria, I.e. aerobic and anaerobic bacteria to grow.These are Haemophilus vaginalis, 
Gardnerella, Mobiluncus and Mycoplama hominis. The bacterial vaginosis is therefore a 
polymicrobial condition. 
It is not sexually transmitted with a variable incubation period. About 50% 
women are asymptomatic carriers of infection, but majority complain of vaginal 
discharge without itching and minimal vulval irritation.   
The characteristics of vaginal discharge : 
          White, milky, non-viscous discharge adherent to the vaginal wall. 
pH of the discharge is more than 4.5. 
Fishy odour when mixed with 10% KOH is due to amino-metabolites from 
various organism. 
Presence of clue cells---the epithelial cells have fuzzy border due to adherence of 
bacteria. 
          Increased number of Gardnerella vaginalis and other organisms and reduced 
number of lactobacilli, and leucocytes. 
Causes: 
                PID 
                Chorioamnionitis 
                Pre-mature rupture of membrane (PROM ) 
                Preterm labour 
Gonococcal vulvovaginitis: 
This is a sexually transmitted disease which can lead to sequelae adversely 
affecting reproductive functions. 
          The causative organism is a gram-negative intracellular diplococcus called 
Neisseria gonorrhoea. The incubation period is 2-10 days. The vaginal squamous 
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epitheliam is resistant to gonococcal infection. The gonococci attack the columnar 
epithelium of glands of Skene, Bartholin, urethra and its glands, cervix and fallopian 
tubes. It ascends in a piggy-back fashion attached to the sperms to reach  the fallopian 
tubes.It is destroyed easily by drying, heat, sunlight, and disinfectants. 
Sites for bacterial recovery:  These include the urethra, cervix, anal canal and 
pharynx. 
Principal sites of invasion: Columnar epithelium of the genital tract, transitional 
epithelium of the urethra and Bartholin’s gland. 
Complications:  
Pelvic inflammatory disease, pyosalpinx formation, tubo-ovarian abscess, pelvic 
abscess followed later on by hydrosalpinx formation, infertility, menstrural disturbances, 
chronic pelvic pain, dysmenorrhoea and dyspareunia. 
Chlamydia: 
Chlamydial infection is common in young, sexually active women but rare after 
the age of 40 years. Two to ten percent of pregnant women are found to have this 
infection during antenatal period and account for 1% of all abortions. The incubation 
period is 6-14 days.       
Chlamydia trachomatis is a small gram-negative bacteria, an obligate intracellular 
parasite that appears as intracytoplasmic inclusion body, and is of two varieties, one that 
causes lymphogranuloma venereum (LGV) and the other of non-LGV, which causes 
non-specific lower genital tract infection. Often, the infection is silent and the women is 
asymptimatic but may develop vaginal discharge, dysuria and frequency of micturation, 
and at times cervicitis. 
             Sometimes  Chlamydia may cause Reiter’s  syndrome with arthritis, skin lesions, 
conjunctivitis and genital infection. It also causes perihepatitis and Fitz-Hugh-Curtis 
syndrome similar to that of gonorrhoea when pelvic inflammatory disease (PID) is 
associated with right upper abdominal pain. During pregnancy, abortion, preterm labour 
and IUGR may occur. Newborn suffers from conjunctivitis, nasopharyngitis, otitis media 
and pneumonia. 
Trichomoniasis: 
In clinical practice, this is amongst the most common. Nearly half the patients 
who complain of pruritus vulvae harbour this organism. It is almost entirely a disease of 
the childbearing era, though young girls and postmenopausal women are not at all 
immune.There is no doubt that this infection is sexually transmissible but, in some 
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instances, it can be acquired by inadequate hygiene or the use of an infected person’s 
towels, bath or clothes. Its ingress to the vagina is favoured by a low general resistance 
and when the pH is raised as during a menstrual period (pH 5-6). It is not uncommon 
during pregnancy and is often associated with gonococcal infection. 
The Trichomonas organism is a protozoa, actively motile, slightly larger than a 
leucocyte and is anaerobic. Three types of trichomonas are known, namely, 
Tr. Buccalis------a normal inhabitant of the mouth. 
Tr. Hominis------a normal inhabitant of the anal canal and rectum. 
Tr. Vaginalis-----it is found in the vagina.  
It has been shown by transplantation experiments that Tr. Buccalis and Tr. 
Hominis are unable to survive in the human vagina. Men may harbour Tr.vaginalis in the 
urethra and prostate. A trichomonad has four anterior flagella and one posterior flagella, 
and they move along the mucous membrane.                   
Symptoms: 
Twenty percent remain asymptomatic – others develop symptoms 4 to 28 days 
following sexual contact with an infected partner, or infected material, like towel or 
toilet. Seventy percent show typical discharge, which is profuse, thin, creamy or slightly 
green in colour, irritating and frothy.  
           The vaginal walls are tender, angry looking and the discharge causes pruritus and 
inflammation of the vulva.  
          There are often multiple small punctuate strawberry spots on the vaginal vault and 
portio vaginalis of the cervix (strawberry vagina ).The characteristic frothy discharge is 
almost self-diagnostic but the presence of secondary infection may alter and mask this 
initial sign.  
           The patient may also complain of urinary symptoms, such as dysuria and 
frequency, and a low-grade urethritis may be discovered on examination. Abdominal 
pain, low backache and dyspareunia may also be complained of if pelvic infection 
occurs. 
Candidal (monilial) vaginitis: 
It is caused by yeast- like microorganisms called Candida or Monilia. The 
commenest species causing human disease is Candida albicans, which is gram positive 
and grows in acid medium. It may be sexually transmitted. Almost 25% women harbour 
Candida in the vagina, these are often asymptomatic. 
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Risk factors: 
These include promiscuity, immunosuppression, pregnancy, steroid therapy, oral 
contraception pills, following long-term broad spectrum antibiotic therapy, diabetes 
mellitus, poor personal hygiene and obesity. 
Clinical features: 
Pruritus vulva is the cardinal symptom. It is often accompanied by vaginal 
irritation, dysuria, or both, and passage of thick curdy or flaky discharge. Speculum 
examination reveals vaginal wall congestion with curdy discharge often visible at the 
vulval mucocutaneous junction and in the posterior fornix. 
Neoplasms: 
Any neoplasm of the lower genital tract causes, initially, serous discharge but 
later due to ulceration of the surface or sloughing of the growth and secondary infection 
causes offensive, foul smelling blood stained vaginal discharge. 
The neoplasms which cause such a vaginal discharge are malignant neoplasms of 
the cervix and body of the uterus, but in some cases purulent blood stained discharge 
may be caused by ulceration of the surface of benign polypi of the cervix and 
endometrium. 
Trauma:  
Any trauma to the genital tract may cause a local inflammatory reaction. It 
initially causes a serous vaginal discharge, but later on the discharge becomes purulent 
due to secondary infection. 
The causes of trauma may be: 
Physical: 
Direct trauma. 
           Foreign body and pessary. 
Chemical: 
Drug and antibiotics causing local irritation and burns. 
Allergic:  
          Local antiseptics and drugs used for douching and cleaning. 
Contraceptives, i.e., diaphragm and condom. 
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3.4. SIDDHA ASPECT OF DISEASE : 
VELLAI NOI : 
Synonyms: 
                     Vettai; Bramium; Bramia rogam; Seezh megam. 
Definition: 
                    Purulent white coloured discharge before or after micturation and burning 
sensation in the urethral orifice. 
Prodromal symptoms: 
• Sexual intercourse with same diseased patient leads to itching in the 
genital organ and burning sensation in the urethral orifice within 3 or 4 
days.  
• During micturation there will be purulent discharge which will be 
viscous like that of thread. 
• Sometimes fever occurs. 
Etiology: 
1. Excessive sexual intercourse. 
2. Sexual into with same diseased patient. 
3. Prolonged starvation. 
4. Excessive walking during hotsun 
5. Excessive intake of tastes like acrid, salt, astringent, bitter. 
Classification: 
It is classified into 21 types 
1.   Valli vellai 
2.   Azhal vellai    
3.   Iya vellai  
4.   Vali azhal vellai  
5.   Azhal Iya vellai 
6.   Mukkutra vellai  
7.   Kal vellai 
8.   Katti vellai  
9.   Nool vellai  
10. Neer vellai  
11. Neechu vellai                                                         
 
12. Manjal vellai   
13. Kiricharam vellai 
14. Karappan vellai 
15. Thanthi vellai                            
16.  Malinam vellai 
17.  Kuruthi vellai                           
18.  Seezh vellai   
19.  Inippu vellai 
20.  Pun vellai 
21.  Kambi vellai                                                         
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Vali vellai: 
           In vali vellai during micturation urine resembles cow’s urine.Pus mixed with the 
urine and also spasmodic pain is present in the lower abdomen. 
Azhal vellai: 
In azhal vellai black colouration and burning sensation present in the 
body.During micturation burning sensation in the urethral orifice and also the urine is 
yellow coloured and mixed with pus. 
Iya vellai: 
       In iya vellai white coloured pus mixed with urine. Burning sensation in the 
urethral orifice. Asper anemia pale colouration is found in the body. 
Vali azhal vellai: 
    In vali azhal vellai the symptoms resembles that something has strucked in the 
urethral orifice. Incontinance, powdered particles and burning micturation is present 
while urination. 
Azhal Iya vellai: 
 In azhal iya vellai disease there is distension and spasmodic pain seen   in the 
lower abdomen.Yellow coloured and pus seen in the urine. 
Mukkutra vellai: 
 In mukkutra vellai frequency of micturation and white discharge is seen. Different 
colour is found in the discharge and precipitate is seen when kept aside.Tingling 
sensation is seen. 
Katti vellai: 
 In katti vellai there is boils in the body, burning and itching in the urethral orifice, 
fistula is seen and while micturation urine passes through it. 
Neer vellai: 
 In neer vellai there is pain the genitals. White discharge and spasmodic pain in 
the lower abdomen is seen. While defecating pus is mixed and white coloured stools are 
passed. Urine are passed as like rice gravel. 
Thanthi vellai: 
 In thanthi vellai white discharge continuos like thread and then followed by urine 
during micturaion. Discharge are always found. Burning sensation in the extrimitis. 
These symptoms are probably concerned to gonorrhoea gleet. 
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Kurithi vellai: 
 In kuruthi vellai giddiness, weakness, there is pain during micturation and urine is 
as that of Rabbit’s blood. Dullness in the   skin colour, urinary incontinence and redness 
is seen in the urine. 
Seezh vellai: 
 In seezh vellai discharge is seen as it is like pus. Boils in the groin, fistula, wound 
in the umbilical occurs.Fever with shiver, giddiness and this symptoms may probably 
acute suppurative urethritis or even acute gonorrhoea. 
Ozhukku vellai: 
 In ozhukku vellai noi the urine is found with blood and pus and discharge is seen 
always.All over the body small pustules are seen, breaks and produce wounds. 
Manjal vellai: 
 In manjal vellai noi dischrge is found as pale yellow colour. Burning sensation as 
that of fire in the urethral orifice. Face becomes yellow, bitterness in the tongue, body 
becomes more hot. 
Neer churukku vellai: 
In neer churukko vellai urithral orifice become more tensed and while micturation 
urine is found yellow coloured.White discharge is found. Desire toward consumption of 
food is decreased and it result in mentally and physically ill. 
Karappan vellai: 
 In karappan vellai noi stool is mixed with pus and pain during defecation. The 
urine is released with more heat. In while body heat is increased and results in wound and 
spreads like eczema. While micturating small stones are released.  
Kal vellai: 
 In kal vellai noi discharge is found like toddy. Pungent body odour. Black 
coloured stones are released. Pain is found between umbilicus and ribs. 
Nool or thandhu vellai: 
In nool vellai noi discharge appears like thin spider web, pain and blood is seen 
during micturation. There are sediments found when collected and kept the urine aside. 
Urine spells like drop by drop.  
Neechu vellai: 
  In neechu vellai noi urine is concentrated and appears like toddy and colour as 
white with pustules. Pricking pain in the lower abdominal and chillness is found. 
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Vali or malina vellai: 
  In malina vellai noi weakness, bitterness in tongue, pain the soles. During 
micturation decomposed muscle partical and discharge are seen together. 
Then vellai: 
In then vellai noi , clearless urine and seen like honey while micturating. Urine 
appears red, fat particles and muscle particles as per water which washed the meat. 
Wound in the urithral orifice, peculiar smell is found in the urine.  
Pun vellai: 
In pun vellai noi, wound is found all over the body. Blood is mixed in the urine. 
The joints are found stiff and normal activities are altered,pain in the joints, body heat are 
increased.           
OTHER PREPARATIONS OF BOMBAX CEIBA : 
Gum of bombax ceiba: 
Theriar vaagadam: 
1. Athividaya kudineer    ------ pg no  
2. Pithaththukku ennai    ------ pg no 183 
3. Neer kazhichaluku kalappuththul  ------ pg no 230 
4. Karkam     ------ pg no 236 
Sigicharathna deepam: 
1. Ingaya chooranam    ------- pg no 111 
2. Kiranikesari kuligai    ------- pg no 152 
3. Katuvai mathirai    ------- pg no 153 
4. Maha madhanakamesura legium  ------- pg no 160 
Vaithya chinthamani: 
1. Utinavayu kirani maruthuvam  ------- pg no 176 
2. Moolavayu kirani maruthuvam  ------- pg no 179 
3. Nalapada azhalnoi maruthuvam  ------- pg no 267 
4. Markka azhal maruthuvam   ------- pg no 268 
5. Asaathiaathisaram    ------- pg no 170 
6. Kirani      ------- pg no 173 
Noigalukku siddha parikaram: 
1. Kudineer     ------- pg no 111 
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Flower of bombax ceiba: 
Theriar maha karisal: 
1.  Mathana kamesvaram   ------- pg no 37 
Root of bombax ceiba: 
Root of bombax ceiba is one of the adjuvants for Loga chenduram and Aya 
chenduram. 
Sarabanthirar vaithya rathnavali  (Part 2 )------pg  no 16 
Chthraka kudabagam : 
Plambago zeylanica  -------- 1400 gm 
Root of Solanum surattense 
Root of Bombax ceiba  Each   700 gm 
Root of Tribuluse terestris            
Root of Tinospora cordifolia 
All ingredients should be dried well then made into chooranam, taken in a pot add  
4  marakkal  water then it is kept for one day.Next day sufficient heat given and reduced 
to 1|4 and then filtered. Add palm jaggery 3500 gm to this mix well and then filter it. 
Take the decoction boil it and reduced it 1/4.  
Next day  Honey    -------- 1120 gm 
Zingiber officinalis 
Piper nigram 
Piper longum                           Each 70 gm 
Cinnamomum verum 
Eletaria cardamomum           
These drugs are mixed with above decoction and grainded well. 
Dosage:        21 gm 
Therapeutic indication: 
Leprosy, cough, bronchial asthma, tuberculosis, peptic ulcer, bleeding piles, 
sinusitis, hydrocele. 
The sinusitis and agnimantham which cannot be cured by many medicines can be 
cured. 
Sarabenthirar vaithya rathnavali ------- pg  no 100         
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Decoction for pitham : 
Root of Bombax ceiba 
Bark of Ficus glamuvata 
Bark of Eugenia jambolana 
Bark of Roxb lannea  
Root of Tribuluse terestris 
Root of Phyllanthus amarus 
Root of Ficus benghalensis 
Orilai tamarai    Each 35 gm 
Pavonia zeylanica 
Pavonia odorats  
Cuminum cyminum 
Alternanthera sessilis 
Oryza sativa  -Nerpori 
Gum of Limonia acidissima 
Above said ingredients partly ground mixed with water 650 ml in a mud pot. 
Sufficient heat given and reduced to 1|2 then allow to cool, mash well and filtered it.  
Dosage: 
60 ml decoction 4 hours once. 
Therapeutic indications: 
Itching, pithathalundana thega erichal, piththathazhaluntha thazhumbu. 
Kannusamy paramparai vaithyam ----pg no 79 
Azhal noi marunthu : 
Root bark of cassia auriculata 
Root of bombax ceiba 
Orilai tamarai 
Root of gmelina arborea 
Phyllanthus amarus                         each 70 gm    
 pavonia zeylanica 
Root of hemidesmus indicus 
Phaseolus trilobatus 
Vilamichu ver 
Root of pergularia extensa 
Terminalia chebula 
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Elataria cardamomum 
Santalum album                               each 17.5 gm 
Nardostachys jatamansi 
Cedrus deodar 
       Aii these drugs are powdered and then sieved add equal amount of powder of 
Cuminum cyminum and sugar then given 3 pinches for Azhal diseases.  
Bark of bombax ceiba : 
Sigicharathna deepam : 
1. Ilagugangaathara chooranam - ----- pg no 121 
2. Viruththa gangaathara chooranam  ----- pg no 122 
Vaithya chinthamani : 
1. Nethira bavuthiram    ----- pg no 211 
2. Thodaathisaram    ----- pg no 169 
Young fruit of bombax ceiba : 
Agathiar attavanai vaagadam : 
1. Athisaram theera podi   ---- pg no 207 
Vaithya chinthamani : 
1. Thontha kirani    ---- pg no 176 
 
3.5. LATERAL RESEARCH: 
1) Hypotensive activity and Hypoglycemic activity:-  
A novel constituent, Shamimin, a C-flavonol glucoside from Bombax ceiba leaves 
showed significant potency as a hypotensive agent at the doses of 15 mg/kg, 3 mg/kg, 1 
mg/kg and significant hypoglycaemic activity at 500 mg/kg in Sprague-Dawley rat 
(Ref : Saleem R, et,al., Hypotensive, hypoglycaemic and toxicological studies on the 
flavonol C-glycoside shamimin from Bombax ceiba. Planta Med. 1999 May;65(4):    
331-4).  
2) Anti-Inflammatory and Hepatoprotective activity:-  
The bark, xylem of stem, and root of Bombax malabarica DC and Ceiba pentandra 
GAERTN are marked as "Mu-mien" in Taiwan. In order to clarify the pharmacological 
effects of these three parts, anti-inflammatory and liver protective effects were evaluated 
with carrageenan-induced paw edema and CCl4-induced hepatotoxicity in rats. 
(Ref : V. Jain, et.al., Free Radical Scavenging Property of Bombax ceiba Linn. Root 
Research Journal of Medicinal Plant Year:2011Volume:5Issue:4PageNo.:462-470,  
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Sampath Kumar Evaluation of RBC Membrane Stabilization and Antioxidant Activity of 
BOMBAX CEIBA in an in vitro Method International Journal of Pharma and Bio Sciences 
vol 2:1:2011).  
3) Antiangiogenic Activity:-  
A methanol extract of the stem barks of Bombax ceiba was found to exhibit a significant 
antiangiogenic activity on in vitro tube formation of human umbilical venous endothelial 
cells (HUVEC). Bioactivity-guided fractionation and isolation carried out on this extract 
afforded lupeol as an active principle. At 50 and 30 µg/mL lupeol showed a marked 
inhibitory activity on HUVEC tube formation while it did not affect the growth of tumor 
cell lines such as SK-MEL-2, A549, and B16-F10 melanoma. 
(Ref : Antiangiogenic activity of lupeol from Bombax ceiba Young-Jae You, 
et.al.,Phytotherapy research Vol 17:4 pp341-44 2003).  
4) Analgesic and Antioxidants Activity:-  
Mangiferin, 2-beta-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one, obtained 
directly from methanolic extracts of Bombax ceiba leaves in substantial amounts 
demonstrated strong antioxidant activity (EC(50) 5.8+/-0.96 mug/ml or 13.74 muM) 
using DPPH assay comparable to rutin, commonly used as antioxidant for medical 
purposes. It displayed significant analgesic effect in acetic acid – induced writhing and 
hot plate test in mice. 
(Ref : Dar A, et.al.,Analgesic and antioxidant activity of mangiferin and its derivatives: 
the structure activity relationship. Biol Pharm Bull. 2005 Apr;28(4):596-600). 
5) Cholinesterase Activity: 
Leaf and stem bark of the seedling were screened for cholinesterase activity the activity 
was observed only in leaf. 
(Ref : Taiwo O. Elufioye, et.al., Acetylcholinesterase and butyrylcholinesterase 
inhibitory activity of some selected Nigerian medicinal plants Revista Brasileira de 
Farmacognosia Brazilian Journal of Pharmacognosy 20(4): 472-477, Ago./Set. 2010).  
7) Hepatoprotective Activity: 
Hepatoprotective activity of methanolic extract of flowers of Bombax ceiba L. (MEBC) 
was investigated against hepatotoxicity produced by administering a combination of two 
anti-tubercular drugs Isoniazid and Rifampicin for 10 and 21 days by intraperitoneal 
route in rats. MEBC were administered at three graded dose i.e. 150, 300 and 450 mg/kg 
i.p. 45 min prior to anti-tubercular challenge for 10 and 21 days. 
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(Ref : Ravi V, et.al.,Hepatoprotective Activity of Bombax ceiba Linn against Isoniazid 
and Rifampicin-induced Toxicity in Experimental Rats. International Journal of Applied  
Research in Natural Products Vol. 3 (3), pp. 19-26, Sep-Oct 2010).  
8) Anticancer and Anti-HIV Activity: 
Methanolic extract of leaves and pure compounds mangiferin and acetyl derivative of 
mangiferin were evaluated in anticancer and anti-HIV activities. All the samples were 
evaluated to be inactive as cytotoxic and as anti-HIV agent. On the contrary, inhibitory 
effects of mangiferin in azoxymethane-induced rat colon carcinogenesis shows its 
chemoprotective nature. This discrepancy may have arisen due to the differences between 
the in vitro vs. in vivo assays used to assess the anticancer activity and thereby 
emphasizes the need to conduct a combination of both types of assays before reaching a 
definite conclusion. 
(Ref : Nam NH, et.al., Inhibitory effects of Vietnamese medicinal plants on tube-like 
formation of human umbilical venous cells, Phytother Res, 17, 2003, 107-111).  
9) Anti-Helicobacter Pylori Activity:  
Ethanolic extracts of Bombax malabaricum DC. evaluated strong anti- Helicobacter 
pylori activities. The minimum inhibitory concentration values of the anti- Helicobacter 
pylori activity given by the ethanolic extracts ranged from 0.64 to 10.24 mg ml (-1). 
(Ref :  Yuan CW, Tung LH, Screening of anti-Helicobacter pylori herbs deriving from 
Taiwanese folk medicinal plants, FEMS Immunology and Medical Microbiology, 43, 
2005, 295–300).  
10) Inhibitory effects on tube-like formation of human umbilical venous cells Seven of 
58 plant materials from Vietnamese medicinal plants were evaluated strong to moderate 
inhibitory activity on the tube-like formation induced by human umbilical venous 
endothelial cells in the in vitro angiogenesis assay. These plant materials include the herb 
of Ephedra sinica, leaves and stem of Ceiba pentandra, seed of Coix lachryma-jobi, 
rhizome of Drynaria fortunei, fruits and stem of Illicium verum and stem of Bombax 
ceiba. The methanol extracts of the herb of Ephedra sinica and stem of Ceiba pentandra 
exhibited the strongest activities with inhibition percentages of 89.3% and 87.5% at 30 
and 100 microgram/mL. 
(Ref : Yoshimi N, et al., The inhibitory effects of mangiferin, a naturally occurring 
glucosylxanthone, in bowel carcinogenesis of male F344 rats, Cancer Lett, 163, 2001, 
163-170).  
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4. MATERIALS AND METHODS 
 
4.1. Preparation of chooranam: 
Material: 
Roots of Bombax ceiba (Ilavu ver). 8kg of Fresh leaves were taken, then it under 
gone for shade dry after that the net weigh of the leaves were around 2.5 kg. 
Collection And Authendication Of The Materials: 
 The plant material used in this study was collected during the month of June 
(2012) from Varusa naadu, Theni Dist, Tamilnadu, India and authenticated from the 
Gunapadam experts in  Deportment of  PG Gunapadam,  Govt. siddha medical college, 
Chennai-106 and Certified from Botanist, Central Research Institute For Siddha, 
Arumbakkam, Chennai-106. The preparation was collected from Gunapadam mooligai 
vaguppu by Ka.Sa. Murugesa mudhaliyar. 
Purification of the Raw Drug: 
The plant roots were well rinsed in water to remove the impurities. Then the 
leaves were cut into pieces and dried in shade. 
Preparation of the chooranam: 
 The well dried Ilavu ver were made into fine powder. To get the finest physical 
form of this drug, the powdered material is sieved through a white cotton cloth 
(Vashthirakayam). 
Purification of chooranam: 
 The Chooranam was moistened with cow’s milk. The pot was half filled with 
milk and water. The mouth of the pot was covered and tied with white cotton cloth. The 
Chooranam (moistened by milk) was placed above the tied cloth. The mouth of the pot 
closed with another mud pot. The gap between the two mud pots was tied with a wet 
cloth to avoid evaporation. Then this arrangement was put on fire and boiled until water 
level gets reduced in the lower pot. Then the powder was taken, dried, powdered finely 
and preserved for usage. 
Preservation:  
 The purified Chooranam was stored in a clean, air tight glass container. Since the 
life period of the Chooranam is only three months, the prepared Chooranam must be 
used within this period.  
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     Figure no : 4.1.1 Ilavu Ver ( Bombax ceiba ) 
 
                              
 
 
 
                  Figure no : 4.1.2 Ilavu Ver chooranam 
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Administration of the drug: 
 Form of the medicine  : Chooranam 
 Route of Administration : Enteral 
 Dose    : 1gm 
 Anubanam (Vehicle)  : Warm water 
 Times of Administration : Two times a day; before food 
 Duration    : 7 weeks 
4.2. Standardization of the drug  
4.2.1. Pharmacognostic aspect: 
Ilavu Ver –Bombax ceiba 
Collection and authentication of the materials: 
Plants were collected from Varusa naadu, Theni dist and identified and 
authenticated by the Gunapadam experts in Department of P.G. Gunapadam, Govt. 
Siddha medical college, Chennai – 106 and certified by Botanist, Central Research 
Institute for Siddha, Chennai – 106. 
Collection of specimens  
The plant specimens for the proposed study were collected from---------------------. 
Care was taken to select healthy plants and normal organs. The required samples of 
different organs were cut and removed from the plant and fixed in FAA (Farmalin-5ml+ 
Acetic acid-5ml + 70% Ethyl alcohol-90ml).After 24 hrs of fixing, the specimens were 
dehydrated with graded series of tertiary –Butyl alcohol as per the schedule given by 
Sass, 1940. Infiltration of the specimens was carried by gradual addition of paraffin wax 
(melting point 58-60 C) until TBA solution attained super saturation. The specimens 
were cast into paraffin blocks. 
Sectioning 
The paraffin embedded specimens were sectioned with the help of Rotary 
Microtome. The thickness of the sections was 10-12 μm. Dewaxing of the sections was 
by customary procedure (Johansen, 1940). The sections were stained with Toluidine 
blue as per the method published by O’Brien et al. (1964). Since Toluidine blue is a 
polychromatic stain. The staining results were remarkably good; and some cytochemical 
reactions were also obtained. The dye rendered pink colour to the cellulose walls, blue to 
the lignified cells, dark green to suberin, violet to the mucilage, blue to the protein 
bodies etc. wherever necessary sections were also stained with safranin and Fast-green 
and IKI(for Starch) 
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For studying the stomatal morphology, venation pattern and trichome distribution, 
paradermal sections (sections taken parallel to the surface of leaf) as well as clearing of 
leaf with 5% sodium hydroxide or epidermal peeling by partial maceration employing 
Jeffrey’s maceration fluid (Sass, 1940) were prepared. Glycerine mounted temporary 
preparations were made for macerated/cleared materials. Powdered materials of different 
parts were cleared with Naoh and mounted in glycerine medium after staining. Different 
cell component were studied and measured.] 
Photomicrographs 
Microscopic descriptions of tissues are supplemented with micrographs wherever 
necessary. Photographs of different magnifications were taken with Nikon labphoto 2 
microscopic Unit. For normal observations bright field was used. For the study of 
crystals, starch grains and lignified cells, polarized light was employed. Since these 
structures have birefringent property, under polarized light they appear bright against 
dark background. Magnifications of the figures are indicated by the scale-bars. 
Descriptive terms of the anatomical features are as given in the standard Anatomy books 
(Esau, 1964). 
4.2.2. Physico-chemical analysis: 
4.2.2.1 Ash and acid insoluble ash: 
 To the ash add 1:5 Hcl: Distilled water 15 ml boil, cooled and then filtered using 
whatman filter paper (No.41) repeat 3 to 4 times till the yellow colour disappear or 
colourless, then remove the filter paper and add to the filter to the original dish and keep 
it in the muffle furnace at 600o C and take constant weight and calculate the acid 
insoluble ash value. 
 Weight of acid insoluble residue x 100 
Acid insoluble ash (%)=  
                   Weight of  the sample 
Acid insoluble residue = Acid insoluble ash value – Empty weight of the dish 
Loss on drying: 
 3gm of the drug is heated in a hot oven at 1050 c to constant weight. The % of 
weight was calculated. 
Loss on drying value at 1050 c - 10.96 %w/w 
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Potential of hydrogen (ph): 
 The pH scale is logarithmic and runs from 0.0 to 14.0 with 7.0 being neutral. 
Readings less than 7.0 indicate acidic solutions, while higher readings indicate alkaline 
or base solutions.  
Above mentioned Quantitative analysis results are showed in the  Table :1 
4.2.2.2  TLC estimation of Ilavu ver chooranam: 
Thin-layer chromatography is a technique in which a solute undergoes 
distribution between two phases, stationary phase acting through adsorption and a mobile 
phase in the form of a liquid. The adsorbent is a relatively thin, uniform layer of dry 
finely powdered material applied to a glass, plastic or metal sheet or plate. Glass plates 
are most commonly used. 
Identification can be effected by observation of spots of identical Rf value and 
about equal magnitude obtained, respectively, with an unknown and a reference sample 
chromatographed on the same plate. A visual comparison of the size and intensity of the 
spots usually serves for semi-quantitative estimation. 
Solvent system: 
Toluene : Ethyl acetate (4:1.5). 
TLC plate: 
  Aluminium plate precoated with silica gel 60F254 of 0.2 mm thickness (Merck). 
Developing chamber: 
 Camag’s twin trough chamber. 
Visualizing reagent: 
 Vanillin-sulphuric acid reagent. 
Extract Preparation: 
4 g of the chooranam was soaked overnight in chloroform. Boiled on a water bath 
for 10 mins, filtered and concentrated to 10 ml.  
Procedure: 
 The extract was applied on the TLC using capillary and developed in the solvent 
system.  The developed TLC plate was air dried and photograph was taken in white light. 
Then dipped in vanillin-sulphuric acid reagent, heated in an oven at 105°C until the 
development of coloured spots and photograph taken. 
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4.2.2.3 Fourier transform infrared spectroscopy (Ftir): 
 
 
 
 
4.2.2.4  scanning electron microscope (sem): 
The Scanning Electron Microscope (SEM) is a microscope that was electrons 
rather than light to form an image. There are many advantages to using the SEM instead 
of a light microscope. 
Resolution : 1.2 nm gold particle separation on a carbon substrate 
Magnification : From a min of 12 x to greater than 1, 00,000 X 
The SEM has a large depth of field, which allows a large amount of the sample to 
be in focus at one time. The SEM also produces images of high resolution, which means 
that closely spaced features can be examined at a high magnification. Preparation of the 
samples is relatively easy since most SEM one require the sample to be conductive. 
The combination of higher magnification, larger depth of focus, greater 
resolution, and easy of sample observation marks the SEM one of the most heavily used 
instruments in research areas today. 
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4.2.3. Qualitative phytochemical analysis: 
S.No Experiment Observation Inference 
1  Test for Alkaloids 
(Dragendorff’s Test) Few 
mg of extract in separate test 
tube was warmed with 2% 
Sulphuric acid for 2 minutes. 
And it was filtered in separate 
test tube and few drops of 
Dragendorff’s reagent were 
added 
.  The presence of orange red 
precipitates indicates . 
 
the presence 
of alkaloids. 
 
2 Test for Flavonoids 
(Shinoda test) 
Substance is dissolved in 
alcohol, added with 
magnesium bits and 
concentrated hydrochloric 
acid. On heating over a water 
bath 
the appearance of majenta 
colour shows 
presence of 
flavonoids.  
 
3 Triterpenoids (Noller’s 
Test)  
To fewmg of extract, add tin 
and thionyl chloride and heat 
in water bath 
Purple colour indicates presence of 
tritepenoids. 
 
4 Test for steroids:An 
ethonolic  extract  of plant 
sample 2ml is mixed with  2 
ml H2SO4 and 0.5 gm Acetic 
anhydride 
The solution turns in to blue to 
green colour 
Presence  of 
Steroids 
5 Test for Phenol 
Substance in water is added 
with 5 % alcoholic ferric 
chloride 
.Dark blue or green colour 
shows 
presence of 
phenol 
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6 Test for Tannin 
Substance is shaken with 
water and added with lead 
acetate solution 
White precipitate shows presence of 
tannin. 
 
7 Test for Saponins 
To few mg of extract distilled 
water is added and shaken 
well 
The formation of foam 
indicates 
presence of 
saponin. 
 
 
4.2.4. Chemical analysis : 
Proximate Chemical Analysis of a Drug 
Methodology For Chemcial Analysis 
Preparation of Extract : 
Add 5 gm of the sample to 50ml of distilled water. Boil the solution for 20 minutes, cool 
and then filter. Use the Extract for the following tests. 
S.No Experiment Observation Inference 
1. Test for reducing Sugar : 
To 5ml of Benedicts qualitative reagent, 
add 10 drops of extract, then boil for two 
minutes 
Green / Yellow 
/ Red PPT 
Presence of 
Reducing Sugar 
2. Test for Starch : 
To 5 ml of extract add 2ml of acetic acid 
and then add few drops of N/50 Iodine 
Solution. 
Blue Colour Presence of 
Starch 
3. Test for Proteins : 
To 2 ml of extract, add 2ml of 5% Sodium 
Hydroxide mix and add 2 drops of Copper 
Sulphate Solution. 
Violet or 
Purple Colour 
Presence of 
Proteins 
4. Test for amino Acid : 
Place  2 drops of extract on a filter paper 
and allow to dry well. Then spray 1% 
ninhydrin over the same and allow to dry. 
 
Violet Colour Presence of 
Amino Acid 
34 
 
5. Test for Albumin : 
To 2 ml of extract, add 2ml of Esboch’s 
reagent. 
Yellow PPT Presence of 
Albumin 
6. Test for Phosphate : 
To 2ml of extract, add 2ml of ammonium 
Molybdate solution and 2ml of 
concentrated Nitric Acid. 
Yellow PPT Presence of 
Phosphate 
7. Test for Sulphate : 
To 2 ml of extract add 2ml of 4% 
ammonium oxalate solution. 
White PPT Presence of 
Sulphate 
8. Test for Chloride :  
Add 2ml of extract to dilute nitric acid till 
the effervescence ceases. Then add 2 ml of 
Silver Nitrate Solution. 
Cloudy White 
PPT 
Presence of 
Chloride 
9. Test for Iron : 
To 2ml of extract, add 2ml of ammonium 
thio cynate solution and add 2ml of 
concentrated Nitric Acid. 
Red Colour Presence of Iron 
10. Test for Calcium : 
To 2 ml of extract, add 2 ml of 4% 
ammonium Oxalate Solution. 
White PPT Presence of 
Calcium 
11. Test for Sodium : 
Make a paste with 2 pinches of the sample 
with Hcl and Introduce it into the blue 
flame.  
Yellow Flame Presence of 
Sodium 
12. Test for Potassium : 
Add a pinch of the sample to 2 ml of 
Sodium Nitrate Solution. Then add 2ml of 
Cobal Nitrate in 20% acetic acid. 
Yellow PPT Presence of 
Potassium 
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S.No Experiment Observation Inference 
13. Test for Zinc : 
To 2ml of extract, add few drops of 
Sodium Hydroxide. 
White PPT Presence of Zinc 
14. Test for Magnesium : 
To 2ml of extract, add few drops of 
Sodium Hydroxide Solution 
White PPT Presence of 
Magnesium 
15. Test for Alkaloids : 
a. To 2ml of extract, add 2ml 
of Potassium Iodide Solution 
b. To 2ml of extract add 2ml of 
Picric Acid. 
c. To 2 ml of extract add 2ml 
of Phosphotunqstic Acid. 
 
Red Colour 
 
 
Yellow Colour 
 
White PPT 
 
Presence of 
Alkaloids 
 
Presence of 
Alkaloids 
Presence of 
Alkaloids 
16. Test for Tannic Acid : 
To 2ml of extract add 2 ml of Ferric 
Chloride Solution 
Black PPT Presence of 
Tannic Acid 
 
4.3 PHARMACOLOGICAL STUDY: 
Antimicrobial activity of ilavu ver chooranam 
Introduction: 
 Pathogens are a major concern for a variety of industries—food, human and 
animal health, and plant. Foodborne illnesses are a continuous threat to public health. 
The 31 major foodborne pathogens account for nearly 9.4 million people becoming sick, 
more than 55,961 hospitalizations, and 1,351 deaths from foodborne illness each year in 
the United States with an estimated economic cost of $152 billion annually. Further, 
losses in major crops due to fungal and bacterial pathogens ranges from 7-22%, with 
losses reported for potatoes (22%), wheat (16%), rice (16%), barley (15%), maize (10%), 
cotton (9%), sugar beet (8%), and soybeans (7-16%). There are many methods of 
inhibiting or inactivating microorganisms, however, interest in the use of natural plant- 
derived products versus chemicals as antimicrobials is increasing significantly, including 
their use in the protection of foods and crops.  
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 Further, various bacteria have developed resistance to certain antibiotics, and 
thus, other forms of bactericidal agents are required. India is a land of rich biodiversity. 
The total number of lower and higher plants in India is about 45,000 species. The plants 
are potential source of medicines since ancient times. According to World Health 
Organization, 80% of the populations in the world depend on traditional medical 
practitioners for their medicinal needs. Many formulations of plants and their products 
such as medicines are said in the form of hymns in the Vedas. Yet a scientific study of 
plant to determine their anti-microbial material is comparatively new. 
  Numerous surveys on antimicrobial medicinal plants had been made in United 
States and in many countries throughout the world. Since ancient times, plants have been 
model source of medicines as they are a reservoir of chemical agents with therapeutic 
properties. The general population is increasingly using herbal medicines as dietary 
supplements to relieve and treat many different human disorders. Herbs and spices are an 
important part of the human diet. They have been used for thousands of year to enhance 
the flavour, colour and aroma of food. In addition to boosting flavour, herbs and spices 
are also known for their preservative and medicinal value, which forms one of the oldest 
sciences. Yet it is only in recent years that modern science has started paying attention to 
the properties of spices.  
 Medicinal and spice plants are renewable raw materials. Their production is an 
alternative to the overproduction of traditional crops in agriculture. They also have an 
increasing economic importance. For thousands of years, plants have been used as a rich 
source of bioactive compounds. Plants are continually attacked by a multitude of 
pathogens and have adapted natural defense mechanisms which protect them from 
developing disease.   
Materials and methods: 
Antimicrobial assay-Isolation and maintenance of cultures 
 Esherichia coli and Bacillus subtilis were extracted from food stuffs by serial 
dilution agar plate method. In this method, serial dilutions of samples obtained from food 
stuffs were prepared and aliquots from each dilution were added to the plates containing 
nutrient agar to allow the growth of microbes. All the bacterial isolates were identified by 
cultural, morphological biochemical characteristics (Gram and endospore staining). The 
plates were kept in an incubator at 37ºC. The slants were prepared from the pure cultures 
obtained and kept in the refrigerator at 40C for further use. 
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Standardization of inoculums: 
 The microbial inoculum was standardized at 0.5 McFarland. In microbiology, 
McFarland standards are used as a reference to adjust the turbidity of bacterial 
suspensions so that the number of bacteria will be within a given range. Original 
McFarland standards were made by mixing specified amounts of barium chloride and 
sulfuric acid together. Mixing the two compounds forms a barium sulfate precipitate, 
which causes turbidity in the solution. A 0.5 McFarland standard is prepared by mixing 
0.05 ml of 1.175% barium chloride dihydrate (BaCl2•2H2O), with 9.95 ml of 1% sulfuric 
acid (H2SO4). The standard could be compared visually to a suspension of bacteria in 
sterile saline or nutrient broth. 
Antibacterial Activity: 
 The antibacterial activity was determined using the hole-in-plate bio assay 
procedure. The pure cultures of the microorganisms were inoculated onto Muller-Hilton 
nutrient broth incubated at temperature of 37°C for 24 hours. Using a sterile cork-borer 
of 5mm diameter, three holes were made into the Petri dishes seeded with bacterial 
culture. Concentrations of 25, 50 and 100µg/ml solution were reconstituted in distilled 
water and transferred into the wells. The plates were incubated at temperature of 37°C for 
18 hours. S. aureus, E. coli, Salmonella typhi, P.aurigunosa, St. pyogenes, Neigerria 
gonorrhea, St. sapro, S. pneumococci, Klebsieela pneumoneae and Candida albicans 
were used as the test microorganisms. All microbial cultures were maintained on nutrient 
agar slants at temperature of 4ºC and sub cultured onto nutrient agar broth for 24 hours 
prior to testing.  
 The plates were kept for 30 min at room temperature to allow diffusion of the test 
drug, and then were incubated at temperature of 37º C for 18 hours. After the incubation 
period, the zones of inhibition will be measured using a caliper. Studies were performed 
in triplicates and the mean value was calculated. The mean zones of inhibitions were 
compared by one way analysis of variance.  
Agar well diffusion method: 
 Antibacterial activity of spices was tested using agar well diffusion method. 200μl 
of bacteria was aseptically introduced and spread using cotton swabs on surface of gelled 
sterile Muller Hilton agar plates. A well of about 6.0mm diameter with sterile cock borer 
was aseptically punched on each agar plate. 50μl of the IVC were introduced into the 
wells in the plates. A negative control well was too made with 50μl of the sterile distilled 
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water. Plates were kept in laminar flow for 30 minutes for pre diffusion of IVC to occur 
and then incubated at 37ºC for 24 hours. Resulting zone of inhibition was measured. 
             For determination of antimicrobial activity of three doses of IVC, different 
bacterial and fungal strains were used by agar ditch method. The pathogenic cultures 
were swabbed separately in each air dried pre-incubated Nutrient Agar and Sabouraud 
Dextrose Agar plates with help of sterile cotton swabs. Ditches were prepared in agar 
plates with the help of surface sterilized borer. After boring the plant extract were added 
separately to the ditches (50µl). 
 The plates were incubated at 370C. Controls were maintained. After 24 h diameter 
of clear zone produced around the ditches were measured to the nearest mm with the help 
of the micro scales. 
4.4  CLINICAL ASSESSMENT: 
Leucorrhoea is one among the common ailments affecting women.  It may be due 
to various causes.  It is a very common presenting disease in general practice.  It is a 
physical, social and  emotional  problem in the prime time of a woman’s life. Most of the 
organisms can infect the female genital tract and totally account for considerable 
suffering. As the above mentioned problem generally prevails among the women. Even 
though there is a lot of medications available for this disease, still there is a thrive for less 
adverse effect drugs. Herbal medicines are playing vital role on curing diseases without 
marked adverse effects even though on long term intake. From this plant kingdom I have 
selected this herb which proved its anti – microbial activity pre clinically. Ilavu Ver 
chooranam, a herbal medicine was used for this clinical trial to prove its safety and 
efficacy against  Leucorrhoea. 
Objectives: 
 The study was conducted on peptic leucorrhoea patients to assess the “anti-
microbial” activity of  “Ilavu Ver Chooranam  ” clinically, both in-patients and out-
patients of both sex and varying age groups.  
Study centre: 
 The clinical study for leucorrhoea  is carried out in outpatient department and in 
patient ward of Govt.Siddha medical college hospital and Arignar Anna  Indian Hospital, 
Arumbakkam, Chennai-106. 
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Design of the study: 
Open clinical trial, phase II B  
Selection : 
 50 patients from women in the age group of 20 – 50 years were chosen.  The 
selection was based on the including and excluding criteria.  They were clinically 
diagnosed on the basis of Siddha principles with modern laboratory findings. 
Registration process 
To register a patient, the following documents has been proceeded. 
¾ Copy of required laboratory tests 
¾ Signed patient consent form 
 then  I verified  eligibility and assigned  a patient study number, drug dose and registered 
the patient on the study. 
Criteria selection: 
Inclusion criteria: 
i) Excessive Watery Discharge 
ii) Yellowish discharge 
iii) Mucoprulent discharge 
iv) Itching in vulva 
v) Low back pain 
vi) Lower abdominal pain 
vii) Dysuria 
viii) Trichomonas  vaginalis 
ix) Candida albicans 
Exclusion criteria: 
i) White discharge with bleeding 
ii) Malignancy condition 
iii) Pelvic inflammatory disease 
iv) Pregnancy 
v) Gonorrhoeal disease 
vi) Sexually transmitted disease 
vii) Any other systemic disorder 
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Criteria for withdrawal: 
Patients were removed from study when any of the criteria listed below applies.In the 
absence of treatment delays due to adverse events, treatment may continue for 2 cycles or 
until one of the following criteria applies: 
¾ Disease progression, 
¾ Deterioration of vital signs with cardiac, respiratory, hepatic, renal and CNS 
changes. 
¾ Intercurrent illness that prevents further administration of treatment, 
¾ Unacceptable adverse event(s), 
¾ Patient decides to withdraw from the study, or  
¾ General or specific changes in the patient’s condition render the patient 
unacceptable for further treatment in the judgment of the investigator. 
Investigation: 
 The patients were undergone routine blood, urine and ultra sonogram for 
abdomen.  Vaginal smear was done in private laboratory. 
 The duration of  treatment ranges between 7-8 weeks according to the severity  of 
symptoms.  Clinical investigations were done before and after treatment. 
Administration of the drug: 
Form of the medicine  : Chooranam 
Route of Administration : Enteral 
Dose    : 1 gm 
Anubanam (Vehicle)  : Warm water 
Times of Administration : Two times a day; after food. 
Duration     : 7 Weeks 
Diet and medical advice: 
• Advise regarding personal hygiene 
• Avoidance of synthetic garments 
• Finger nails should be clipped short. 
• Avoidance of contamination of vulva with ablution water after bowel action. 
• Improving general health by advising to take adequate vegetables. 
• The partners should also be enquired for infection and advised for treatment. 
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Trial conduct: 
This study will be conducted in compliance with the protocol approved by 
the Institutional Review Board, and according to Good Clinical Practice 
standards. No deviation from the protocol will be implemented without the prior 
review and approval of the IRB except where it may be necessary to eliminate an 
immediate hazard to a research subject. In such case, the deviation will be 
reported to the IRB as soon as possible. 
Criteria for assessment of response to therapy: 
1. Good Response: 
 a.  Relief of symptoms above 75%. 
2. Fair Response: 
 a.   50 % to  70 %  relief in symptoms. 
3. Poor Response: 
25 % to  49%  relief  in symptoms.  
4. No response: 
Follow up: 
Assessment was taken for every three days before treatment and after treatment. 
During this period clinical assessment and laboratory investigation was carried out. 
Statistical analysis: 
The data will be tabulated and analyzed by students ‘T’ test. The resuls are 
showed in Table:6 and 7 
Ethical review: 
The protocol and amendments were submitted to the Govt siddha medical 
college, Institutional Ethical Committee (IEC) and got formal approval for conducting 
the study. The decision of the IEC concerning the conduct of the study was made in 
writing to the investigator. 
All  subjects  for  this  study  was  provided  a  consent  form  describing  this  study and 
provided  sufficient  information for  subjects  to  make an informed decision about their 
participation in this study. This consent form was submitted with the protocol for review 
and  approval by the  IEC.  The formal  consent of  a subject,  using the  IEC - approved 
consent form, was obtained before that subject is submitted to any study procedure. This 
consent  form  was signed  by  the subject  or  legally acceptable  surrogate,  and  the 
investigator-designated research professional obtaining the consent.
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CLINICAL STUDY ON “ILAVU VER CHOORANAM” IN INPATIENTS DEPT. IN THE MANAGEMENT OF “VELLAI NOI” 
Sl. 
No 
IP 
No. 
Name 
Age & 
Sex 
Complaints Duration 
of 
treatment 
(in days) 
BT 
& 
AT 
Investigation
Blood Urine
DC (%) ESR 
(mm) 
Hb 
gm 
Sug 
(R) 
Mg/
dl 
 
TC 
cells/ 
Cum
m 
P% L 
% 
E 
% 
½ 
hr 
1 
hr 
Al Su
g 
Dep Vaginal 
smear 
VDRL Result 
1. 831/  
936 
Soorya 
35/ F 
Mucopurulent 
discharge, 
itching in vulva, 
lower abdomen 
& low back pain, 
dysuria.  
28.06.2012   
to 
03.08.2012 
BT 10200 57 37 6 11 33 11.5 108 Nil Nil  Few epi 
thelial cells 
seen 
Tv+ve Non-
Reacti
ve  
 
 
Good 
AT 10100 58 39 3 14 26 11.8 100 Nil Nil Nil Tv -ve - 
2. 1072/
6653 
Devi 
38/F 
Excessive 
watery 
discharge, lower 
abdomen pain, 
low back pain.  
20.07.2012 
to  
28.07.2012 
BT 8900 53 40 7 13 34 10.6 110 Nil Nil  Few pus 
cells seen 
Non - 
specific 
Non-
Reacti
ve 
 
Good 
AT 8500 54 39 7 12 18 10.5 114 Nil Nil Nil - - 
3. 1160/
9231 
Devi 
33/F 
Mucopurulent 
discharge, 
itching in vulva, 
lower abdomen 
& low back pain, 
dysuria. 
30.07.2012 
to 
05.08.2012 
BT 9800 60 36 4 14 28 10.9 98 Nil Nil  Few pus 
cells seen 
Tv+ve Non-
Reacti
ve  
 
 
Good 
AT 9900 57 38 5 11 32 11 94 Nil Nil Nil Tv-ve - 
4. 1155/
9011 
Sundari 
40/F 
Mucopurulent 
discharge, 
itching in vulva, 
lower abdomen 
& low back pain, 
dysuria.  
30.07.2012  
to  
09.08.2012 
BT 9700 57 36 7 12 24 11 100 Nil Nil  Few epi 
thelial cells 
seen 
C.albica
ns +ve 
Non-
Reacti
ve  
 
 
 
Mild  
AT 
 
9100 
 
55 
 
 
40 
 
5 
 
10 
 
24 
 
11 
 
114 
 
Nil 
 
Nil 
 
Nil 
C.albica
ns +ve 
- 
5. 1300/
3431 
Miniyamm
al 
35/F 
Mucopurulent 
discharge, 
itching in vulva, 
lower abdomen 
& low back pain,  
17.08.2012 
to           
03.10.2012 
BT 8100 59 39 2 15 36 12 110 Nil Nil  Nil Tv+ve Non-
Reacti
ve  
 
 
Good 
 
AT 
 
8100 
 
53 
 
43 
 
4 
 
12 
 
24 
 
12.5 
 
110 
 
Nil 
 
Nil 
 
Nil 
 
Tv-ve 
- 
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6. 1354/
5569 
Narayani 
40/F 
Mucopurulent 
discharge, 
itching in vulva, 
low back pain, 
dysuria . 
27.08.2012 
to 
03.09.2012 
BT 9100 53 40 7 13 26 9 104 Nil Nil  Few pus 
cells seen 
Tv+ve Non-
Reacti
ve  
 
 
Good 
 
AT 
 
9300 
 
52 
 
43 
 
5 
 
14 
 
36 
 
9.5 
 
110 
 
Nil 
 
Nil 
 
Nil 
 
Tv-ve 
- 
7. 1428/
7477 
Magathun 
bi 
39/F 
Mucopurulent 
discharge, 
itching in vulva, 
lower abdomen 
& low back pain, 
dysuria  
04.09.2012 
to 
15.09.2012 
BT 9700 54 40 6 15 30 11.5 98 Nil Nil  Nil Tv+ve Non-
Reacti
ve  
 
 
Good 
 
AT 
 
9000 
 
56 
 
40 
 
4 
 
10 
 
26 
 
11.5 
 
98 
 
Nil 
 
Nil 
 
Nil 
 
Tv-ve 
- 
8. 146/  
3822 
Fathima 
41/F 
Mucopurulent 
discharge, 
itching in vulva 
& low back pain, 
dysuria.  
01.10.2012 
to 
12.10.2012 
BT 10100 57 38 5 14 36 11 105 Nil Nil  Few pus 
cells seen 
Tv+ve Non-
Reacti
ve  
 
Good 
 
AT 
 
10200 
 
54 
 
43 
 
3 
 
15 
 
42 
 
11.5 
 
105 
 
Nil 
 
Nil 
 
Nil 
 
Tv-ve 
- 
9. 224/  
6423 
Rabekha 
39/F 
Mucopurulent 
discharge, 
itching in 
vulva,low back 
pain, dysuria.  
11.10.2012 
to 
12.11.2012 
BT 9500 54 39 7 16 32 11.6 101 Nil Nil  Few pus 
cells seen 
Tv+ve Non-
Reacti
ve  
 
Good 
 
AT 
 
9700 
 
56 
 
37 
 
7 
 
11 
 
24 
 
12 
 
106 
 
Nil 
 
Nil 
 
Nil 
 
Tv-ve 
- 
10. 540/  
6355 
Lakshmi 
39/F 
Mucopurulent 
discharge, 
itching in vulva, 
low back pain, 
dysuria  
28.11.2012 
to 
06.12.2012 
BT 9500 54 40 6 17 34 12 114 Nil Nil  Nil Tv+ve Non-
Reacti
ve  
 
Good 
 
AT 
 
9500 
 
55 
 
43 
 
2 
 
15 
 
30 
 
11.5   
 
100 
 
Nil 
 
Nil 
 
Nil 
 
Tv-ve 
- 
 
ABBREVATION : 
BT - Before Treatment TC – Total count 
AT - After Treatment  DC – Differential count 
     P – Polymorphs 
     L – Lymphocytes 
     E – eosinophil 
      
  
ESR – Erythrocyte sedimentation rate 
Hb – Haemoglobin 
Al – Albumin 
Sug – Sugar 
Dep – Deposits 
VDRL – Venereal disease research 
Laboratory.  
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CLINICAL STUDY ON “ILAVU VER CHOORANAM” IN OUT-PATIENTS DEPT. IN THE MANAGEMENT OF “VELLAI NOI” 
Sl. 
No 
OP. 
No. 
Name 
Age & 
Sex 
Complaints Duration 
of 
treatment  
(in days) 
BT 
& 
AT 
Investigation
Blood Urine
DC (%) ESR 
(mm) 
Hb  
gm 
Sug 
(R) 
mg/
dl 
 
TC 
cells/ 
Cumm 
P
% 
L 
% 
E 
% 
½ 
hr 
1 
hr 
Al Sug Dep Vaginal 
smear 
VDRL Result 
1. 2957 Bhavani 
29/F 
Excessive watery 
discharge, lower 
abdomen pain, 
low back pain. 
06.07.2012 
to 
17.08.2012 
BT 10200 52 41 7 12 24 10.6 83 Nil Nil  Few epi 
thelial cells 
seen 
Non- 
specific 
Non-
Reactiv
e  
 
Good 
AT 10100 54 43 3 11 20 11.2 90 Nil Nil Nil - - 
2. 3866 Geetha 
34/F 
Mucopurulent 
discharge, itching 
in vulva, lower 
abdomen pain, 
low back pain, 
dysuria. 
10.07.2012 
To 
19.08.2012 
BT 8200 55 39 6 5 13 10.2 83 Nil Nil  Few puscells 
seen 
 
- 
Non-
Reactiv
e 
 
 
Good 
AT 8100 57 38 5 9 18 11.5 90 Nil Nil Nil - - 
3. 785 Elizabath 
354F 
Muco prulent 
discharge, Itching 
in vulva, lower 
abdomen and low 
back pain, 
dysuria. 
10.07.2012 
to 
20.08.2012 
BT 9200 55 42 3 5 9 10.5 105 Nil Nil  Few puscells 
seen 
Tv+ve Non-
Reactiv
e  
 
Good 
AT 9000 53 42 5 6 12 10 100 Nil Nil Nil Tv-ve - 
4. 5423 Eswarii  
35/F 
Excessive watery 
discharge, low 
back pain, lower 
abdomen pain. 
12.07.2012 
to 
23.08.2012 
BT 8100 54 43 3 15 30 11.5 105 Nil Nil  Few puscells 
seen 
Non -
specific 
Non-
Reactiv
e  
 
 
Mild 
AT 8400 54 41 5 11 23 11.6 108 Nil Nil Nil - - 
5. 3629 Sheela 
34/F 
Mucopurulent 
discharge, Itching 
in vulva, dysuria. 
14.07.2012 
to 
26.08.2012 
BT 8700 58 37 5 16 32 10 89 Nil Nil Few pus cells 
seen 
Tv+ve Non-
Reactiv
e  
 
 
Good 
AT 8500 56 40 4 8 20 10.5 94 Nil Nil Nil Tv-ve - 
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6. 5480 Vanaja  
31/F 
Mucopurulent 
discharge, Itching 
in vulva, low back 
pain, dysuria. 
16.07.2012 
 to  
28.08.2012 
BT 9000 54 42 4 12 38 12.4 88 Nil Nil Few pus cells 
seen 
Tv+ve Non 
Reactiv
e 
 
 
Mode
rate AT 9200 52 43 5 14 30 12 90 Nil Nil Nil Tv+ve - 
7 3287 Sumathy 
36/F 
Mucopurulent 
discharge, Itching 
in vulva, low back 
pain,  dysuria. 
19.07.2012 
To 
 
01.09.2012 
BT 9700 60 36 4 16 30 10.6 85 Nil Nil Few pus Cells 
seen 
c.albica
ns+ve 
Non 
Reactiv
e 
 
 
 
Mild AT 9400 56 37 7 10 29 10.8 90 Nil Nil Nil c.albica
ns+ve 
- 
8. 2652 Sowmia  
35/F 
Mucopurulent 
discharge, Itching 
in vulva, low back 
pain, dysuria. 
22.07.2012 
to  
04.09.2012 
BT 9400 53 44 3 15 32 11 102 Nil Nil Few pus Cells 
seen 
Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 9000 52 43 5 12 22 11.6 98 Nil Nil Nil Tv-ve - 
9. 986 Padhmav
athy 
40/F 
Mucopurulent 
discharge, Itching 
in vulva, low back 
pain, dysuria. 
27.07.2012 
to  
07.09.2012 
BT 8900 53 41 6 12 28 9.8 90 Nil Nil Few pus Cells 
seen 
Tv+ve Non 
Reactiv
e 
 
 
 
Good AT 8500 57 41 2 9 26 10.2 98 Nil Nil Nil Tv-ve - 
10. 3524 
 
Sharmila 
25/F 
Mucopurulent 
discharge, Itching 
in vulva, lower 
abdomen pain,  
dysuria. 
03.08.2012 
 to  
15.09.2012 
BT 9300 57 39 4 5 18 11.6 84 Nil Nil Few pus Cells 
seen 
Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 9100 55 39 6 5 16 11.5 90 Nil Nil Nil Tv-ve - 
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11. 4821 Vidhya 
26/F 
Mucopurulent 
discharge, Itching 
in vulva, low back 
pain, dysuria. 
07.08.2012 
 to  
19.09.2012 
BT 8100 53 40 7 9 22 11.6 84 Nil Nil Few pus Cells 
seen 
Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 8700 54 41 5 5 16 11 90 Nil Nil Nil Tv-ve - 
12. 3249 Kalpana 
35/F 
Excessive watery 
discharge, low 
back pain, lower 
abdomen pain. 
14.08.2012 
to  
25.09.2012 
BT 10300 55 39 6 7 16 10.4 116 Nil Nil Few pus Cells 
seen 
Non- 
specific 
Non 
Reactiv
e 
 
 
Good 
AT 10200 56 37 7 8 22 11.5 110 Nil Nil Nil - - 
13. 1267 Renuga 
devi 
39/F 
Mucopurulent 
discharge, Itching 
in vulva, low 
abdomen pain, 
low back pain. 
23.08.2012 
to  
04.10.2012 
BT 9300 57 36 7 11 24 11 98 Nil Nil Nil Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 9100 56 39 5 12 26 11.5 90 Nil Nil Nil Tv-ve - 
14. 7812 Hema 
27/F 
Mucopurulent 
discharge, Itching 
in vulva, low back 
& low abdomen 
pain, dysuria 
05.09.2012 
to  
14.10.2012 
BT 7900 56 39 5 8 16 9.5 98 Nil Nil Few pus Cells 
seen 
Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 7700 53 43 4 7 14 10.5 99 Nil Nil Nil Tv-ve - 
15. 8466 Uma 
mahesw
ari 
26/F 
Mucupurulent 
discharge, Itching 
in vulva, low back 
pain, dysuria. 
08.09.2012 
to 
21.10.2012 
 
BT 7300 57 37 6 10 19 9.5 110 Nil Nil Few pus Cells 
seen 
Tv+ve Non 
Reactiv
e 
 
Mode
rate 
AT 7700 56 39 5 8 15 9.8 108 Nil Nil Nil Tv+ve - 
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16. 8771 Jothy 
27/F 
Excessive watery 
discharge, lower 
abdomen pain, 
low back pain.  
10.09.2012 
to 
 
21.10.2012 
BT 8500 53 41 6 12 26 10.6 102 Nil Nil Nil  Non-
specific 
Non 
Reactiv
e 
 
 
Good 
AT 8600 57 41 2 10 22 10.8 112 Nil Nil Nil - - 
17. 7569 Sangeet
ha 
32/F 
Mucopurulent 
discharge, low 
back pain, Itching 
in vulva, dysuria. 
13.09.2012 
to  
25.10.2012 
BT 9400 56 37 7 13 26 11 108 Nil Nil Few pus 
Cells seen 
Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 9700 54 42 4 12 22 11.4 98 Nil Nil Nil Tv-ve - 
18. 3548 Gomathy 
36/F 
Mucopurulent 
discharge, Itching 
in vulva, lower 
abdomen pain, 
dysuria. 
16.09.2012 
to  
27.10.2012 
BT 9400 54 41 5 14 34 11.6 106 Nil Nil Few 
epithelial 
cells  
Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 9100 54 42 4 13 20 12 105 Nil Nil Nil Tv-Ve - 
19. 5821 Subathra
devi 
34/F 
Mucopurulent 
discharge, Itching 
in vulva, dysuria. 
21.09.2012 
 to 
01.11.2012 
BT 9000 55 39 6 18 34 8.6 112 Nil Nil Few pus 
Cells seen 
Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 9100 58 40 2 10 24 9.6 110 Nil Nil Nil Tv-ve - 
20. 2533 Dhana 
lakshmi 
37/F 
Mucopurulent 
discharge, Itching 
in vulva, low back 
pain, dysuria. 
25.09.2012 
to 
06.11.2012 
 
 
BT 8300 51 43 6 10 20 10 94 Nil Nil Few pus 
Cells seen 
Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 8600 55 42 3 12 20 10.2 98 Nil Nil Nil Tv-ve - 
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21. 983 Lakshmi 
39/F 
Mucopurulent 
discharge, Itching 
in vulva, low back 
pain, dysuria. 
03.10.2012 
to 
12.11.2012 
 
BT 8700 55 42 3 12 32 10.6 100 Nil Nil Few pus 
Cells seen 
Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 8900 55 40 5 8 24 10.8 110 Nil Nil Nil Tv-ve - 
22. 6547 Meena 
33/F 
Mucopurulent 
discharge, low 
back pain, Itching 
in vulva. 
07.10.2012 
to  
19.11.2012 
BT 8200 55 39 6 15 32 9.8 110 Nil Nil Few pus 
Cells seen 
C.albico
ns +ve 
Non 
Reactiv
e 
 
 
Mild 
AT 8000 54 42 4 11 22 9 105 Nil Nil Nil C.albico
ns +ve 
- 
23. 5791 Kanimoz
hi 
25/F 
Excessive watery 
discharge, lower 
abdomen pain, 
low back pain. 
09.10.2012 
to  
21.11.2012 
BT 9700 60 33 7 16 32 10.6 92 Nil Nil Few pus 
Cells seen 
Non-
specific 
Non 
Reactiv
e 
 
 
Good 
AT 9900 59 35 6 11 24 10.5 98 Nil Nil Nil - - 
24. 6744 Chithra 
30/F 
Mucopurulent 
discharge, Itching 
in Vulva. low back 
pain. dysuria.  
10.10.2012 
 to  
23.11.2012 
BT 8300 56 39 6 12 32 10.8 90 Nil Nil Nil Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 8800 54 42 4 8 16 11 86 Nil Nil Nil Tv-ve - 
25. 6087 Bhuvane
swari 
24/F 
Excessive watery 
discharge, lower 
abdomen pain, 
low back pain. 
10.10.2012 
to 
22.11.2012 
BT 10300 58 38 4 12 36 10.6 84 Nil Nil Nil  Non- 
specific 
Non 
Reactiv
e 
 
 
Good 
AT 10000 54 43 3 12 24 11 96 Nil Nil Nil - - 
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26. 6387 Hilda 
mary 
22/F 
Excessive watery 
discharge, lower 
abdomen pain, 
low back pain. 
11.10.2012 
to 
 
23.11.2012 
BT 9200 56 40 4 20 36 10.5 98 Nil Nil Few pus 
Cells seen 
Non-
specific 
Non 
Reactiv
e 
 
 
Good 
AT 9000 57 41 2 13 26 10 86 Nil Nil Nil - - 
27. 7811 Manjula 
33/F 
Mucopurulent 
discharge, Itching 
in Vulva, lower 
abdomen & low 
back pain, 
dysuria.  
17.10.2012 
to  
28.11.2012 
BT 9700 55 39 6 18 32 11.6 112 Nil Nil Few pus 
Cells seen 
Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 9200 56 40 4 9 22 11.5 110 Nil Nil Nil Tv-ve - 
28. 5213 Kala 
42/F 
Mucopurulent 
discharge, Lower 
abdomen pain, 
low back pain, 
dysuria.  
24.10.2012 
to 
05.12.2012 
BT 7700 52 41 7 12 24 9.6 108 Nil Nil Few pus 
Cells seen 
Tv+ve Non 
Reactiv
e 
Mode
rate 
AT 7900 52 42 5 10 16 9 112 Nil Nil Nil Tv+ve - 
29. 344 Jothy 
lakshmi 
29/F 
Mucopurulent 
discharge, Itching 
in Vulva, low back 
pain, dysuria.  
31.10.2012 
to 
 
11.12.2012 
BT 9800 60 34 6 14 32 11.4 102 Nil Nil Nil Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 9100 58 38 4 14 24 11 100 Nil Nil Nil Tv-ve - 
30 315 Aanandhi 
35/F 
Mucopurulent 
discharge, Itching 
in Vulva, low back 
pain, dysuria.  
31.10.2012 
to  
13.12.2012 
BT 10200 55 39 6 10 20 10.5 98 Nil Nil Few pus 
Cells seen 
Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 10100 52 43 5 8 16 10.8 90 Nil Nil Nil Tv-ve - 
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31. 597 Nithya 
25/F 
Mucopurelnt 
discharge, itching 
in vulva, low back 
pain, dysuria. 
01.11.2012 
to 
09.12.2012 
 
BT 7300 53 41 6 15 30 11 90 Nil Nil Few pus 
Cells seen 
C.albica
ns +ve 
Non 
Reactiv
e 
 
 
Mild 
AT 7100 53 40 7 8 16 11.5 94 Nil Nil Nil C.albica
ns +ve 
- 
32. 602 Uma 
24/F 
Mucopurulent  
discharge, Itching 
in vulva, low back 
pain, dysuria.  
01.11.2012 
to 
08.12.2012 
 
BT 9900 52 38 9 14 34 10 98 Nil Nil Few pus 
Cells seen 
Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 9400 54 43 3 7 14 10.6 94 Nil Nil Nil Tv-ve - 
33. 1258 Vasanthi 
40/F 
Excessive watery 
discharge, lower 
abdomen and low 
back pain. 
03.11.2012 
to 
09.12.2012 
 
BT 9300 57 37 6 9 18 11 90 Nil Nil Few pus 
Cells seen 
Non - 
specific 
Non 
Reactiv
e 
 
 
Good 
AT 9500 57 41 2 10 24 10.8 98 Nil Nil Nil - - 
34. 138 Shanthi 
40/F 
Mucopurulent 
discharge, 
Itchingin vulva, 
low back pain, 
dysuria. 
05.11.2012 
to 
10.12.2012 
 
BT 10200 55 39 6 15 30 10.4 90 Nil Nil Few 
epithelial  
Cells seen 
Tv+ve Non 
Reactiv
e 
 
 
Mode
rate AT 10200 56 42 2 12 22 10.6 84 Nil Nil Nil Tv+ve - 
35. 1390 Vasumat
hy 
35/F 
Mucopurulent 
discharge, Itching 
in vulva, low back 
pain, dysuria. 
05.11.2012 
to 
12.12.2012 
BT 9700 61 34 5 9 18 11.2 102 Nil Nil Few pus 
Cells seen 
Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 9200 58 40 2 11 26 10.8 110 Nil Nil Nil Tv-ve - 
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36. 1378 Malliga  
35/F 
Excessive watery 
discharge, lower 
abdomen pain, 
low back pain. 
05.11.2012 
to 
11.12.2012 
 
BT 8200 53 39 8 12 26 8.6 92 Nil Nil Few pus 
Cells seen 
Non- 
specific 
Non 
Reactiv
e 
 
 
Good 
AT 8100 56 40 4 8 16 8.5 98 Nil Nil Nil - - 
37. 1376 Sumathi 
24/F 
Mucopurelnt 
discharge, itching 
in vulva, lower 
abdomen pain, 
low back pain, 
dysuria.  
05.11.2012 
to 
11.12.2012 
BT 8400 51 44 5 20 40 10 110 Nil Nil Nil Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 8600 51 44 5 11 22 10.6 100 Nil Nil Nil Tv-ve - 
38. 1679 Ramani 
35/F 
Mucopurelnt 
discharge, itching 
in vulva, low back 
pain, dysuria.  
06.11.2012 
to 
 
15.12.2012 
BT 10000 56 38 6 12 24 10.8 110 Nil Nil Few pus 
Cells seen 
Tv+ve Non 
Reactiv
e 
 
 
Good 
AT 10300 53 44 3 8 22 11 104 Nil Nil Nil Tv-ve - 
39. 1931 Sundari 
35/F 
Mucopurelnt 
discharge, itching 
in vulva, low back 
pain, dysuria.  
07.11.2012 
to 
17.12.2012 
BT 9200 52 42 6 14 28 11.6 110 Nil Nil Few pus 
Cells seen 
Tv+ve Non 
Reactiv
e 
 
 
Mode
rate AT 9600 52 45 3 12 26 11 100 Nil Nil Nil Tv+ve - 
40. 1933 Malathy     
37/F 
Excessive watery 
discharge, low 
back pain, lower 
abdomen pain. 
07.11.2012 
to 
16.12.2012 
 
BT 9200 52 40 8 15 34 10 96 Nil Nil Few pus 
Cells seen 
Non-
specific 
Non 
Reactiv
e 
 
 
 
Good AT 9600 53 43 4 8 14 10.5 90 Nil Nil Nil - - 
 
ABBREVATION: 
BT - Before Treatment TC – Total count 
AT - After Treatment  DC – Differential count 
     P – Polymorphs 
     L – Lymphocytes 
     E – eosinophil 
      
 
 
ESR – Erythrocyte sedimentation rate 
Hb – Haemoglobin 
Al – Albumin 
Sug – Sugar 
Dep – Deposits 
VDRL – Venereal disease research 
Laboratory.  
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Clinical assessment: 
The observation regarding: 
¾ Age variation 
¾ Occupational status 
¾ Socio economic status 
¾ Signs and symptoms during admission 
AGE DISTRIBUTION 
Table No. : 4.4.1 
Age group No of cases Percentage 
21-30 14 28% 
31-40 34 68% 
41-50 2 4% 
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Inference: 
  Among 50 patients,  
• 28% of the patients belong to the age group 21-30 
• 68% of the patients belong to the age group 31-40 
• 4% of the patients belong to the age group 41-50 
SOCIO ECONOMIC STATUS 
 
Table No. : 4.4.2 
Socio economic 
status 
No of cases Percentage 
Poor 31 62% 
Middle class 14 28% 
Rich 5 10% 
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Inference: 
  Among 50 patients,  
• 62% of the patients belong to poor category 
• 28% of the patients belong to middle class 
• 10% of the patients belong to rich class. 
 
                                   OCCUPATIONAL STATUS 
 
Table No. : 4.4.3 
Occupation No of cases Percentage 
Daily labour 29 58% 
House wife 13 26% 
Tailor 5 10% 
Teacher 3 6% 
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Inference:  
  Among 50 patients, 
• 26% had  Excessive watery discharge. 
• 76% had Mucopurulent discharge. 
• 72% had Itching in Vulva. 
• 52% had Lower abdomen pain. 
• 62% had Low back pain. 
• 66% had Dysuria. 
5. RESULTS AND DISCUSSION: 
 The word drug itself comes from the Swedish word “drug”, which means  “dried 
plant”. Dried Root powder of Bombax ceiba, (Ilavu Ver chooranam) was taken for its anti 
– microbial activity. This tree is widely distributed to through out the world.This root 
contains rich phytochemicals and abundantly in quantity in root buttresses. So availability 
of this drug always meets the demands for the treatment for the whole year. Here, various 
studies have been carried out in this study drug. The study includes literary collections, 
Pharmacognostic study, physico and Phyto chemical analysis, toxicological study, 
pharmacological study, and clinical study. The drug has been selected for the treatment of 
Leucorrhoea in reference with GUNAPADAM MOOLIGAI VAGUPPU. 
  Literary collections about the drug from various text books were done. It indicates 
the efficacy of the drug in the treatment of Peptic ulcer .Botanical aspect deals with the 
identification description, cultivation and ethno medicinal importance of the plant. 
Gunapadam aspect expressed that the drug possess good anti mirobial property. 
4.2.1. Pharmacognostic aspect of Bombax ceiba : 
Root of bombax ceiba: 
  The root is 4.5 mm thick. It is circular in outline with dark outer zone, wide 
secondary phloem and thick vascular cylinder (Fig 4.2.1.1). The outer most part of the 
root consists of uniformly thick and continuous periderm. It is 100 μm thick (Fig4.2.1.2, 
4.2.1.5 ). The periderm cells are dark and compressed. They are tabular in shape and are 
subcrized. The epidermal layer is broken and obliterated. The cortical zone is not evident. 
The vascular cylinder includes thick secondary phloem cylinder and central thick, solid 
and dense xylem cylinder. 
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The secondary phloem is differentiated into outer, wider zone of collapsed 
phloem and inner, narrow non-collapsed phloem. The collapsed phloem consists of very 
wide, funnel shaped, dilated rays and prominent, conical, segments of phloem fibers and 
sieve elements (Fig 4.2.1.2 ). The dilated rays consists of thin walled, square shaped cells 
arranged in tangential bands. The conical phloem segments have several, tangential 
blocks of fibers alternating with crushed several elements which appear as dark tangential 
lines (Fig 4.2.1.4).The non-collapsed phloem is narrow and has no fiber bands.It consist 
of narrow, non-collopsed phloem  rays ,sieve elements and  parenchyma cells.The cells 
are in parallel lines.secondary  xylem consists of fairly wide, undilated rays and 
several,radial lines of solitary vessels and xylem fibers. The vessels are circular and thin 
walled.The vessels in centre are narrow and those towards the periphery are wider.The 
diameter of the vessels range from 40-200 μm (Fig 4.2.1.2,4.2.1.3 & 4.2.1.7). 
The phloem fibers and vessels elements and xylem fibers have lignified walls (Fig 
4.2.1.6).The primary xylem strands are endarch with exarch protoxylem strands (Fig 
4.2.1.3). 
Legend for the figures :Bombax ceiba. 
Fig 4.2.1.1. T,S. of Root – Entire view  
4.2.1.2 T,S. of Root –A sector enlarged showing periderm,secondary phloem & a part of 
the secondary xylem.(cPh – collapsed phloem ,NCPH –Non –collopsed phloem,pe-
periderm,PhF-phloem fiber,Sx –secondary xylem,ve-vessels) 
Fig 4.2.1.5  periderm zone- Enlarged. 
4.2.1.4 Secondary phloem showing Non-collapsed and collapsed phloem. (cPh- collapsed 
phloem, NCPh- Non- collapsed phloem, pe-periderm, PhF- phloem Fiber). 
Fig 4.2.1.3, Secondary xylem showing thin walled, wide, angular vessels of thick walled 
fiber. ( PX-Proto xylem, ve- vessels, XF-Xylem Fibers, XR-Xylem Ray) 
Fig 4.2.1.7, vessels &Fibers-Enlarged. 
4.2.1.6 Secondary phloem and secondary xylem viewed under polarized light to show the 
lignified cell walls (PhF- Phloem Fiber, SPh- Secondary Phloem, SX-Secondary Xylum, 
Ve- Vessels, XF-Xylum Fiber). 
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\              Fig 4.2.1.1 T.S of root-Entire view  Fig 4.2.1.2 T.S of root- Enlarged section 
        
 
 
               Fig 4.2.1.3 Secondary xylem               .Fig 4.2.1.4 Secondary phloem 
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Fig4.2.1.5 Periderm zone    Fig 4.2.1.6 Secondary phloem &  
         Secondary xylum   
           
 
   
                         
 
 
 
 
 
               Fig 4.2.1.7 Vessels & Fibers 
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4.2.2. Physico-chemical analysis: 
 
                             REPORT OF ILAVU VER CHOORANAM 
Table : 4.2.2.1 
 
S.No Parameter Mean Value 
1. Loss on Drying at 105°C 7.202 % 
2. Total Ash  7.577 % 
3. Acid insoluble Ash   1.026 % 
4. Water Soluble Extractive 9.1 % 
5. Alcohol Soluble Extractive 8.4 % 
6. Particle size Sieve no 44 
7. pH 6.5 
 
Discussion : 
The analytical parameters like that of ash value, loss on drying values, acid 
insoluble ash values were within limits. These mean values are useful us to interpret the 
digestion and solubility capacity of the crude extract. As per the results the tested sample 
contains good percentage of solubility and also digestive capacity.It also indicates the 
purity of the sample. 
PH analysis : 
Optimum pH for growth of Candida albicans is 4 – 5. Since my drug have Ph of 
6.5. The increasing Ph value is more beneficial effect against Candida albicans. 
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4.2.2.2 TLC   Estimation of Ilavu Ver chooranam: 
Figure No.4.2.2.2 
 
 
                                                  After spray with visualizing agent 
Table  : 4.2.2.2 
Sl.No After Dipping in Vanillin-Sulphuric acid 
Rf value Colour of the spot 
1 0.04 Purple 
2 0.20 Grey 
3 0.32 Grey 
4 0.39 Grey 
5 0.43 Yellow 
6 0.47 Grey 
7 0.56 Grey 
8 0.65 Yellow 
11 0.71 Purple 
12 0.76 Purple 
13 0.84 Green 
14 0.89 Pale Blue 
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Thin Layer Chromotography is utilised for accurate identification and adulterant 
of the plant drug.. Identification was effected by observation of spots of identical Rf 
value and about equal magnitude obtained, respectively, with an unknown and a 
reference sample chromatographed on the same plate. The visual comparison of the size 
and intensity of the spots supported in semi-quantitative estimation of plant. 
Standardization of drugs aids in confirmation of identity and determination of 
quality, effectiveness of Ilavu Ver. 
4.2.2. 3  Fourier transform infrared spectroscopy (Ftir ) : 
Ftir results of Ilavu Ver chooranam 
3408.9 cm-1 -  Monomeric -- Alcohols, Phenols  (O – H stretching)
      Hydrogen-bonded -- Alcohols, Phenols   
 2930.8 cm-1 -  Alkyl  ( C-H stretching ) 
 2344.9 cm-1 -  Alkyl  ( C-H stretching ) 
2138.3 cm-1 -  Carboxylic acids    (O-H stretching) 
1636 cm-1 -   Amines    (N-H stretching) 
1438 cm-1 -  Alkanes   (C-H stretching) 
1249.9 cm-1 - Nitro Compounds (NO2 stretching) 
1159.2 cm-1 -  Alcohols, Ethers, Carboxylic acids, Esters (C – O  
stretching) 
1030.7 cm-1 -  Amines (C – N stretching) 
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  4.2.2.4.  Scanning electron microscope (sem): 
                        Figure no 4.2.2.4 
 
Results:  
  SEM picture shows Nano particle (Micro level) size of the sample.  
 Physical properties of known elements and materials can change as their surface 
to area ratio is dramatically increased, i.e. when nanoscale sizes are achieved. These 
changes do not take place when going from macro to micro scale. Changes in physical 
properties such as colloidal properties, solubility and catalytic capacity have been found 
very useful in areas of bioremediation and drug delivery. The extremely small size of 
nanoparticles allows them to penetrate cells and interact with cellular molecules. Due to 
nanoparticle size a low dose of the drug can cure the diseases. 
4.2.3. Qualitative phytochemical analysis: 
Results and discussion 
Table : 4.2.3 
Qualitative Phytochemical Tests 
1. Alkaloids - ve 
2. Flavonoids + ve 
3. Triterpenes + ve 
4. Steroids + ve 
5. Phenol + ve 
6. Tannin + ve 
7. Saponin + ve 
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The qualitative analysis on phyto chemical substance on Ilavu Ver.  Shows 
presence of  Flavonoids, Triterpenoids,  Steroids, Phenol, Tannin and saponin. 
¾ Flavanoids have anti microbial activity (T.P.Tim cushnie – 2005 ) 
¾ Triterpenoids have anti microbial activity ( C. Mutai – 2009 ) 
¾ Phenol have anti microbial (S.O. Salawu – 2011 ) 
¾ Tannin have anti microbial (Min B.R – 2008 ) 
¾ Saponin have anti microbial (Soetan K.O – 2006 ) 
¾ Principle action of Tannin through an astringent effect on Protein, Coagulating it  
to form an insoluble protective membrane on the mucus membrane and inhibits  
secretary.  Processes in the mucus membrane. Astringent  contracts organic tissue  
thus lessening secretion. 
¾ Tannin decreasing vaginal mucous discharge  (Harvey wickes felter,1898 ) 
¾  The synergistic effects of ellagitannins with antibiotics against antibiotic-
resistant bacteria.    is one of the most noticeable antimicrobial activity fo tannins. 
Corilagin and tellimagrandin I markedly potentiated the activity of B-Lactams 
against methicillin-resistant staphylococcus aureus.  Potent anti-human immune 
deficienty virus (HIV) activities were found for the dimeric ellagitannins 
oenotheins, coriariin a and argimoniin. ( Molecules 2011 ). 
¾ Antimicrobial activity of Tannin against multidrug resistant strains fo Escherichia 
coli, Klebsiella Pneumoniae, Candia albicans and ATCC strains of streptococcus 
mutans, staphylococcus aureus, streptococcus bovis, salmonella typhimurium. 
(Johnson M et,al 2012). 
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4.2.4  Chemical Analysis of Ilavu ver chooranam : 
The   bio-chemical analysis of Ilavu Ver chooranam showed the following 
chemicals, Chloride, Iron, Tannin, Zinc and Potassium present. 
¾ Zinc have anti- bacterial activity ( Muhammad Idrees Zaidi et,al.,2012 ) 
¾ Zinc is very important roll on genital infection ( M.S. Cosmell et, al., 1987 ) 
¾ Potassium prevents of female disorders by stimulating hormones. 
4.3. PHARMACOLOGICAL STUDY: 
ANTIMICROBIAL PROPERTY OF ILAVU VER  CHOORANAM 
Results and discussion:  
Conclusion: 
 The antibacterial and antifungal activity of Ilavu Ver Chooranam was tested. For 
the Ilavu Ver Chooranam, the maximum inhibition zone was observed for the fungal 
Candida 10mm at the concentration of 100µg/ml.  
 
Figure no :4.3 
 
                    
 
               Anti –microbial activity 
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4.4. CLINICAL ASSESMENT 
IMPROVEMENT SHOWING SIGNS & SYMPTOMS  BEFORE AND 
AFTER TREATMENT 
Table : 4.4.5                 
 
Signs & 
Symptoms 
No of 
cases 
Before 
No of 
cases 
After 
Improvement Percentatage 
Excessive watery 
discharge 
13 0 13 100% 
Mucopurulent 
discharge 
38 3 35 92% 
Itching in Vulva 36 2 34 94% 
Lower abdomen 
pain 
26 3 23 89% 
Low back pain 31 4 27 87% 
Dysuria 33 2 31 93% 
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Inference: 
 Among 50 patients, 
• 82% of the patients showed Good result. 
• 12% of the patients showed moderate result. 
• 6% of the patients showed mild result. 
 
DESCRIPTIVE STATISTICAL FOR IMPROVEMENT OF  
SIGNS & SYMPTOMS IN VELLAI NOI 
Paired t test calculater : 
P value and statistical significance:  
  The two-tailed P value equals 0.0117 
  By conventional criteria, this difference is considered to be statistically significant.  
Confidence interval: 
  The mean of Group One minus Group Two equals 1.00 
  95% confidence interval of this difference: From 0.34 to 1.66  
Intermediate values used in calculations: 
  t = 3.8730 
  df = 5 
  standard error of difference = 0.258  
 
Table : 4.4.7 
Treatment Signs & Symptoms Mean SD S.E.M. 
Before 6 29.50 9.09 3.71 
After 6 28.50 8.55 3.49 
 
From the table we calculated the descriptive statistic like Mean, S.D & S.E.M of mean 
for the improvement score before and after treatment. 
‘t’ Table : 4.4.8 
t-table SD S.E.M ‘t’ value p value 
Pre Vs post 5 0.258 3.8730 0.0117 
 
 The two tailed “p’ value equals by conventional criteria, this difference is 
considered to very statistically significant. 
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Result : 
 From the above table we got a significant difference  (p<0.05). There was 
significant improvement in the symptoms like excessive watery discharge, mucopurulent 
discharge, itching in vulva, lower abdominal pain, low back pain, dysuria etc. So we 
conclude that there is an improvement between before and after treatment. 
 
6. CONCLUSION 
The Siddha drug “Ilavu ver chooranam” was tested for its efficacy in the 
management of vellai noi in this study. 
The model and study design demonstrates the feasibility of evaluating powdered 
form of  Bombax ceiba ( Ilavu Ver chooranam) in the management of Leucorrhoea 
(Vellai noi) 
The literature reviews along with phytochemical, chemical constituent’s aids in 
justification of drug.Standardisation of tested drug through various physico chemical 
analysis and pharmacognostic study  for quality and acceptability of drug. 
The availability, collection and preparation of the drug is easy and also 
economical. 
  Presence of of flavanoids, Triterpinoids, Steroids, Phenols, Tannin, Saponin.   
helps in treating leucorrhoea because of these promote anti – microbial activity. 
Tannin is powerful astringent. So acts on vaginal mucous membrane thus 
decreasing discharge and also occur anti-microbial activity.  
The trial drug was subjected to  pharmacological, clinical studies were analysed 
and revealed that the trial drug has potent Anti microbial activity. 
The antibacterial and antifungal activity of Ilavu Ver Chooranam was tested. For 
the Ilavu Ver Chooranam, the maximum inhibition zone was observed for the fungal 
Candida 10mm at the concentration of 100µg/ml.  
The clinical study showed improvement in the symptoms like excessive watery 
discharge, mucopurulent discharge, itching in vulva, lower abdominal pain, low back 
pain, dysuria etc. The results were found to be good in 82% of patients, moderate in 12% 
of patients and mild in 6% of patients.  . Statistical analysis shows p value < 0.05 which 
is considered very statistically significant. 
All the above studies have proved that the trial drug Ilavu ver has potent Anti-
microbial activity and also effective in the treatment of Vellai. 
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7.SUMMARY 
 
The herb Ilavu Ver was collected from Varasa naadu, Theni (Dt) and purified 
then powered and stored. This drug was subjected to various studies by the author. 
Ilavu Ver Chooranam was selected for this study to evaluate the  Anti – microbial 
activity, and to prove its efficacy and safety in Leucorrhoea.  
 The trial drug has got more literature evidence for its efficacy in the Leucorrhoea. 
The Ilavu Ver chooranam was subjected to various process of investigations like 
pharmacognostic study phytochemical, chemical and physio-chemical analysis to report 
the creditability of drug 
The pharmacological analysis showed that the drug has got significant Anti 
microbial activity. 
The clinical study showed improvement in the symptoms like excessive watery 
discharge, mucopurulent discharge, itching in vulva, lower abdominal pain, low back 
pain, dysuria etc. The results were found to be good in 82% of patients, moderate in 10% 
of patients and mild in 8% of patients.   
Bombax ceiba  ( Ilavu Ver chooranam ) will be  significantly safe and  highly 
effective for Leucorrhoea ( Vellai noi ). 
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1.INTRODUCTION 
 
Siddha system of science is the most effective, valuable system for the human 
beings in all occasions without any side effects.  
 Siddhars goal is spiritual and holistic approach. This art comprises the four main 
branches vaadham, vaithyam, yogam and gnanam. According to these branches the 
service to humanity is not only preventive and treatment but also the way of longevity 
and better life style. 
Nowadays WHO says that the definition for health is physical, mental, social well 
being. But our siddhars know the art of better well being through kayakarpam. 
In Siddha aspect : 
Classification of  disease based upon  : 
Causes,  Symptoms,  Treatment method 
Diagnosis of disease based upon ; 
Naadi,  Envagaithervu,  Neer kuri, Nei kuri 
Treatment is based upon 5 properties of the drugs : 
Suvai (Taste), Gunam (character),Veeriyam (Potency ),                                   
Privu (Class ),Mahimai (Action ). 
Siddhars classified the total diseases in human body according to the literature  
“Agathiyar rathina churukka naadi” as 4448 diseases. 
Gunmam is 8 types under these classification. The aetiology, types and clinical 
features of gunmam are mentioned in “Yugi chinthamani”. 
Gunmam as explained by great siddhars, has clinical symptoms as like that of 
acid peptic disorders (APD ). 
Peptic ulcer is one of the most important gastro intestinal disorder. It is caused by 
irregular food habits, NSAIDS, helicobacter pylori, infection, chronic alcohol 
consumption, smoking, anxiety, emotional stress. 
It occurs by a lack of equilibirium between the gastric destruction factors (Acid, 
Pepsin) and the protective factors (Mucus and Bicarbonate). 
In modern world gastro intestinal disorders are the universal problem. Because 
people are getting too much stress in the modern life style and they are also eating fast 
foods which contains spices and preservatives. 
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10% of the population will some time during life develop peptic ulcer disease. It 
is common among women 9.5% as among men 10.5% . Duodenal ulcer are most frequent 
individuals 30 to 55 years of age. In the general population 20-50% are infected with H. 
pylori, the prevalence increases with age. 15-20% of the infected individuals will develop 
peptic ulcer. 
Chronic peptic ulcer leads to haematemesis and malaena, pyloric stenosis, 
perforation, perigastric adhesion, subdiaphragmatic abscess, pancreatitis, gastro-colic 
fistula. 
So I have decided to choose one of the most important “Gastro intestinal 
disorder” as my dissertation topic “Gunmam” . 
Anti ulcer drugs act by Histamin H2 receptor antagonist, Proton pump inhibitors, 
5-HT4 receptor agonist, cyto protectant, Healing agents. The advers effects of these 
drugs are cardiac arrhythmias, Blood dyscrasias, CNS & GI disturbances, 
Gynaecomastia, Impairment of sexual drive, Granulocytopenia, Nephritis, Hepatitis, 
Pancreatitis, Increased liver enzyme activity and triglycerides, Reduction in leucocytes 
and thrombocytes, cell hyperplasia,Pharyngitis, Rhinitis, Pruritis, GIT infection, Water 
and sodium retention, Potassium depletion, Hypertension, Mental 
confusio(Pharmacology and pharmacotherapeutics, R.S.Satoskar 22 edition). So the 
author has decided to take the herbo- minerel formulation of “hingu chooranam”. Since it 
will be less toxic and will not produce the adverse effects like the modern medicines. 
In the siddha literature “Sarabentherar vaithya muraigal-Gunmaroga sigichai” 
the compound medicine “Hingu chooranam” is indicated for Gunmam.so this compound 
drug has been selected to the dissertation work in treating the disease Peptic ulcer. 
Hingu chooranam is a compound drug which contains 8 drugs. In the siddha 
literature “Gunapadam mooligai and Thaathu vaguppu” all drugs are indicated for 
Gunmam. That is Sodium chloride impure and Plambago zylanica indicated for Atta 
gunmam. Ferula asafoitida, Cuminum cyminum, Acorus calamus, Zingiber officinale and 
Terminalia chebula are indicated for Gunmam. costus specious indicated for viranam. 
So Hingu chooranam is most effective for peptic ulcer. If the people is healthy, 
they will give our best for the development of society, nation and world.   
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2. AIM AND OBJECTIVES 
 
AIM: 
In the siddha pharmacopeia, the siddhars have used 4 types of crude drugs which 
is crude drugs of plant origin, animal origin, mineral origin and metal origin for 
preparing medicines. Thease crude drugs are used for preparing compound medicine. 
Hingu chooranam is a compound medicine which contains 8 drugs. In the siddha 
literature “ Gunapadam mooligai and thathu vaguppu” all drugs are indicated for 
Gunmam, that is Sodium chloride impure and Plumbago zyelanica indicated for atta 
gunmam. Ferula asafetida, Cuminum cyminum, Acorus calamus, Zingiber officinale and 
Terminalia chebula are indicated for gunmam. Costus specious indicated for viranam. So 
hingu chooranam is most effective for peptic ulcer.Currently cost effective and less 
toxicity medicine for peptic ulcer.      
The ultimate aim of my dissertation work is to prove the ANTI – ULCER  
ACTIVITY of   Hingu chooranam 
OBJECTIVES 
In this dissertation work, the “Hingu chooranam” is analyzed to assess the following 
aspects: 
 Collecting the literature evidences related to the trail drug 
 Getting the proper authentication of Raw drugs 
 Preparation of the trial drug, according to the text in a sasthrik  manner 
 Physico-chemical, Chemical Analysis for the trial drug to identify the 
active components.  
 Toxicological studies to prove the safety of the drug.  
 Pharmacological study to evaluate the Anti ulcer activity  of the drug 
  Clinical studies Evaluating the therapeutic efficacy of HINGU 
CHOORANAM  through open clinical trial on GUNMAM  patients 
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3.  REVIEW OF LITERATURE 
 
3.1 Botanical aspect : 
 Bentham & Hooker’s classification: 
Kingdom             Plantae  
Subkingdom        Tracheobionta  
Superdivision      Spermatophyta  
Division               Magnoliophyta  
Class                    Magnoliopsida  
Subclass               Rosidae 
Order                    Apiales 
Family                  Apiaceae  
Genus                   Cuminum L.  
Species                 Cuminum cyminum L.  
 
Vernacular names: 
Tamil   - Seeragam, Pithanasini, Posanakudori, Asai, Meththium 
English  - Cumin seeds or fruits 
Sanskrit - Jirakams 
Hindi  - Zira 
Kanadam  - Jirlga 
Malayalam - Jirakam 
Telugu  - Jilakarra   
Actions: 
Carminative, Stimulant, Stomachic, Astringent 
Chemical constituents: 
The chief constituent of the volatile oil is cumaldehyde, the iol contains p-
cymene, pinene, dipentene, cumene, cuminic alcohol, β-phellandrene and α-terpeneol. 
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3.2  Gunapadam aspect : 
 Part used: 
  Seed 
Taste (Suvai): 
            Acrid, Sweet 
Character (Thanmai ): 
             Thatpam 
Classification (Pirivu ): 
Inippu 
Gunam : 
வாந்தி யருசிகுன்மம் வாய்ேநாய்பீ லிகமிரைரப் 
ேபற்றருமல் கல்லைடப்பி லாஞ்சனமுட் – ேசƫந்தகம்மல் 
ஆசனகு டாrெயனும் அந்தக் கிரகணயும் 
ேபாசனகு டாrயுண்ணப் ேபாம். 
                  ேதைரயƫ குணவாகடம் 
வாந்தி, சுைவயின்ைம, குன்மம், வாய் ேநாய், பீலிக ேநாய், இைரப்பிருமல், 
கல்லைடப்பு, கிரகண திரும். 
Medicinal uses : 
• Cumin seeds are dried and powdered and take with butter for Erigunmam 
• Cumin seeds, cardamom, borneo camphor these are take each 1part and add 3 
parts of sugar, then made into chooranam for mandha vayu 
• For getting good appetizing, it is added food. 
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3.1. Acorus calamus : 
Bentham & Hooker’s classification: 
Kingdom    - Plantae  
Subkingdom    - Tracheobionta  
Superdivision   - Spermatophyta  
Division    - Magnoliophyta  
Class     - Liliopsida  
Subclass    - Arecidae  
Order     - Arales  
Family    - Acoraceae  
Genus    - Acorus L.  
Species    - Acorus calamus L.  
Vernacular names:  
Tamil   - Vasambu, Pillai marunthu, Vasai, Ukkiram 
English  - Sweet-flag 
Sanskrit  - Vacha 
Hindi   - Bach 
Kanadam  - Baja 
Malayalam  - Vayamba 
Telugu  - Vasa 
Actions: 
Carminative, Anti-spasmodic, Anti- periodic, Anti-bacterial, Stimulant, Sedative, 
Disinfectant, Germicide, Analgesic, Stomachic, Nauseant, Emetic, Tonic. 
Chemical constituents: 
Calamenol, calamene, calamenone, methyl eugenol, eugenol, α-pinene and 
camphene, palmitic, hepatic and butyric acids, asaronaldehyde, calamol, calamine, 
azulene, acorone, calerene, calacone, calacorene, acorenone, acolamone, isoacolamone, 
acoragermacrone, isoacolamone, preisocalamendiol, caryophyllene, calamenene, adalene 
and humulene. 
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3.2. Gunapadam aspect : 
Part used: 
Root 
Taste (Suvai): 
            Acrid 
Character(Thanmai): 
            Veppam 
Classification(Pirivu): 
            Kaarppu 
Gunam : 
பாம்பாதி நஞ்சற் புதப்புண் வலிவிடபாகங் குன்மம் 
சூம்பா rரத்தபித் தம்முக நாற்றம்வன் சூைலசன்னி 
வ ம்பம்ைப காசம் பிலிகஞ் சிலிபதம் வ றருமல் 
தாம்பாங் கிருமி யிைவேயகு மாசிவ சம்பிைனேய. 
                            ேதைரயƫ குணவாகடம் 
வசம்பினால் எல்லா நஞ்சுகள், புண் வைககள், ஐவைகவலி, குன்மம், இரத்த பித்தம், 
வாய்நாற்றம், சூைல, முப்பிண, இருமல், ஈரல் ேநாய், யாைனக்கால், நாடாப்புழு தரும். 
Medicinal uses : 
• Sweet flag powder mixed with honey for indigestion, flatulence, diarrhoea, 
gaseous accumulation in the stomach. 
• Sweet flag, glycyrrhiza glabra both equal quantity made it into decoction for 
cough, fever, abdominal pain especially in children. 
• A piece of sweet flag put it into mouth then chew it for a time. It increases the 
salivary secretion there by inducing good digestion. 
 
 
 
 
 
 
 
 
 
78 
 
3.1.zingiber officinale: 
Bentham & Hooker’s classification: 
Kingdom                 Plantae  
Subkingdom            Tracheobionta  
Superdivision          Spermatophyta  
Division                  Magnoliophyta  
Class                       Liliopsida  
Subclass                  Zingiberidae 
Order                      Zingiberales 
Family                    Zingiberaceae  
Genus                     Zingiber       
Species                   Zingiber officinale   
Vernacular names: 
Tamil   - Chukku,Sundi, Aarthrakam, Nakaram, Verkkombu 
English - Dried ginger 
Sanskrit  - Nagaram 
Hindi   - Sonth 
Kanadam - Ona-shunti or sunthi 
Malayalam - Chukku 
Telugu  - Sonti 
Arab & Per  - Znagebilarataba 
Actions: 
Carminative, stomachic stimulant 
Chemical constituents: 
Zingiberol, gingerol, oleoresin, zingerone, oil contains sesquiterpene 
hydrocarbons, sesquiterpene alcohols, monoterpenoids and associated compounds. 
Sesquiterpenes present in the oil are ar-curcumene, farnesene and smaller amounts of β- 
bisabolene, α-selinene, β –elemence and β –sesquiphellandrene. 
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3.2. Gunapadam aspect : 
Part used: 
Rhizome (Dry ) 
Taste (Suvai ): 
  Acrid 
Character (Thanmai ): 
  Veppam 
Classification (Pirivu): 
   Kaarpu 
Gunam : 
சூைலமந்தம் ெநஞ்ெசrப்பு ேதாடேமப் பம்மழைல 
மூலம் இைரப்பிருமல் மூக்குநƫ – வாலகப 
ேதாடமதி சாரந் ெதாடƫவாத குன்மநƫத் 
ேதாடம்ஆ மம்ேபாக்குஞ் சுக்கு. 
அகத்தியƫ குணவாகடம் 
சுக்கினால் ெசrயைம, மாரெபrச்சல், புளேயப்பம், ெவப்பம், இைரப்பு இருமல், 
கழிச்சல், நேரற்றம், குன்மம், சூைல வலி, பாண்டு, ஐய சுரம் தரும் 
Medicinal uses : 
• Decoction of dried ginger 40- 80ml for indigestion, abdominal pain, vomiting, 
fever, flatulence. 
• Dried ginger powder 2 -4 gm with ghee for diarrhoea, burning sensation,in 
epigastric region, indigestion. 
• Dried ginger powder is taken with sugar cane juice in the morning time for 
burning sensation in the epigastric region. 
3.1. Terminalia chebula : 
Bentham & Hooker’s classification : 
Kingdom - Plantae. 
Division -     Magnoliophyta.  
Class  -     Magnoliopsida.  
Order  -     Myrtales. 
Family  -     Combretaceae. 
Genus  -    Terminalia.   
Species -    Chebula Rtz. 
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Vernacular names : 
Tamil   - Kadukkai,Amutham, Arithagi, Varikkai 
English  - Chebulic myrobalan 
Sanskrit  - Pathya, Bhishak priya, Haritaki 
Hindi   - Pile Hara 
Kanadam - Anile-kayi, Alale-kayi 
Malayalam  - Katukkai 
Telugu  - Karak- kaya 
Arab   - Halila 
Pers   - Palilahe zard 
Actions : 
Chemical constituents : 
Tannin (tannic acid ) 45%, and a large amount of gallic acid, lucilage, a brownish 
yellow colouring matter, chebulinic and which when heated in water splits up into tannic 
and gallic acids. 
3.2. Gunapadam aspect : 
Part used: 
Fruit 
Taste (Suvai ): 
Astringent, Sweet, Sour, Bitter, Acrid 
Character (Thanmai): 
Veppam 
Classification (Pirivu): 
Inippu 
 ெபாதுப் பண்பு 
காமாைல, கண் ேநாய்கள், இருமல், குன்மம், ேசாைப, ஈரல் ேநாய்கள், குட்டம், 
ெபருவயிறூ, பாண்டு, மாƫபு ேநாய், ேமகேராகம், மூல ேராகம், வாய்ப்புண், வாந்தி, 
விைர வாதம், ெவண் குட்டம், பவுத்திரம், கிரந்தி தரும். 
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Medicinal uses: 
• Kadukkai vadagam 1 or 2 for peptic ulcer, vomiting, haemarrhoids, diarrhoea, 
anaemia. 
• Pavana kadukkai for peptic ulcer, abdominal pain, vomiting, haemarrhoids, 
indigestion, anaemia. 
• Kadukkai nei 10gm for eriyagni, indigestion, constipation, anaemia. 
3.1. Plumbago zeylanica : 
Bentham & Hooker’s classification : 
Kingdom                 Plantae   
Subkingdom            Tracheobionta   
Superdivision          Spermatophyta   
Division                  Magnoliophyta   
Class                       Magnoliopsida   
Subclass                  Caryophyllidae 
Order                      Plumbaginales 
Family                    Plumbaginaceae   
Genus                    Plumbago L.   
Species                  Plumbago zeylanica L.   
Vernacular names: 
Tamil   - Kodiveli, chithiramoolam 
English  - Ceylon lead-wort 
Sanskrit  - Angi-shika, Chitraka-vrikshaha 
Hindi   - Chita, Chitra 
Kanadam  - Chitra-mula 
Malayalam  - Tumpa-koduveli 
Telugu  - Tella-chitra-mulam, Agnimata 
Actions : 
             Anti- periodic, Diaphoretic 
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Chemical constituents : 
Plumbagin, glucose, fructose and enzymes protease and invertase. Root in 
stimulating digestive processes. The leaves and the stem contain volatile oil but little or 
no plumbagin.The flowers of the plant contain azulein ( 5-methoxy quercetin 3- 
rhamnosid ) and 3-rhamnosides of delphinidin. 
3.2 gunapadam aspect : 
Part used : 
Root 
Taste (Suvai ); 
  Acrid  
Charecter (Thanmai ): 
Veppam 
Classification (Pirivu ): 
Kaarpu 
Gunam : 
கட்டிவிர ணங்கிரந்தி கால்கள அைரயாப்புக் 
கட்டிச்சூ ைலவ க்கங் காழ்மூலம்-முட்டிரத்தக் 
கட்டுந ேரற்றங் கனத்த ெபருவயிறூம் 
அட்டுங் ெகாடிேவலி யாம். 
கட்டி, புண், வளிேநாய், அைரயாப்புக்கட்டி, குத்தல்,ேசாைப, மூலேராகம், நேரற்றம், 
ெபரு வயிறூ தரும். 
Medicinal uses : 
• Ceylon lead wort, mercury per chloride, carum capticum these are each 1 part and 
3 parts of  jiggery , then grind it all and make a tablet in the size of pepper for 8 
types of gunmam, fistula. 
• Ceylon lead wort root powder decoction has anti- periodic and diaphoretic action. 
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3.1. Costus speciosus ; 
Bentham & Hooker’s classification : 
Kingdom            Plantae   
Subkingdom      Tracheobionta   
Superdivision    Spermatophyta   
Division            Magnoliophyta   
Class                 Liliopsida   
Subclass           Zingiberidae 
Order                Zingiberales 
Family              Costaceae   
Genus               Costus L.   
Species             Costus speciosus  .   
Vernacular names : 
Tamil   - Kottam, Kuraa, oli 
English - Costus root 
Sanskrit  - Koshtam 
Kanadam  - Koshtam 
Malayalam   - Kottam 
Telugu  - Kostam 
Arab   - Qusth 
Pers   - Kosht 
Actions : 
      Stomachic, Expectorant, Tonic, Stimulant, Diaphoretic 
3.2. Gunapadam aspect : 
Part used : 
  Root 
Taste (Suvai): 
Bitter 
Character (Thanmai ): 
  Veppam 
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Classification (Pirivu): 
Kaarpu  
Gunam : 
திட்டிகவுள் அகடுகளஞ் ெசன்னி நாவாய் 
ெசறபிண ெவப் பைதப்புதா வƫத்தம் ஊைத 
முட்டிெயழு மு   விரணம் சுவாசகாசம் 
மூடிகத்ேதா டரவுமர விடங்கள்  
ெதாைலயும்விர ணாrக்குச் சுகப்ேபாறாேம. 
கண், தாைட, வயிறூ, கழுத்து, தைல, நா, வாய் இவ்விடத்திலுண்டாகும் ேநாய்கள், 
சுரம், அைதப்பு, வாயு, மூலமு   , புண், இைரப்பு, ேமகக்கட்டி, பயித்தியம் தரும். 
Medicinal uses ; 
• Costus root is added in gunma kudori mezhugu which in the effective drug in the 
treatment of peptic ulcer. 
• Costus root is added in thaleesadhi chooranam which in the drug to treat digestive 
disorders. 
• Costus root is added in drakshadhi chooranam which is treat for vomiting in 
peptic ulcer, pitha diseases. 
3.1. Ferula asafoetida : 
Bentham & Hooker’s classification :  
Kingdom Plantae  
Subkingdom Tracheobionta  
Superdivision Spermatophyta  
Division Magnoliophyta  
Class Magnoliopsida  
Subclass Rosidae  
Order Apiales  
Family Apiaceae  
Genus Ferula L.  
Species Ferula assa-foetida L.  
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Vernacular names : 
Tamil --------Perungayam, Iranam, Valleegam, Kanthi 
English ------- Asafoetida 
Sanskrit ------- Hingu 
Hindi --------Hing 
Kanadam ----- Ingu 
Malayalam --- Perungayam 
Telugu --- Inguva 
Arab -----Hiltit 
Pers ------ Angusthagandh 
Actions : 
             Stimulant, Carminative, Anti-spasmodic, Expectorant, Laxative, Anthelmintic, 
Diuretic, Aphrodisiac, Emmenagogue. 
Chemical constituents : 
              Organic sulpher compound; valatile oil containing essential oil of garlic-allyl, 
allyl persulphide and two turpenes; a resin contain ferrulic acid ester of asaresino-tannol 
from ferulic acid, gum 25%, ash 4% also malic, acetic, formic and valeranic acids. Resin 
on dry distillation yields umbelliferon. When fused with potash it yields resorcin and 
pyrocatachuic acid. 
3.2. Gunapadam aspect : 
Part used : 
Gum resin 
Taste (Suvai ): 
   Bitter 
Character (Thanmai ): 
  Veppam 
Classification (Pirivu): 
Kaarpu 
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Gunam : 
மந்தம்வாதம் உதாவƫத்தம் அல்குல்ேநாய் 
 மாƫபணங்கட்ட குன்மம்மேகாதரம் 
உந்துெகƫப்பத்தின் வித்திரஞ்சூைல 
மாயுநாறூநற் காயங்கிைடக்கிேன. 
மந்தம், ஏப்பம், வாதம், சூதகவாயு, குன்மம், ெபருவயிறூ, சூதகச்சூைல தரும். 
Medicinal uses : 
• Ferula asafetida 1 part, common salt 2 parts , piper longum 4 parts these are dried 
then make into chooranam for gunmam, soolai, dhanurvayu. 
• Asafoetida mix with yellow egg yolk and give it for dry cough. 
• Asafoetida mix with vigna mungo powder and make it as fumes for asthma and 
flatulence. 
3.2 .SODIUM CHLORIDE IMPURA : 
Tamil   - Indu- uppu, Saindhavam, mathi- uppu 
English - Rock salt 
Sanskrit  - Saindhava 
Hindi   - Sendhalon, sedhalon 
Malayalam  - Intu- uppu 
Telugu  - Saindhalavanam 
Arab   - Mil-he-tabazard 
Pers  - Namakesang 
Source : 
               Found in nature in extensive beds mostly associated with clay and calcium 
sulphate. To obtain it, holes are dug into these rocks which soo become filled up with salt 
water; the water is evaporated and the salt is left ready to use. 
Character : 
              It is found in small white crystalline grains or transparent cubes. It is brownish 
white externally and white internally. It has pure saline taste and burns with a yellow 
flame. 
Action : 
       In small doses it is highly carminative, stomachic and digestive. In large dose ( 4.2 
gm or 8.4 gm )it is laxative and (16.8gm or 21gm ) it is purgative . Rock salt posseses of 
stronger purgative properties than cream of tartar. 
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Gunam : 
அட்டகுன்ம மந்தம் அசிƫக்கரஞ்சூƫ சதீபித்தந் 
துட்டைவயம் நாடிப்புண் ேடாடங்கள் – ெகட்டமலக் 
கட்டுவிட விந்ைதயக் காமியேநாய் வங்கரப்பான் 
விட்டுவிட விந்துப்ைப விள். 
இந்துப்பினால் எண்வித குன்மம், அலசம், அசிƫக்கரம், நரம்புக்கிரந்தி, மலபந்தம், 
விஷம், திrேதாஷம், கடுவன், இரத்த மூலம், ேநத்திர காசம், சுவாசம் தரும். 
Medicinal uses : 
Induppu chooranam : 
       It contains rock salt, Cuminum cyminum, Pipper longum, Carum copticum, Zingiber 
officinale, Terminalia chebula in equal parts mixed and made into powder is used in 
anorexia, flatulence and biliousness. 
Thengaisharam : 
      It is highly recommended in chakradhatta as valuble in the form of dyspepsia which 
is attended with pain two or three hours after meals. It is thus prepared:  Take a cocoanut 
fruit full of water make a hole in it and fill the cocoanut with rock- salt and dissolve it in 
its water. Then close the opening, cover the nut with a layer of clay and roast it in a pit of 
fire.              
3.3.  MODERN ASPECT OF DISEASE : 
PEPTIC ULCER DISEASE : 
Ulcers are defined histologically as a breach in the mucosa of the alimentary tract 
that extends through the muscularis mucosa into the submucosa or deeper.It occurs in the 
lower oesophagus, stomach or duodenum, in the jejunum rarely, in the ileum adjacent to 
a Meckel’s diverticulum.Ulcers in the stomach or duodenum may be acute or chronic; 
both penetrate the muscularis mucosae but the acute ulcer shows no evidence of fibrosis. 
Peptic ulcers : 
Peptic ulcers are usually solitary lesions less than 4 cm in diameter, located in the 
following sites, in order of decreasing frequency, 
• Duodenum, first portion 
• Stomach, usually antrum 
• At the gastroesophageal junction, in the setting of gastroesophageal reflux or 
Barrett esophagus 
• Within the margins of a gastrojejunostomy 
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• In the duodenum, stomach and jejunum of patients with Zollinger- Ellison 
syndrome 
• Within or adjacent to an ileal Meckeldiverticulam that contains ectopic gastric 
mucosa. 
Aetiology : 
Helicobacter pylori : 
Around 90% of duodenal ulcer patients and 70% of gastric ulcer patients are 
infected with H. pylori; the remaining 30% of gastric ulcers are due to NSAIDs. 
Pathogenesis and pathophysiology : 
H.pylori is Gram- negative,live deep beneath the mucus layer closely adherent to 
the epithelial surface. It uses an adhesin molecule (bABa ) to bind to the Lewis b antigen 
on epithelial cells. 
Here the surface Ph is close to neutral and any acidity is buffered by the 
organism’s production of the enzyme urease. This produces ammonia from urea and 
raises the pH around the bacterium and between its two cell membrane layers. The 
bacteria spread by person to person contact via gastric refluxate or vomit.  
H. pylori induces an intense inflammatory and immune response. There is 
increased production of pro- inflammatory cytokines such as interleukin (IL)- 1, IL-6, 
tumor necrosis facter (TNF ), and, most notably, IL-8. This cytokine is produced by the 
mucosal epithelial cells, and it recruits and activates neutrophils. 
  The bacterium stimulates chronic gastritis by provoking a local inflammatory 
response in the underlying epithelium. This depends on numerous factors, notably 
expression of bacterial cagA and vacA genes. 
Which the cagA product is injected into epithelial cells, ultimately interacting 
with numerous cell- signalling path-ways involved cell replication, apoptosis and 
morphology. H.pylori strains expressing cagA  are more often associated with disease 
than cagA strains. Most strains also secrete a large pore- forming protein called vacA 
which causes large vacuoles to form in cells in vitro. In vivo, vacA has many effects 
including increased cell permeability, efflux of micronutrients from the epithelium, 
induction of apoptosis and suppression of local immune cell activity. 
In most people H. pylori causes antral gastritis associated with depletion of 
somatostatin(from D cells) and gastrin release from G cells. The subsequent 
hypergastrinaemia stimulates acid production by parietal cells, but in the majorityof cases 
this has no clinical consequencs.  
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In a minority of patients (perhaps smokes) this effect is exaggerated, leading  
To duodenal ulcration. The role of H. pylori probably acts by reducing gastric mucosal 
resistance to attack from acid and pepsin. In approximately  
1% of infected people, H. pylori causes a gastritis leading to gastric atrophy and 
hypochlorhydria. This allows bacteria to proliferate within the stomach; these may 
produce mutagenic nitrites from dietary nitrates, predisposing to the development of 
gastric cancer. 
NSAID: 
           The major drawback of NASIDs is gastrointestinal toxicity. Prostaglandins of the 
E series play a major role in gastroduodenal defence mechanisms. By depleting mucosal 
prostglandin levels, aspirin and NSAIDs impair this ‘cytoprotection’, resulting in 
mucosal injury, erosions and ulceration. NSAIDs are an important aetiological factor in 
up to 30% of gastric ulcers. These drugs also reduce the integrity of the duodenal mucosa 
but are probably responsible for only a small proportion of duodenal ulcers. They greatly 
increase the risk of bleeding of perforation from pre-existing gastric and duodenal ulcers. 
Risk factors for nsaid-induced ulcers: 
1. Age > 60 years 
2. Past history of peptic ulcer 
3. Past history of adverse effect with NSAIDs 
4. Concomitant corticosteroid use  
5. High-dose or multiple NSAIDs 
6. Individual NSAID—highest with azapropazone, piroxicam, 
7. ketoprofen;   lower with ibuprofen 
Smoking: 
      Smoking confers an increased risk of gastric ulcer and, to a lesser extent, 
duodenal ulcer. 
Acid-pepsin versus mucosal resistance: 
An ulcer forms  when there is an imbalance between aggressive factors, i.e. the 
digestive power of  acid and pepsin, and defensive factors, i.e. the ability of the gastric 
and duodenal mucosa to resist this digestive power . This mucosal resistance constitutes 
the gastric mucosal barrier. Ulcers occur only in the presence of acid and pepsin; they are 
never found in achlorhydric patients such as those with pernicious anaemia. On the other 
hand, severe intractable peptic ulceration nearly always occurs in patients with the 
Zollinger-Ellison syndrome which is characterized by very high acid secretion. 
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Genetic predisposition: 
Multiple Endocrine Neoplasia (syndrome I) is associated with Peptic ulcer 
disease. 
Emotional strees: 
   This is in someway related to increased acid production and hence peptic 
ulceration. 
 delayed gastric emptying: 
  This may increase gastrin release and more acid secretion. 
Clinical features: 
PAIN : 
Pain has got several important features: 
Location: 
Usually in the epigastric region 
Character:  
Usually burning, sometimes aching or stitching or gnawing in character. 
Relation with Food: 
Food minimizes of abolishes pain in 50% cases. Pain comes 2-3 hours after 
taking food. 
Radiation: 
Sometimes pain is radiated to the chest. Post bulbar ulcer pain may be radiated 
backwards. 
Relieving Factors: 
After taking soda, alkali or antacid, 
Pain is relieved. Food also causes relief of pain in about 50% of subjects or by induced 
vomiting pain is relieved. 
Nocturnal or Hunger Pain: 
Pain  appears at midnight of late hours of the night often awakening the patient 
from the bed. It is very characteristic (and is present in about 60%-70% cases.) 
Periodicity of Pain: 
During winter months pain is prominent but it disappears during summer months. 
Clock-like Reguarity of Pain: 
Same type of food taken in same hours : 
1. Heart burn, acidity, acid regurgitation and water-brash are common. 
1. Vomiting may be present, it is often induced and may relieve pain. 
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Complications of peptic ulcer disease: 
Bleeding 
1. Occurs in 15% to 20% of patients 
2. Most frequent complication 
3. May be life-threatening 
4. Accounts for 25% of ulcer deaths 
5. May be the first indication of an ulcer 
Perforation 
1. Occurs in about 5% of patients 
2. Accounts for two thirds of ulcer deat 
3. Rarely, is the first indication of an ulcer 
Obstruction from edema of scarring 
1. Occurs in about 2% of patients 
2. Most often due to pyloric channel ulcers 
3. May also occur with duodenal ulcers 
4. Causes incapacitating, crampy abdominal pain 
5. Rarely, may lead to total obstruction with intractable vomiting 
Investigations: 
 Complete Blood Picture- Tc, Dc, ESR, and Hb. 
 Routine Blood Examination- Blood sugar and urea 
 Video Endoscopy 
 To know the extent of the lesion 
 To confirm the diagnosis 
 To take biopsy 
 EGD -esophagogastroduodenoscopy 
 Ultrasound abdomen 
 Barium Meal Study 
 Duodenal ulcer - deformed duodenal cap is seen 
 Gastric ulcer - appears as a Niche in the lesser curvature due to ulcer crater and as a       
    Notch on the greater curvature due to the spasm of stomach. 
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 Test for h.pylori 
 Non- invasive test  
1.Serology 
2. Urea breath test 
3. Faecal antigen test 
 Invasive test -  
1.Histology (Antral biopsy)  
2. Rapid urease test 
3. Microbiological culture 
3.4.  SIDDHA ASPECT OF DISEASE : 
GUNMAM : 
Main features of peptic ulcer : 
• Burning sensation and pain in the abdomen. 
• Digestion is not proper.The food is not get digested. 
• Vomiting is the worst symptom there by all the food product intake are vomited 
out, as a result, nutritional status and stamina of the body day by day decreases. 
So patient become depress day by day and also have the suicidal tendency. 
• Some authors called this disease has ‘kulmam’ because one type of this disease, 
have the feature of forming flatulence, it more like ball from one side to another 
in the abdomen and produce discomfort. 
Causes of peptic ulcer : 
• Eating hot and belching substance. 
• Eating food mixed with sand, bran, stone and dust. 
• Drinking contaminated water like spring water, stagnant water and mixed water. 
• Eating food which cann’t be digested early like coconut milk 
• By getting angry, starvation and depression frequently 
• Practising yoga in a wrong manner especially in breath control. 
Prodromal symtoms: 
Anorexia, nausea, frequent flatulence, excessive salitary secretion, 
regurgitation,abdominal pain, vomiting, flatulence with sourness, increased bowel 
sounds. 
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Types of the disease: 
 Saint yugi classified this disease onto 8 types and they are described as  follows, 
• Vayu gunmam 
• Vatha gunmam  
• Pitha gunmam 
• Ery gunmam 
• Vali gunmam 
• Sathi gumam 
• Sanni gunmam 
• Sethuma gunmam 
Saint THIRUKANDA MINIVAR classified this disease into 8 types and they are 
described as follows, 
• Vatha gunmam 
• Pitha gunmam 
• Kapha gunmam 
• Vatha pitha gunmam 
• Vatha kapha gunmam 
• Pitha silethuma gunmam 
• Tridodha gunmam 
• Raththa gunmam 
Again this Raththa gunmam is sub divided into raththa vatha gunmam and raththa vatha 
pitha gunmam. 
Some ancient physician have classified a disease into 3 types as follows 
• Saamaniya vatha gunmam 
• Saamaniya pitha gunmam 
• Saamania silethuma gunmam. 
Vatha gunmam 
The disease mostly appears during the age of 20 to 30 years which is the ‘Vatha 
period’. Patient may develop severe abdominal pain and also develop tiredness, 
giddiness, thirst and dryness of tongue.Vomiting may also follow which will reduce the 
pain slightly. In this disease the food indigested will not be digested properly and 
produces stomach pain . Even though the patient will not take food properly, the body 
will appear as obese. However, patient will loose his strength and will become lean. 
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There may be small quantity of blood in the vomit which appears dark in colour.In later 
the disease will produce indigestion throughout the life of the patient.Unbearable pain in 
the abdomen and over the chest below the xiphisternal region. 
Pitha gunmam : 
Pain in the upper abdomen and urine will appear red in colour. The patient will be 
having burning pain in the stomach and also develop nausea and vomiting. The vomitus 
may be found mixed with mucus and pitha. Excessive thirst, vertigo are other features of 
the disease.Patient may become unconscious after vomiting. As the vomiting increases, 
burning pain in the chest and abdomen. The npitha dodha causes uncontrollable pain and 
produced uncontrollable vomiting.It is considered that the disease occurs in the age of 30 
-50 years. Besides, there will be loss of body strength and impaired quality of blood as 
the foods taken are vomited out this causes yellow colouration of skin.As the disease, 
progresses, the pain in the abdomen will be severe after eating.The abdomen will appear 
heavy; the appetite will be impaired and patient will dislike to eat.Ageusia, dryness of 
tongue, regurgitation of fluid in the stomach 
Iya gunmam : 
If the disease occurs in the old age period which is the period of ‘Kapha period’. 
The essential features of the disease are dislike of food, lean body mass due to 
malnutrition leading to anaemia, vertigo, tremors and frequent fright. The ingested food 
will not get digested and stays in the stomach; the food will get fermented and come out 
only in vomitus with asmell of meat. In later,continuous pain in the abdomen and 
excessive haemetemesis. The body may become lean day by day; these features will 
make one to suspect that patient might be having cancer in stomach.Patient may also 
develop vomiting of white coloured substance frequently. 
Sanni gunmam : 
In this type of disease , there will be excessive salivary secretion; the abdomen 
will be distended and mition will be passed hot with excessive sound; the mouth will 
have salty taste; there will be also irritation of the throat . the patient may not have the 
desire for food. The patient will frequently develop belch, dysponea and giddiness, the 
body also will become cool. 
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Vayu gunmam : 
The excessive activity of vatha dosha in this disease causes damage to the 
stomach. The disease may be also called as paayuru gunmam and soolai gunmam. Patient 
may also develop unbearable pain in the stomach due to gas like pulling sensation. The 
downward directing factor (abana vayu ) gets stimulated and it prevents the digestion of 
ingested food; this results in abdominal pain, irritation of chest, pain as if the intestine is 
twisted. The patient may also develop dislike to food. Even though the food ingested will 
be small quantity, abdomen will appear distended like gas filled belly; there will be loss 
of strength. 
Eri gunmam : 
The patient will develop pain as if the stomach is twisted. Excessive salivary 
secretion, pain in the head, sour belch from the stomach, distention of abdomen with 
excessive bowel sound, diarrhoea and sweating over the root of hair are other features of 
the disease. In this type of disease, unbearable irritation in the stomach develops within a 
short time after taking the food. Ultimately, the patient will become lean. 
Vaanthi gunmam : 
In this disease, the patient will develop indigestion, vomiting, burning pain in 
stomach, constipation, giddiness, spasm and irritation of stomach, a sensation of heat of 
fire in the body, inability to walk and ageusia. There will be protuberance of nerves and 
patient may develop numbness. Ultimately, the patient will develop loss of strength. 
Vali gunmam : 
As the kaphadosha and vatha doshas are associated in this disease, the ingested 
food will not be digested and also will not be vomited out. The food stays in the stomach 
and causes pricking pain in throat and twisting pain in stomach. In this disease, the food 
ingested will not be digested and the abdomen will be distended with gas. Pain at the rib 
sites as if it is pricked by thorn, pain in the hip and in the vertebral region, throbbing pain 
of the whole body, dislike to food, diarrhoea with excessive bowel sounds are the other 
features of the disease. Sometimes , the patient may not be in a position to bear the pain 
and even develop suicidal tendency. 
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General features of the disease : 
The disease occur in women and also in the older age. The disease usually occurs 
in men in the age group of 25 -45 years. The disease progresses gradually and other 
features such as indigestion, appearance as if the abdomen is distended, rolling pain in 
the abdomen may also appear. When patients have good body strength and capacity to 
digest any type of food, may suddenly develop anorexia, nausea, bilious vomiting, belch 
and sour belch from the stomach. As the disease increases in severity, patient may 
develop unbearable pain and may put the finger into the throat to inducing vomiting; 
after vomiting the  pain may be reduced slightly. 
Doshas and other facters : 
1. Ancient saint theran said ‘ Thodar vatha bandhamallathu gunmam  varadhu ‘. 
2. Due to the wrong food habit nad bad activities the Vatha dosha worsens. 
3. The other dosha will also associated with it and fail to perform their natural 
junctions. Due to this the downward directional factors and the upward 
directional factor (udhana vayu ) malfunctioning; the food ingested will not be 
digested and purity of blood is also lost. 
4. In addition to the above, the downward directional factor controls the passage of 
stool and causes increase of gas in the stomach the upward directional factor 
causes vomiting and aggravate the disease.  
Pulse :  
1. If the vatha and pitha pulses appear to be associated and their strength also appear 
to be integrated as single strength, it can be considered that this tends to 
erigunmam due to mantham. 
2. If the Vatha pulse runs in the left side or by the side may denote Vatha gunmam. 
3. The other types of pulses do not move in their proper direction and move to the 
left or by the side, they may give due to appropriate gunmam disease. 
4. In the vatha pulse is felt abnormally like a vibration is tightly held rope which 
was raised with a finger and has suddenly dropped, it may be suggestive of vali 
gunmam disease. 
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OTHER PREPARATIONS OF FERULA ASAFOETIDA : 
Sarabendirar gunma roga sigichai : 
1. Sinjashara vadagum    -  pg no 6 
2. Kumattikai ennai     -  pg no 96 
 Sarabendirar vaidhya rathnavali : 
1. Thengai paagu    -  pg no 86 
2. Gunma kudori    - pg no 379 
Siddha vaithya thirattu : 
1. Thaleesadhi chooranam     - pg no 225 
2. Kumatti kuzhambu     - pg no 179 
3. Gunma kudori mezhugu    - pg no 200 
4. Kowshikar kuzhambu    - pg no 201 
OTHER PREPARATIONS OF SODIUM CHLORIDE IMPURA : 
Sarabendirar gunma roga sigichai : 
1. Nava sinjashara vadagam   - pg no 5 
2. Lavana chenduram    - pg no 59 
3. Sarabendhira kuligai    - pg no 134 
Sarabendirar vaidhya rathnavali : 
1. Gunmathukku kalkam   - pg no 376 
Siddha vaithya thirattu : 
1.   Vengara mathirai    - pg no 45 
2. Pancha lavana parpam   - pg no 116 
3. Nayuruvi uppathi kuzhambu   - pg no 193 
4. Sanga thiravagam    - pg no 298 
OTHER PREPARATIONS OF CUMINUM CYMINUM : 
Sarabendirar gunma roga sigichai : 
1. Sangashaaram    -  pg no 10 
2. Kozhi parpam    - pg no 124 
Siddha vaithya thirattu : 
1. Inji legium     -  pg no 247 
2. Panchadeepsgni chooranam   - pg no 220 
3. Navarasa thuvaial   - pg no 192 
4. Seeraaga chooranam    - pg no 211 
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OTHER PREPARATIONS OF ACORUS CALAMUS : 
Sarabendirar gunma roga sigichai : 
1. Kukilathy mathirai   - pg no 13 
2. Punarnavaadhi krutham   - pg no 32 
Siddha vaithya thirattu : 
1. Meganatha kuligai    - pg no 39 
2. Pirandai vadagam    - pg no 228 
OTHER PREPARATIONS OF ZINGIBER OFFICINALE : 
Sarabendirar gunma roga sigichai : 
1. Koda soozhi mathirai   - pg no 36 
2. Sanga kudori kuligai    - pg no 140 
3. Gunmathy kudaaram    - pg no 73 
Sarabendirar vaidhya rathnavali : 
1. Gunmathukku kasayam   - pg no 94 
Siddha vaithya thirattu : 
1.   Sanjeevi mathirai    - pg no 19 
2. Sianar amirtham    - pg no 161 
3. Amukkara chooranam   - pg no 213 
4. Thairchundi chooranam   - pg no219 
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4.MATERIALS AND METHODS 
 
4.1 preparation of Hingu chooranam : 
Selection of drug: 
The trial drug Hingu chooranam was selected from the Siddha literature 
“Sarabendhirar vaitya muraigal- gunmaroga sigichai”. 
Collection of drug: 
Raw drugs were bought from the TAMCOL sales counter, Arumbakkam, 
chennai-106. The raw material was identified and authenticated by PG Gunapadam dept. 
Govt Siddha medical college, Chennai 106.  
Purification of the ingredients: 
Purification of Zingiber officinale : 
 Peel off the skin and put in calcium carbonate for 3 hours then dried it in sunlight 
and washed. 
Purification of cuminum cyminum : 
Dried 6 hours in sunlight and fried slightly . 
Purification of Ferula asafoetida : 
 Fried till water content evaporated. 
Purification of Acorus calamus : 
 Slow it in fire and made it into carbon form ( Before ash form ). 
Purification of Sodium chloride impure : 
 Soak it in kaadi (Vinigar ) and then dried it in sunlight. 
Purification of Plumbago zeylanica : 
Remove the inner nerve and outer bark only should powdered and place it in a 
cloth which is tied in the mouth of a pot filled with milk, then closing  with another pot 
above and put it in a flame for 3 hours. Then take the powder dried and grind it well. 
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         Figure no :4.1.1                 Figure no :4.1.2 
                    
    Purified Sodium chloride impure     Purified Ferula asafoetida 
 
 
 
                Figure no :4.1.3               Figure no : 4.1.4 
          
           Purified Zingiber officinale                           Purified Cuminum cyminum 
 
 
 
                  Figure no :4.1.5             Figure no :4.1.6  
                                                
           Plumbago zyelanica       Purified Plumbago zyelanica 
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                 Figure no : 4.1.7    Figure no : 4.1.8 
        
         Purified Costus speciosus    Purified Terminalia chebula 
 
 
 
              Figure no : 4.1.9    Figure no :4.1.10 
                                                  
             Acorus calamus         Purified Acorus calamus 
Preparation of chooranam : 
Ferula asafoetida                    - 1 Part 
Sodium chloride impure         - 2 Part 
 Cuminum cyminum                - 3 Part 
Acorus calamus                      - 4 Part 
Zingiber officinale                   - 5 Part 
Terminalia chebula                  - 6 Part 
Plumbago zeylanica                 - 7 Part 
Costus speciosus                     - 8 Part 
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Thease ingridients were purified by sasthrik method from siddha literature of “ 
Sarakkugalin suddhi muraigal ”.Thease drugs were made into fine powder. Then mixed 
well into form of homogenous mixture. To get the finest physical form of this drug, the 
powdered material is sieved through a white cotton cloth (Vashthirakayam). 
Purification of chooranam: 
 The Chooranam was moistened with cow’s milk. The pot was half filled with 
milk and water. The mouth of the pot was covered and tied with white cotton cloth. The 
Chooranam (moistened by milk) was placed above the tied cloth. The mouth of the pot 
closed with another mud pot. The gap between the two mud pots was tied with a wet 
cloth to avoid evaporation. Then this arrangement was put on fire and boiled until water 
level gets reduced in the lower pot. Then the powder was taken, dried, powdered finely 
and preserved for usage. 
Preservation:  
 The purified Chooranam was stored in a clean, air tight glass container. Since the 
life period of the Chooranam is only three months, the prepared Chooranam must be 
used within this period.  
 
 
 
          Figure no : 4.1.11 Hingu chooranam 
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Administration of the drug: 
Form of the medicine  :  Chooranam 
 Route of Administration :  Enteral 
 Dose    :  3 pinches 
 Anubanam (Vehicle)  :  Warm water 
 Times of Administration :  Two times a day; before food 
 Duration    :  7 weeks 
4.2. Standardization of the drug 
4.2.1. Physico-chemical analysis: 
4.2.1.1. Ash and acid insoluble ash: 
 To the ash add 1:5 Hcl: Distilled water 15 ml boil, cooled and then filtered using 
whatman filter paper (No.41) repeat 3 to 4 times till the yellow colour disappear or 
colourless, then remove the filter paper and add to the filter to the original dish and keep 
it in the muffle furnace at 600o C and take constant weight and calculate the acid 
insoluble ash value. 
 Weight of acid insoluble residue x 100 
Acid insoluble ash (%)=  
                   Weight of  the sample 
 
Acid insoluble residue = Acid insoluble ash value – Empty weight of the dish 
Loss on drying: 
 3gm of the drug is heated in a hot oven at 1050 c to constant weight. The % of 
weight was calculated. 
Loss on drying value at 1050 c - 10.96 %w/w 
Potential of hydrogen (pH): 
 The pH scale is logarithmic and runs from 0.0 to 14.0 with 7.0 being neutral. 
Readings less than 7.0 indicate acidic solutions, while higher readings indicate alkaline 
or base solutions. 
4.2.1.2 TLC estimation of Hingu chooranam: 
Thin-layer chromatography is a technique in which a solute undergoes 
distribution between two phases, stationary phase acting through adsorption and a mobile 
phase in the form of a liquid. The adsorbent is a relatively thin, uniform layer of dry 
finely powdered material applied to a glass, plastic or metal sheet or plate. Glass plates 
are most commonly used. 
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Identification can be effected by observation of spots of identical Rf value and 
about equal magnitude obtained, respectively, with an unknown and a reference sample 
chromatographed on the same plate. A visual comparison of the size and intensity of the 
spots usually serves for semi-quantitative estimation. 
Solvent system: 
Toluene : Ethyl acetate (6:1.5). 
TLC plate: 
  Aluminium plate precoated with silica gel 60F254 of 0.2 mm thickness (Merck). 
Developing chamber: 
 Camag’s twin trough chamber. 
Visualizing reagent: 
 Vanillin-sulphuric acid reagent. 
Extract Preparation:  
4 g of the chooranam was soaked overnight in chloroform. Boiled on a water bath 
for 10 mins, filtered and concentrated to 10 ml.  
Procedure: 
 The extract was applied on the TLC using capillary and developed in the solvent 
system.  The developed TLC plate was air dried and photograph was taken in white light. 
Then dipped in vanillin-sulphuric acid reagent, heated in an oven at 105°C until the 
development of coloured spots and photograph taken. 
4.2.1.3. Fourier transform infrared spectroscopy  (FTIR ): 
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4.2.1.4. Scanning electron microscope (sem): 
The Scanning Electron Microscope (SEM) is a microscope that was electrons 
rather than light to form an image. There are many advantages to using the SEM instead 
of a light microscope. 
Resolution : 1.2 nm gold particle separation on a carbon substrate 
Magnification : From a min of 12 x to greater than 1, 00,000 X 
The SEM has a large depth of field, which allows a large amount of the sample to 
be in focus at one time. The SEM also produces images of high resolution, which means  
that closely spaced features can be examined at a high magnification. Preparation of the 
samples is relatively easy since most SEM one require the sample to be conductive. 
The combination of higher magnification, larger depth of focus, greater 
resolution, and easy of sample observation marks the SEM one of the most heavily used 
instruments in research areas today. 
4.2.2  Qualitative phytochemical analysis: 
Test for Phenol 
Substance in water is added with 5 % alcoholic ferric chloride. Dark blue or green 
colour shows presence of phenol. 
Test for Tannin 
Substance is shaken with water and added with lead acetate solution. White 
precipitate shows the presence of tannin. 
Test for Flavonoids (Shinoda test) 
Substance is dissolved in alcohol, added with magnesium bits and concentrated 
hydrochloric acid. On heating over a water bath, the appearance of majenta colour shows 
the presence of flavonoids.  
Triterpenoids (Noller’s Test)  
To fewmg of extract, add tin and thionyl chloride and heat in water bath. Purple 
colour indicates the presence of tritepenoids. 
Test for steroids : 
An ethonolic extract of plant sample 2ml is mixed with 2 ml H SO  and o.5 gm 
Acetic anhydride. The solution turns in to blue to green colour shows the presence of 
steroids. 
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Test for Anthraquinones 
Few milligram of crude powder is shaken with 10 ml of benzene and  filtered. To 
this filtrate, 0.5 ml of 10 % ammonia solution is added and the mixture is shaken well 
and the presence of the violet colour in the layer phase indicates the presence of the 
anthraquinone.  
Test for Alkaloids (Dragendorff’s Test)  
Few mg of extract in separate test tube was warmed with 2% Sulphuric acid for 2 
minutes. And it was filtered in separate test tube and few drops of Dragendorff’s reagent 
were added.  The presence of orange red precipitates indicates  the presence of alkaloids. 
Test for Saponins 
To few mg of extract distilled water is added and shaken well. The formation of 
foam indicates the 
presence of saponin. 
Test for Cardiac glycoside (Keller-Killani Test) 
Add 2 ml of glacial acetic acid containing a drop of ferric chloride solution  and 
and 0.5 ml of concentrated sulphuric acid to the chloroform extract of the plant. The blue 
color in the acetic acetic acid layer shows presence of cardiac glycosides. 
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4.2.3  chemical analysis:  
Proximate Chemical Analysis of a Drug 
Methodology For Chemcial Analysis 
Preparation of Extract : 
Add 5 gm of the sample to 50ml of distilled water. Boil the solution for 20 minutes, cool 
and then filter. Use the Extract for the following tests. 
S.No Experiment Observation Inference 
1. Test for reducing Sugar : 
To 5ml of Benedicts qualitative 
reagent, add 10 drops of extract, 
then boil for two minutes 
Green / Yellow / 
Red PPT 
Presence of 
Reducing Sugar 
2. Test for Starch : 
To 5 ml of extract add 2ml of acetic 
acid and then add few drops of N/50 
Iodine Solution. 
Blue Colour Presence of 
Starch 
3. Test for Proteins : 
To 2 ml of extract, add 2ml of 5% 
Sodium Hydroxide mix and add 2 
drops of Copper Sulphate Solution. 
Violet or Purple 
Colour 
Presence of 
Proteins 
4. Test for amino Acid : 
Place  2 drops of extract on a filter 
paper and allow to dry well. Then 
spray 1% ninhydrin over the same 
and allow to dry. 
Violet Colour Presence of 
Amino Acid 
5. Test for Albumin : 
To 2 ml of extract, add 2ml of 
Esboch’s reagent. 
Yellow PPT Presence of 
Albumin 
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S.No Experiment Observation Inference 
6. Test for Phosphate : 
To 2ml of extract, add 2ml of 
ammonium Molybdate solution and 
2ml of concentrated Nitric Acid. 
Yellow PPT Presence of 
Phosphate 
7. Test for Sulphate : 
To 2 ml of extract add 2ml of 4% 
ammonium oxalate solution. 
White PPT Presence of 
Sulphate 
8. Test for Chloride :  
Add 2ml of extract to dilute nitric 
acid till the effervescence ceases. 
Then add 2 ml of Silver Nitrate 
Solution. 
Cloudy White PPT Presence of 
Chloride 
9. Test for Iron : 
To 2ml of extract, add 2ml of 
ammonium thio cynate solution and 
add 2ml of concentrated Nitric 
Acid. 
Red Colour Presence of Iron 
10. Test for Calcium : 
To 2 ml of extract, add 2 ml of 4% 
ammonium Oxalate Solution. 
White PPT Presence of 
Calcium 
11. Test for Sodium : 
Make a paste with 2 pinches of the 
sample with Hcl and Introduce it 
into the blue flame.  
Yellow Flame Presence of 
Sodium 
12. Test for Potassium : 
Add a pinch of the sample to 2 ml 
of Sodium Nitrate Solution. Then 
add 2ml of Cobal Nitrate in 20% 
acetic acid. 
Yellow PPT Presence of 
Potassium 
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S.No Experiment Observation Inference 
13. Test for Zinc : 
To 2ml of extract, add few drops of 
Sodium Hydroxide. 
White PPT Presence of Zinc 
14. Test for Magnesium : 
To 2ml of extract, add few drops of 
Sodium Hydroxide Solution 
White PPT Presence of 
Magnesium 
15. Test for Alkaloids : 
a. To 2ml of extract, add 2ml 
of Potassium Iodide Solution
b. To 2ml of extract add 2ml of 
Picric Acid. 
c. To 2 ml of extract add 2ml 
of Phosphotunqstic Acid. 
 
Red Colour 
 
 
Yellow Colour 
 
White PPT 
 
Presence of 
Alkaloids 
 
Presence of 
Alkaloids 
Presence of 
Alkaloids 
16. Test for Tannic Acid : 
To 2ml of extract add 2 ml of Ferric 
Chloride Solution 
Black PPT Presence of Tannic 
Acid 
 
4.3. TOXICOLOGICAL STUDY : 
EVALUATION OF ACUTE AND SUB ACUTE TOXICITY STUDY ON                  
HINGU CHOORANAM  
Animals:  
 Mice of either sex weighing 25-30g and rats weighing 210-240g were obtained 
from the animal house of Vels University. The animals were used with the approval of 
the Institute animal ethics committee and obtained from Vels University, Chennai. They 
were fed with a balanced standard pellet diet and maintained under standard laboratory 
conditions, providing 24-280C temperature, standard light cycle (12 h light, 12 h dark) 
and water ad libitum.  
 Animals were kept in cages with raised floors of wide mesh to prevent 
coprophagy. Animal welfare guidelines were observed during the maintenance period 
and experimentation. The rats were randomly assigned to control and different treatment 
groups, six animals per group. The animals were acclimatized for one week under 
laboratory conditions.  
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Acute toxicity study-oecd 425 guidelines: 
 Acute oral toxicity test for the Hingu Chooranam was carried out as per OECD 
Guidelines 425. As with other sequential test designs, care was taken to ensure that 
animals are available in the appropriate size and age range for the entire study. The test 
substance is administered in a single dose by gavage using a stomach tube or a suitable 
intubation cannula. The fasted body weight of each animal is determined and the dose is  
calculated according to the body weight. After the substance has been administered, food 
was withheld for a further 2 hours in mice.  
 The animals were observed continuously for the first 4 h and then each hour for 
the next 24 h and at 6 hourly intervals for the following 48 h after administering of the 
test drug, to observe any death or changes in general behaviour and other physiological 
activities. Single animals are dosed in sequence usually at 48 h intervals. However, the 
time interval between dosing is determined by the onset, duration, and severity of toxic 
signs. Treatment of an animal at the next dose was delayed until one is confident of 
survival of the previously dosed animal. General behavior, respiratory pattern, 
cardiovascular signs, motor activities, reflexes, change in skin and fur, mortality and the 
body weight changes were monitored daily. The time of onset, intensity, and duration of 
these signs, if any, was recorded.  
Sub-acute toxicity : 
In a 28-days sub acute toxicity study, twenty four either sex rats were divided into 
four groups of 6 rats each. Group I that served as normal control was administered with 
distilled water (p.o.) while groups II, III and IV were administered daily with the Hingu 
Chooranam (p.o.) for 28 days at a dose of 100, 200 and 400mg/kg respectively. The 
animals were then observed daily for gross behavioural changes and any other signs of 
subacute toxicity.  
 The weight of each rat was recorded on day 0 and weekly throughout the course 
of the study, food and water consumption per rat was calculated. At the end of the 28 
days they were fasted overnight, each animal was anaesthetized with diethylether, 
following which they were then dissected and blood samples were obtained by cardiac 
puncture into heparinised tubes. The blood sample collected from each rat was 
centrifuged with 3000 X g at 4oC for 10 min to separate the serum and used for the 
biochemical assays.  
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Hematological and blood biochemical analysis : 
 At the end of the study, all animals were kept fasted for 16-18 h and then 
anesthetized with anesthetic ether on the 28th day. Blood samples for hematological and 
blood chemical analyses were taken from retro orbital vein. Heparinized blood samples 
were taken for determining complete blood count (white blood cell count, differential 
white blood cell count, platelet count, red blood cell count, hematocrit, and hemoglobin) 
by semiautomated hematology analyzer.  
 The serum from non-heparinized blood was carefully collected for blood 
chemistry and enzyme analysis glucose, creatinine, total protein, albumin, total and direct 
bilirubins, serum glutamate-oxaloacetate transaminase (SGOT), serum glutamate 
pyruvate transaminase (SGPT), and alkaline phosphatase (ALP)) were automatically 
determined using autoanalyzer. 
Necropsy : 
 All rats were sacrificed after the blood collection. The positions, shapes, sizes and 
colors of internal organs were evaluated. The Spleen, Testes, Pancrea, Lung, Liver, 
Brain, Heart, Stomach, Intestine, Bone, Ovary, and Kidney tissues were excised from all 
rats to visually detect gross lesions, and weighed to determine relative organs’ weights 
and preserved in 10% neutral formalin for histopathological assessment. The tissues were 
embedded in paraffin, and then sectioned, stained with haematoxylin and eosin and were 
examined microscopically. 
Statistical analysis : 
Values were represented as mean ± SEM. Data were analysed using one-way 
analysis of variance (ANOVA) and group means were compared using the Tukey-
Kramer Multiple Comparison test using GraphPad Instat-V3 software. P < 0.05 were 
considered significant. 
4.4. PHARMACOLOGICAL STUDY: 
EVALUATION OF ANTIULCER PROPERTY OF HINGU CHOORANAM  
Introduction: 
 The prevalence of gastrointestinal ulcers differs around the world: duodenal 
ulcers are dominant the Western populations and gastric ulcers are more frequent in Asia, 
especially in Japan. As the prevalence of this disease increases over time, one would 
expect peptic ulcers to continue to have a significant global impact in the basic health and 
economic systems and in patients' life quality. Peptic ulcers are a deep gastrointestinal 
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erosion disorder that involves the entire mucosal thickness, penetrating the muscular 
mucosa.  
 For decades it was believed that gastrointestinal ulcerations were caused by the 
excessive secretion of gastric acid, but many patients presenting such ulcerations had 
normal acid secretion rates. Then, researchers reported that peptic ulcers were been 
caused by an imbalance between the aggressive factors and a number of known defense 
mechanisms. Exogenous aggressive factors such as smoke, anti-inflammatory drugs, 
alcohol, stress, fatty foods and Helicobacter pylori infections triggered tissue necrosis 
through mucosal ischemia, free radical generation and cessation of nutrient delivery,  
hydrochloric acid together with pepsin, pancreatic enzymes and bile decreased the 
defense mechanisms of gastrointestinal mucosa such as the intercellular junctions, local 
blood flow, mucus/bicarbonate secretion and cellular growth.  
 In recent years, a large advance in chemical and pharmacological studies has 
contributed to the knowledge about new therapeutically active compounds obtained from 
the natural products. These compounds can be used directly as leads for the development 
of new medicines or as pharmacological tools to discover new active compounds, so they 
can be life-saving or determine the quality of life in long-lasting diseases.  
 However, the incorrect use of the natural products offers dangers to society, so it 
is important to identify the active compounds, linking its structure with the biological 
activity and report the correct manner to use them with regards to dose, route of 
administration and frequency of use. Hence, the present study was undertaken to 
systematically determine the acute toxicity and antiulcer potential of the Hingu 
Chooranam using Aspirin induced experimental ulcer model. 
Materials and methods : 
Chemicals : 
 All chemicals used in the present study were analytical grade and purchased from 
SD fine chemicals Ltd (Mumbai, India). Aspirin was obtained from BD Pharmaceutical 
Works and Ranitidine (Reference drug) was obtained from Ranbaxy Laboratories. 
Stock solution preparation:  
 The powdered form of Hingu Chooranam was mixed uniformly in 2% CMC 
solution to achieve 100mg/ml as main stock solution and used in this study.  
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Animals 
 Albino mice of either sex weighing 25-30g (For acute toxicity study) and Healthy 
Swiss Albino rats of the Wister strain weighing 150-200 g were used for the study. The 
animals were used with the approval of the Institute animal ethics committee and 
obtained from Vels University, Chennai. They were fed with a balanced standard pellet 
diet and maintained under standard laboratory conditions, providing 24±280C 
temperature, standard light cycle (12 h light, 12 h dark) and water ad libitum. Animals 
were kept in cages with raised floors of wide mesh to prevent coprophagy. Animal 
welfare guidelines were observed during the maintenance period and experimentation. 
The rats were randomly assigned to control and different treatment groups, six animals 
per group. (XIII/VELS/PCOL/45/2000/CPCSEA/IAEC/08.08.2012). The animals were 
acclimatized for one week under laboratory conditions.  
Acute toxicity study 
 Acute oral toxicity test for the Hingu Chooranam was carried out as per OECD 
Guidelines 425. As with other sequential test designs, care was taken to ensure that 
animals are available in the appropriate size and age range for the entire study. The test 
substance is administered in a single dose by gavage using a stomach tube or a suitable 
intubation cannula. The fasted body weight of each animal is determined and the dose is 
calculated according to the body weight. After the substance has been administered, food  
was withheld for a further 2 hours in mice. Single animals are dosed in sequence usually 
at 48 h intervals.  
 However, the time interval between dosing is determined by the onset, duration, 
and severity of toxic signs. Treatment of an animal at the next dose was delayed until one 
is confident of survival of the previously dosed animal. The time interval was adjusted as 
appropriately in case of inconclusive response. The test is simpler to implement when a 
single time interval is used for making sequential dosing decisions. Special attention was 
given during the first 4 hours and daily thereafter, for a total of 14 days, except where 
they need to be removed from the study and humanely killed for animal welfare reasons 
or are found dead.  
 All observations are systematically recorded and Observations include changes in 
skin and fur, eyes and mucous membranes, and also respiratory, circulatory, autonomic 
and central nervous systems, and somatomotor activity and behaviour pattern. Attention 
was directed to observations of tremors, convulsions, salivation, diarrhea, lethargy, sleep 
and coma. The principles and criteria summarized in the Humane Endpoints Guidance 
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Document taken into consideration. Animals found in a moribund condition and animals 
showing severe pain or enduring signs of severe distress was humanely killed. When 
animals are killed for humane reasons or found dead, the time of death was recorded.  
Anti-ulcer evaluation: 
Aspirin induced gastric ulcer: 
 Animals were divided into four groups (n = 6) Hingu Chooranam (100, 
200mg/kg) inter peritoneal and control vehicle were administered 30 min. before the 
administration of aspirin (400mg/kg) per orally. The animals were scarified, after 6 hours  
following the administration of aspirin, stomachs were removed and 2% formalin was 
injected into the stomach. The stomach was open along with greater curvature and 
immersed in 2% formalin solution. The length of each lesion was measured under the 
dissecting microscope. The sum of the length (mm) of all lesions for each rat was used in 
lesion index. 
 The ulcer score was determined by using a 10 × magnifying hand lens. The 
scoring of severity of ulceration was as follows: 1 mm (pin point) = 1; 1-2 mm = 2; > 2 
mm = 3; > 3 mm = 4. The mean ulcer score was determined by dividing the total ulcer 
indices in a group by the total number of animals in that group. Ulcer Score = Total ulcer 
index (UI) in a group/Total number of animals in that group.              
Statistical analysis:  
 The statistical analysis was carried out using one-way ANOVA followed by 
Dunnett's multiple comparison test. All the results obtained in the study were compared 
with the vehicle control group. P values <0.05 were considered statistically significant. 
4.5. CLINICAL ASSESSMENT: 
 Nowadays Life style changed the food habits. This condition made considerable 
impact in changing the human physiology into pathology. Which leads to GI disorders 
are emerged. Even though there is a lot of medications available for this disease, still 
there is a thrive for less adverse effect drugs. Herbal medicines are playing vital role on 
curing diseases without marked adverse effects even though on long term intake. From 
this plant kingdom I have selected this herb which proved its anti – ulcer activity pre 
clinically. Hingu chooranam, a herbal medicine was used for this clinical trial to prove 
its safety and efficacy against Peptic ulcer disease. 
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Objectives : 
 The study was conducted on peptic ulcer patients to assess the “anti-ulcer” 
activity of “HINGU CHOORANAM” clinically, both in-patients and out-patients of both 
sex and varying age groups.  
Study centre : 
 The clinical study for PEPTIC ULCER is carried out in outpatient department 
and in patient ward of Govt.Siddha medical college hospital and Arignar Anna  Indian 
Hospital, Arumbakkam, Chennai-106. 
Design of the study: 
Open clinical trial, phase II B  
Selection: 
50 patients from both sexes of various age groups were selected for clinical trial. 
Among 50 patients 40 patients were treated as out-patients, 10 patients were treated as in 
– patients. The selection was based on the including and excluding criteria.  They were 
clinically diagnosed on the basis of siddha principles with modern laboratory findings. 
Registration process 
To register a patient, the following documents has been proceeded. 
¾ Copy of required laboratory tests 
¾ Signed patient consent form 
 then  I verified  eligibility and assigned  a patient study number, drug dose and registered 
the patient on the study. 
Criteria selection: 
Including criteria: 
K Epigastric pain 
K Heart burn 
K Regurgitation  
K Nausea/vomiting 
K Loss of appetite 
K Abdominal discomfort 
Excluding criteria: 
K Complication of peptic ulcer such as  
K Haemorrhage,  
K Perforation, 
K Gastric outlet obstruction 
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K Radiating abdominal pain as in pancreatitis, appendicitis 
K Acute abdominal colic’s 
K Cancer of the stomach  
K Gall stone and hiatus hernia  
K Cirrhosis of liver and jaundice 
Criteria for withdrawal: 
Patients were removed from study when any of the criteria listed below applies.In the 
absence of treatment delays due to adverse events, treatment may continue for 2 cycles or 
until one of the following criteria applies: 
¾ Disease progression, 
¾ Deterioration of vital signs with cardiac, respiratory, hepatic, renal and 
CNS changes. 
¾ Intercurrent illness that prevents further administration of treatment, 
¾ Unacceptable adverse event(s), 
¾ Patient decides to withdraw from the study, or  
¾ General or specific changes in the patient’s condition render the patient 
unacceptable for further treatment in the judgment of the investigator. 
Investigation: 
For all the cases full clinical data were recorded and they were diagnosed on the 
basis of SIDDHA principles i.e. ENVAGAI THRVUGAL, EZHU UDAL THATHUKKAL 
etc. All the patients under study were subjected to blood investigations for TC, DC, ESR, 
and Hb. Blood urea, serum cholesterol and Blood sugar were also investigated. 
Urine test for albumin, sugar, deposits and motion test for ova, cysts were done. 
  The disease Peptic Ulcer was confirmed in the patients by means of Endoscope 
examination, Barium meal examination and clinically. 
Routine examination and assessment : 
 The full details of history and physical examination of the patients were recorded 
as per the proforma. The clinical assessment was done initially at the end of 7 days, 14 
days and 21 days during treatment and at the end of the 21 days follow up were done. 
The laboratory investigation and the physiological parameters will be recorded initially 
and the end of the treatment and at follows up as per the Proforma. 
 
 
 
117 
 
Administration of the drug: 
 Form of the medicine  :  Chooranam 
 Route of Administration :  Enteral 
 Dose    :  3 Pinches 
 Anubanam (Vehicle)  :  Warm water 
 Times of Administration :  Two times a day; before food 
 Duration   :  7 weeks 
Diet and medical advice: 
Do’s 
¾ Timely food 
¾ Banana  
¾ Almond milk 
¾ Raw goat’s milk 
¾ Carrots and cabbage juice 
¾ Butter milk 
¾ Should chew every morsel thoroughly 
¾ Meals must be small and frequent 
 Dont’s 
¾ Fatty and tough meats 
¾ Fried foods, Sour foods  
¾ Unripe citrus fruits like oranges and sweet lime 
¾ Spicy foods, carbonated drinks 
¾ Strongly flavored veggies like cauliflower, turnip, radish, onion, etc 
¾ Strong tea and coffee 
 Alcoholic Beverages 
¾ Intake of steroids and NSAIDS. 
¾  Above all avoid worrying! 
Trial conduct: 
 This study will be conducted in compliance with the protocol approved by the 
Institutional Review Board, and according to Good Clinical Practice standards. No 
deviation from the protocol will be implemented without the prior review and approval of 
the IRB except where it may be necessary to eliminate an immediate hazard to a research 
subject. In such case, the deviation will be reported to the IRB as soon as possible. 
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Criteria for assessment of response to therapy: 
1) Good Relief : 75% relief in the presenting signs and symptoms 
marked normality pathological investigation. 
2) Satisfactory : 60 – 75% relief signs and symptoms, moderate 
normality of pathological investigation. 
3) Moderate : 50% relief of signs and symptoms, mild changes in 
pathological investigations. 
4) Poor :  less than 50% relief in symptoms and no significant 
improvement in laboratory parameters. 
Then clinical signs and symptoms like Epigastric pain, Heart burn, regurgitation 
and distension of abdomen were observed regularly under the supervision of HOD, 
Lecturers, and Asst.Lecturers.  
Follow up : 
Assessment was taken for every three days before treatment and after treatment. 
During this period clinical assessment and laboratory investigation was carried out. 
Statistical analysis : 
The data will be tabulated and analyzed by students ‘T’ test. The resuls are 
showed in Table:8 and 9. 
Ethical review : 
The protocol and amendments were submitted to the Govt siddha medical 
college, Institutional Ethical Committee (IEC) and got formal approval for conducting 
the study. The decision of the IEC concerning the conduct of the study was made in 
writing to the investigator. 
All subjects for this study was provided a consent form describing this study and 
provided sufficient information for subjects to make an informed decision about their 
participation in this study. This consent form was submitted with the protocol for review 
and approval by the IEC. The formal consent of a subject, using the IEC-approved  
consent form, was obtained before that subject is submitted to any study procedure. This 
consent  form  was  signed  by  the  subject or  legally  acceptable  surrogate,  and  the 
investigator-designated research professional obtaining the consent.  
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CLINICAL STUDY ON HINGU CHOORANAM IN OUT PATIENTS DEPT. IN THE MANAGEMENT OF PEPTIC ULCER 
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L
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1. 7185 Saraeshwathy 
23/ Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
23.7.12 
To 
1.9.12 
BT 8900 56 40 4 8 20 12 80 23 148 NIL NIL NIL  
 Good 
 AT 9700 58 38 4 10 20 12 80 24 152 NIL NIL NIL  
2. 9577 
 
Aashivatham 
63/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
1.8.12 
To 
10.9.12 
BT 9700 57 36 7 10 24 12 83 38 183 NIL NIL FPC  
- 
Good 
 
AT 9700 57 39 4 14 24 12 94 26 180 NIL NIL NIL 
3. 1573 Sivagami 
60/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
8.8.12 
To 
19.9.12 
BT 8500 58 38 4 13 20 12 100 20 160 NIL NIL FPC  
- 
Good 
 
AT 8500 58 38 4 15 23 12 100 22 165 NIL NIL NIL 
4. 5742 Selvanathan 
38/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
10.8.12 
To 
21.9.12 
BT 9700 57 39 4 14 24 12 85 24 165 NIL NIL FPC  
- 
Good 
 
AT 9700 55 41 4 12 24 13 85 18 160 NIL NIL NIL 
5. 3224
… 
Rathinam 
42/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
11.8.12 
To 
24.9.12 
BT 9200 56 39 5 27 43 12 94 24 162 NIL NIL NIL  
- 
 
Satisfactory   
                   AT 9200 57 39 4 26 44 13 94 26 168 NIL NIL NIL 
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6. 4521 Meenakshi 
32/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
14.8.12 
To 
27.9.12 
BT 8600 53 43 4 12 23 11 94 26 150 NIL NIL PCS  
- 
Good 
 
AT 8600 54 42 4 14 26 11.5 96 24 144 NIL NIL NIL 
7. 598 Mani 
43/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
17.8.12 
To 
1.10.12 
 
BT 9500 57 37 6 14 32 12.5 85 23 164 NIL NIL NIL  
- 
Good 
 
AT 9500 58 38 4 14 30 13.5 86 20 163 NIL NIL NIL 
8. 5872 Shanmugam 
34/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
25.8.12 
To 
7.10.12 
BT 9400 57 39 4 15 33 12 95 21 159 NIL NIL FPC  
- 
 
Moderate 
AT 9400 58 38 4 15 30 14 93 23 168 NIL NIL NIL 
9. 5649 Latha 
46/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
27.8.12 
To 
8.10.12 
BT 9300 56 39 5 6 13 11 99 21 161 NIL NIL NIL  
- 
Good 
 
AT 9300 58 37 5 6 13 11 98 26 157 NIL NIL NIL 
10. 5896 Valli 
47/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
28.8.12 
To 
8.10.12 
BT 10200 56 38 6 24 40 11.2 121 19 156 NIL NIL FPC  
- 
Good 
 
 
                   
AT 10200 54 41 5 22 38 12 118 20 164 NIL NIL NIL 
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11. 986 Govindhan 
38/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
29.8.12 
To 
10.10.12 
BT 8700 58 37 5 20 43 12.
5 
85 23 162 NIL NIL PCS  
- 
Good 
 
AT 8900 59 36 5 22 40 12.
5 
85 19 158 NIL NIL NIL 
12. 1026 Sundareswari 
34/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
30.8.12 
To 
12.10.12 
BT 9500 56 40 4 15 30 11.
6 
84 21 168 NIL NIL NIL  
- 
Good 
 
AT 9600 55 41 4 14 32 11 80 19 162 NIL NIL NIL 
13. 3274 Senthil kumar 
36/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
3.9.12 
To 
15.10.12 
BT 9900 59 36 5 12 20 13 85 23 171 NIL NIL FPC  
- 
Good 
 
AT 9900 56 39 5 12 20 12.
5 
84 26 164 NIL NIL NIL 
14. 5923 Aarumugam 
54/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
5.9.12 
To 
16.10.12 
BT 8600 57 38 5 20 42 12.
5 
75 26 162 NIL NIL NIL  
- 
Moderate 
AT 8600 55 40 5 22 45 12 75 23 166 NIL NIL NIL 
15. 1273 Selvi 
36/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
6.9.12 
To 
17.10.12 
BT 10000 61 32 7 13 26 12 98 26 158 NIL NIL FPC  
- 
 
 
Good 
 
                   
AT 10000 63 32 5 13 24 12 115 28 165 NIL NIL NIL 
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16. 853 Nagajothi 
37/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
9.9.12 
To 
18.10.12 
BT 9700 56 38 6 12 28 11.5 95 21 155 NIL NIL PCS  
- 
    
Satisfactory    
AT 9800 56 39 5 10 24 11 94 26 166 NIL NIL FPC 
17. 3258 Rajan 
43/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
12.9.12 
To 
23.10.12 
BT 9500 58 38 4 15 43 13 116 26 158 NIL NIL NIL  
- 
Good 
 
AT 9600 58 37 5 14 40 12.5 108 20 160 NIL NIL NIL 
18. 245 Aaisha 
32/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
15.9.12 
To 
26.10.12 
BT 9300 58 37 5 8 18 14 108 27 153 NIL NIL FPC  
- 
Good 
AT 9300 59 38 3 10 15 13 110 23 162 NIL NIL NIL 
19. 5644 Thangam 
54/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
17.9.12 
To 
29.10.12 
BT 8600 60 35 5 14 32 10.6 89 36 165 NIL NIL NIL  
- 
Good 
 
AT 8500 58 37 5 14 30 10 89 26 158 NIL NIL NIL 
20. 1836 Sundhar 
36/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
21.9.12 
To 
1.11.12 
BT 8900 53 40 7 22 43 12.5 89 23 159 NIL NIL PCS  
- 
 
Moderate 
 
                   
AT 8700 55 39 6 14 30 13 86 22 160 NIL NIL FPC 
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21. 1421 Ssvitha 
32/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
24.9.12 
To 
5.11.12 
BT 10300 61 34 5 13 30 11.4 105 23 162 NIL NIL PCS  
- 
Good 
 
AT 10300 60 36 4 12 24 11.5 106 19 164 NIL NIL FPC 
22. 5831 Ansaari 
37/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
30.9.12 
To 
11.11.12 
BT 10000 57 38 5 35 60 13.5 101 28 168 NIL NIL PCS  
- 
Good 
 
AT 10100 60 34 6 15 30 13 96 21 160 NIL NIL NIL 
23. 3229 Krishnan 
42/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
6.10.12 
To 
17.11.12 
BT 9900 59 34 7 13 30 12 87 21 162 NIL NIL FPC  
- 
Good 
 
AT 9800 58 36 6 12 24 12.5 88 23 158 NIL NIL NIL 
24. 6134 Revathy 
51/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
10.10.12 
To 
22.11.12 
BT 8600 56 37 7 10 20 11.5 89 26 158 NIL NIL PCS  
- 
    Good 
AT 8500 57 39 4 8 28 11 91 20 161 NIL NIL FPC 
25. 6388 Shyamala 
24/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
10.10.12 
To 
21.11.12 
BT 10100 61 34 5 13 34 10 88 20 153 NIL NIL NIL  
- 
Moderate 
 
 
 
                   
AT 10200 62 34 4 11 20 10.5 86 18 155 NIL NIL NIL 
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26. 694 dhanraj 
34/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
13.10.12 
To 
25.11.12 
BT 10000 56 38 6 13 32 11.5 94 24 159  NIL NIL FPC  
- 
Good 
 
AT 9900 58 38 4 10 30 12 83 23 160 NIL NIL NIL 
27. 1387 Hemalatha 
42/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
17.10.12 
To 
29.11.12 
BT 9500 59 36 5 14 34 11.5 112 26 163 NIL NIL PCS  
- 
Good 
 
AT 9600 57 38 5 14 22 11.5 110 18 161 NIL NIL NIL 
28. 5843 Ganesan 
46/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
24.10.12 
To 
5.12012 
BT 10100 62 35 3 8 26 13 85 20 170 NIL NIL NIL 
 
- 
Good 
 
AT 10100 60 36 4 10 30 13 88 18 168 NIL NIL NIL 
29. 316 Maheswari 
37/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
31.10.12 
To 
11.12.12 
BT 10200 55 38 7 12 25 11.5 100 32 167 NIL NIL PCS  
- 
 
      
Satisfactory    AT 10200 58 37 5 12 20 12 98 20 168 NIL NIL FPC 
30. 598 Umamaheswari 
24/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
1.11.12 
To 
13.12.12 
 
BT 8200 61 35 4 5 10 11.5 84 23 152 NIL NIL FPC  
- 
 
 
Good 
                   
AT 8400 60 34 6 5 10 11.6 86 21 154 NIL NIL NIL 
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31. 944 muhamad 
38/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
3.11.12 
To 
13.12.12 
BT 10100 60 35 5 10 30 13 106 32 157 NIL NIL NIL  
- 
 
      
Satisfactory    AT 9900 59 38 3 10 30 13 104 26 155 NIL NIL NIL 
32. 945 Suresh 
37/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
3.11.12 
To 
11.12.12 
BT 9500 57 37 6 6 8 32 115 23 167 NIL NIL PCS  
- 
Good 
 
AT 9600 58 37 5 5 10 24 112 20 160 NIL NIL NIL 
33. 1376 Sumathy 
24/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
5.11.12 
To 
14.12.12 
BT 8400 58 39 3 7 22 11 100 27 157 NIL NIL PCS  
- 
   Good       
AT 8400 56 39 5 7 20 11 97 23 159 NIL NIL FPC 
34. 1377 Girija 
28/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
5.11.12 
To 
15.12.12 
BT 10100 60 36 4 12 32 12 98 18 154 NIL NIL NIL  
- 
Good 
 
AT 9900 57 40 3 8 26 12.5 92 17 158 NIL NIL NIL 
35. 1389 Manikkam 
51/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
 
5.11.12 
To 
13.12.12 
BT 9400 54 39 7 25 50 12 116 22 159 NIL NIL PCS  
- 
 
Moderate 
 
 
                   
AT 9400 55 41 4 15 25 12 126 20 158 NIL NIL FPC 
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36. 1381 Baskar 
35/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
5.11.12 
To 
16.12.12 
BT 9800 59 34 7 8 22 12 100 23 156 NIL NIL NIL  
- 
Good 
 
AT 9700 60 36 4 8 20 12 98 23 149 NIL NIL NIL 
37. 1677 Kannan 
40/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
6.11.12 
To 
17.12.12 
BT 10000 59 36 5 14 36 12 100 26 168 NIL NIL PCS  
- 
Good 
 
AT 10000 61 35 4 8 32 12.
5 
108 20 164 NIL NIL FPC 
38. 1927 Rajavel 
41/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
7.11.12 
To 
18.12.12 
BT 8900 58 37 5 14 30 12 120 21 162 NIL NIL PCS  
- 
Moderate 
AT 8700 56 39 5 10 20 12 118 23 163 NIL NIL FPC 
39. 1929 Selvakumar 
35/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
7.11.12 
To 
17.12.12 
BT 9100 61 32 7 12 20 12.
5 
88 22 158 NIL NIL FPC  
- 
Good 
 
AT 9200 64 31 5 10 24 12.
8 
87 26 165 NIL NIL NIL 
40. 1935 Rathinasamy 
40/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
7.11.12 
To 
19.12.12 
BT 8100 57 36 7 10 15 12.
5 
98 22 159 NIL NIL NIL  
- 
 
Good 
 
                   
AT 8200 60 34 6 10 26 13 93 18 158 NIL NIL NIL 
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CLINICAL STUDY ON HINGU CHOORANAM  IN, IN-PATIENTS DEPT.IN THE MANAGEMENT OF GUNMAM 
 
 
 
 
SI 
NO 
IP. 
No Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD    
Blo
od 
CL 
Urine X ray bms/ 
Endoscopy TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
1. 711/   
7334 
 
Sikkanthar 
baanu 
52/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
18.6.12 
To 
27.6.12 
BT 9200 58 37 5 15 45 10.4 110 19 166 NIL NIL PCS  
- 
 
 
Poor 
AT 9100 59 38 3 16 46 10.6 102 20 162 NIL NIL NIL 
2. 1079/
7070 
Palani 
38/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
23.7.12 
To 
1.9.12 
BT 10000 57 39 4 11 28 12 110 23 159 NIL NIL PCS  
- 
Good 
 
AT 9900 57 40 3 13 35 12.5 108 24 162 NIL NIL NIL 
3. 1219/
1109 
Ramakrishnan 
42/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
7.8.12 
To 
15.8.12 
BT 10100 62 32 6 12 32 11.6 106 36 171 NIL NIL FPC  
- 
Good 
 
AT 9700 60 38 2 10 20 11.8 110 28 164 NIL NIL NIL 
4. 1364/
5791 
Kalyani 
50/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
28.8.12 
To 
7.9.12 
BT 8800 57 40 3 8 36 11 108 23 164 NIL NIL FPC  
- 
Good 
 
AT 8100 60 36 4 7 28 11 110 26 157 NIL NIL NIL 
5. 1353/
5570 
Eswari                
50/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
27.8.12 
To 
3.9.12 
BT 9500 58 37 5 14 26 9.6 116 20 163 NIL NIL NIL  
- 
 
Satisfactory     
AT 9300 61 36 3 10 30 9 106 23 157 NIL NIL NIL 
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CLINICAL STUDY ON HINGU  CHOORANAM IN, IN-PATIENTS DEPT.IN THE MANAGEMENT OF GUNMAM 
 
 
 
SI 
NO 
IP. 
No Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD    
Blo
od 
CL 
Urine X ray bms/ 
Endoscopy TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
6. 1494/
9533 
Moorthy 
52/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
12.9.12 
To 
10.10.12 
BT 8100 57 36 7 8 28 11 110 22 163 NIL NIL PCS  
- 
 
 
Poor 
 
AT 7400 60 37 3 10 20 10.8 120 26 162 NIL NIL NIL 
7. 167/  
4480 
Ajmalkan  
48/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
4.10.12 
To 
19.11.12 
BT 10200 55 38 7 10 20 12.6 108 26 159 NIL NIL FPC  
- 
Good 
 
AT 10100 60 36 4 12 32 12 120 23 156 NIL NIL NIL 
8. 341/   
593 
Raja 
35/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
1.11.12 
To 
13.12.12 
BT 9300 55 40 5 15 40 12.5 106 20 158 NIL NIL FPC  
- 
Moderate 
AT 9100 56 38 6 10 30 12.5 110 23 162 NIL NIL NIL 
9. 376/  
1785 
Palani 
34/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
7.11.12 
To 
21.12.12 
BT 9900 60 36 4 8 28 12.5 104 23 160 NIL NIL FPC  
- 
Good 
 
AT 9700 58 36 6 15 32 12.8 98 21 159 NIL NIL NIL 
10. 393/  
2738 
Kannan          
35/MMale 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
12.11.12 
To 
19.12.12 
BT 8300 55 38 7 15 32 12.5 94 26 163 NIL NIL NIL  
- 
 
 
Good          AT 8100 60 36    4 12 30 12.6 90 23 160 NIL NIL NIL 
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CLINICAL ASSESSMENT 
AGE WISE DISTRIBUTION 
Tablet no 4.5.1 
SL. NO AGE IN YEARS NO. OF PATIENTS PERCENTAGE (%) 
1 20-30 5 10 
2 31-40 24 48 
3 41-50 13 26 
4 51-60 6 12 
5 61-70 2 4 
TOTAL 50 100 
 
 
 
AGE WISE DISTRIBUTION 
 
Inference: 
Among 50 patients, 
 5 patients belongs to the age group of 20-30 years 
 24 patients belongs to the age group of 31-40 years 
 13 patients belongs to the age group of 41-50 years 
 9 patients belongs to the age group of 51-60 years 
 2 patients belongs to the age group of 51-60 years 
0
10
20
30
40
50
60
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SEX DISTRIBUTION 
Tablet no 4.5.2 
SL. NO SEX NO. OF 
PATIENTS 
PERCENTAGE 
1 Male 29 58 
2 Female 21 42 
 
 
 
Inference: 
Among 50 patients, 
• 29 patients were male 
• 21 patients were female 
SOCIO-ECONOMIC STATUS 
Tablet no 4.5.3 
SL. NO SOCIO–ECONOMIC STATUS NO. OF PATIENTS PERCENTAGE (%) 
1 Poor 26 52 
2 Lower middle 16 32 
3 Upper middle 6 12 
4 Rich 2 4 
TOTAL 50 100 
 
0
10
20
30
40
50
60
70
Male Female
No.of.Patients
Percentage
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SOCIO-ECONOMIC STATUS 
 
 
Inference: 
 Among 50 patients, 
• 26 patients were poor. 
• 16 patients were lower-middle. 
• 6 patients were upper middle. 
• 2 patients were rich. 
  
OCCUPATIONAL STATU 
Tablet no 4.5.4 
SL. NO OCCUPATION NO. OF PATIENTS PERCENTAGE (%) 
1 Students 4 8 
2 Home makers 13 26 
3 Retired persons 4 8 
4 Drivers 12 24 
5 Workers 17 34 
TOTAL 50 100 
 
 
 
0
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OCCUPATIONAL STATUS 
 
Inference: 
 Among 50 patients, 
• 4 (8%) patients were Students. 
• 13 (26%) patients were Home makers. 
• 4 (8%) patients were Retired persons. 
• 12 (24%) patients were Drivers. 
• 17 (34%) patients were Workers. 
PERSONAL HABITS 
Tablet no 4.5.5 
SL. NO PERSONAL HABITS NO. OF PATIENTS PERCENTAGE (%) 
1 Vegetarian 15 30 
2 Non-vegetarian 35 70 
3 Smoking 12 24 
4 Alcohol 14 28 
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4.2.1  physico-chemical analysis: 
 
REPORT OF HINGU CHOORANAM 
Table : 4.2.1.1 
 
S.No Parameter Mean Value 
1.  Loss on Drying at 105°C 8.098 % 
2.  Total Ash  12.197 % 
3.  Acid insoluble Ash   0.89 % 
4.  Water Soluble Extractive 33.3 % 
5.  Alcohol Soluble Extractive 23.95 % 
6.  Particle size 44 
7.  pH 6.0 
 
Physico-chemical analysis revealed that the Ash and  Acid insoluble Ash value were with 
in limits. In indicates the purity of sample. 
4.2.1.2 TLC   Estimation of Hingu chooranam : 
 
                                 Figure no : 4.2.1.2 
 
                                                After spray with visualizing agent 
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Table : 4.2.1.2 
Sl.No After Dipping in Vanillin-Sulphuric acid 
 
Rf value Colour of the spot 
 
1 0.24 Purple 
2 0.31 Purple 
3 0.40 Purple 
4 0.49 Purple 
5 0.55 Purple 
6 0.65 Purple 
8 0.82 Blue 
 
Thin Layer Chromotography is utilised for accurate identification and adulterant 
of the plant drug.. Identification was effected by observation of spots of identical Rf 
value and about equal magnitude obtained, respectively, with an unknown and a 
reference sample chromatographed on the same plate. The visual comparison of the size 
and intensity of the spots supported in semi-quantitative estimation of plant. 
Standardization of drugs aids in confirmation of identity and determination of 
quality, effectiveness of Hingu chooranam. 
4.2.1.3. Fourier transform infrared spectroscopy (FTIR) 
FTIR results of Hingu chooranam 
 3358 cm-1 -  Monomeric -- Alcohols, Phenols  (O – H stretching)
     Hydrogen-bonded -- Alcohols, Phenols   
 2925.4 cm-1 -  Alkyl  ( C-H stretching ) 
 2119.9 cm-1 -  Carboxylic acids    (O-H stretching) 
1636 cm-1 -   Amines    (N-H stretching) 
1438 cm-1 -  Alkanes   (C-H stretching ) 
1159.2 cm-1 -  Alcohols, Ethers, Carboxylic acids, Esters (C – O  
stretching) 
1030.7 cm-1 -  Amines (C – N stretching) 
868.7 cm-1 -   Aromatic  ( C –H stretching ) 
817.9cm-1 -   Aromatic ( C-H Bending ) 
136 
 
 4.2.1.4. Scanning electron microscope (sem): 
Figure no :4.2.1.4 
 
Results:  
  SEM picture shows Nano particle (Micro level) size of the sample.  
 Physical properties of known elements and materials can change as their surface 
to area ratio is dramatically increased, i.e. when nanoscale sizes are achieved. These 
changes do not take place when going from macro to micro scale. Changes in physical 
properties such as colloidal properties, solubility and catalytic capacity have been found 
very useful in areas of bioremediation and drug delivery. The extremely small size of 
nanoparticles allows them to penetrate cells and interact with cellular molecules. Due to 
nanoparticle size a low dose of the drug can cure the diseases. 
4.2.2  qualitative phytochemical analysis: 
Results and discussion 
Table : 4.2.2 
Qualitative Phytochemical Tests 
1. Alkaloids - ve 
2. Anthraquinone + ve 
3. Flavonoids - ve 
4. Triterpenes + ve 
5. Steroids + ve 
6. Phenol + ve 
7. Tannin + ve 
8. Saponin content - ve 
9. Coumarin + ve 
10. Cardiac glycoside  - ve 
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Discussion :  
  Tannin have anti- ulcer activity, anti- Helicobacter pylori activity and anti- 
oxidant activity (Neyres Zinia Taveira de Jesus 2012 )  
Tannins are used in peptic ulcer disease  because of their astringent properties. 
These properties are due to the fact that tannins react with the tissue proteins . In peptic 
ulcers, this tannin-protein complex layer protects the stomach by promoting greater 
resistance to chemical and mechanical injury or irritation.  Tannins present antioxidant 
activity, promote tissue repair, exhibit anti Helicobacter pylori effects, and also involved 
in gastrointestinal tract anti-inflammatory processes.   
(2002 ). Anthraquinone have anti biotic with anti- Helicobacter pylori activity  
 Tanguchi M et, al., 
Triterpenes have anti –ulcer activity (Queirogo CL et, al., 2000 ) 
Steriods have anti –ulcer activity ( Ahmad Aet, al., 2012 ) 
Coumarin have anti –ulcer activity ( Goel RKet,al., 1997 ) 
Saponin have anti –ulcer activity ( R Gadekaret,al., 2010 ) 
4.2.3  chemical analysis of Hingu chooranam :  
Results: 
The  bio-chemical analysis of Hingu chooranam showed the following chemicals, 
Phosphate, Sulphate, Chloride, Iron, Tannin, Zinc, Protein, Starch, Sugar and Potassium 
present. 
Sodium, potassium, chloride and Calcium regulates the acid – base balance of the 
body and preserves the permeability of cells , hence  helps to balance the aggressive and 
protective factors  of ulcer  by protecting mucosal layer. ( Crystal kaczkowski, 2002 ). 
  Zinc is extremely important in digestive system.  It is required for all digestive 
enzyme production.  It is also required to rebuild the fast-growing intestinal tissue, and 
for the production of bile, and liver and pancreatic secretions.  Ulcers, irritable bowel 
syndrome, yeast infections, colitis, and many other digestive problems often have to do 
with low zinc. ( Lawrence Wilson, 2012 ) 
Potassium  is essential for the maintaining gastric secretions. 
Presence of Sodium, Potassium, Calcium, Ferrous and Phosphate aids in mucosal 
protection and heals ulcer. 
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4.3. Toxlogical study 
Results 
 All the animals from control and all the treated dose groups up to 400 mg/kg 
survived throughout the dosing period of 28 days. No signs of major or significant 
intoxication were observed in animals from lower to higher dose groups during the 
dosing period of 28 days. Animals from all the treated dose groups exhibited comparable 
body weight gain with that of controls throughout the dosing period of 28 days. Food 
consumption of control and treated animals was found to be comparable throughout the 
dosing period of 28days.  
 The results of haematological investigations on day 28, revealed following 
significant changes in the values of different parameters investigated when compared 
with those of respective controls; However, the increase or decrease in the values 
obtained was within normal biological and laboratory limits. Results of Biochemical 
investigations revealed the following significant changes in the values of different 
parameters studied when compared with those of respective controls; however, the values 
obtained were within normal biological and laboratory limits.  
 Ophthalmoscopic examination, conducted prior to and at the end of dosing period 
on animals from control and all the treated dose groups did not reveal any abnormality. 
Functional observation tests conducted at termination revealed no abnormalities. Urine 
analysis, conducted at the end of the dosing period revealed no abnormality attributable 
to the treatment. Organ weight data of animals sacrificed at the end of the dosing period 
was found to be comparable with that of respective controls. Gross pathological 
examination of animals in control as well as the treated groups did not reveal any 
abnormalities. 
Conclusion : 
Based on these findings, no toxic effect was observed upto 400mg/kg of Hingu 
Chooranam treated via oral route over a period of 28 days. So, it can be concluded that 
the Hingu Chooranam can be prescribed for therapeutic use in human with the dosage 
recommendations of upto 400mg/kg. body weight p.o. 
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Table 4.3.1: Dose finding experiment and its behavioral Signs of Toxicity 
N
o 
Dose 
mg/k
g 
1 2 3 4 5 6 7 8 9
1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
1
7 
1
8 
1
9 
2
0 
1 2000 + - - + - + - - - - - - - - - - - - -  - 
2 5000 + - - + - + + - - - - - + - - - - - - - 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle 
Spasm 11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 
15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. 
Mortality 
 
 
Table4.3.2. Body wt (g) of albino rats exposed to Hingu Chooranam for 28days. 
Dose 
(mg/kg/day) 
Days 
1 7 14 21 28 
Control 124.04±5.25 125.54±6.00 124.42±5.28 130.00±6.14 133.01±5.02 
100 127.05±4.38 129.28±5.15 132.10±5.54 135.23±5.10 136.45±6.04 
200 124.20±5.00 128.21±6.88 132.00±4.16 134.14±5.11 137.88±5.18 
400 122.10±5.12 125.52±5.34 131.14±4.41 133.22±6.00 134.54±5.14 
Values are mean of 6 animals ± S.E.M. (Dunnett's test). nsP>0.05. 
     
 
     Table 4.3.3. Food (g/day) intake of rats exposed to Hingu Chooranam for 28days. 
Dose 
(mg/kg/day) 
Days (gms/rats) 
1 7 14 21 28 
Control 44.12±2.48 44.22±2.14 46.10±2.17 45.86±2.52 47.47±3.22 
100 42.20±2.54 45.34±2.48 46.41±2.46 49.17±2.64 48.18±3.40 
200 40.32±2.17 42.06±2.52 44.64±2.44 45.62±3.18 46.04±3.18 
400 43.14±2.62 45.24±2.43 46.18±2.71 45.10±2.04 45.02±3.11 
Values are mean of 6 animals ± S.E.M. (Dunnett's test). nsP>0.05. 
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 Table 4.3.4 Water (ml/day) intake of rats exposed to Hingu Chooranam for 28days. 
 
Dose 
(mg/kg/day) 
Days(ml/rat) 
1 7 14 21 28 
Control 55.46±2.34 52.20±3.32 53.25±3.12 52.34±3.14 51.22±3.22 
100 52.21±2.40 50.28±3.04 45.24±3.02 46.14±3.00 40.56±2.48* 
200 49.44±2.18 40.44±3.70 40.71±3.36 42.15±2.90 41.14±3.24 
400 52.14±3.25 54.26±3.25 51.25±3.42 48.40±3.14 45.21±3.06 
Values are mean of 6 animals ± S.E.M. (Dunnett's test). *P<0.05. 
 
 
Table 4.3.5. Hematological parameters after 28days treatment with Hingu 
Chooranam in rats. 
Parameter Control 100 mg/kg 200 mg/kg 400 mg/kg 
Red blood cell 
(mm3) 
8.11±0.62 8.12±0.45 8.12±0.55 8.00±0.50 
HB (%) 14.20±0.41 15.14±0.30 14.13±0.48 15.11±0.44 
Leukocyte 
(x106/mL) 
10445±110.12 10502±120.45 10400±136.20 10378±117.23 
Platelets/ul 1212±40.10 1291±35.44 1134±38.12 1205±30.40 
MCV (gl) 54.42±5.00 53.53±4.88 55.42±5.12 54.42±4.96 
N 45.22±1.12 45.23±1.20 44.18±0.92 45.51±2.00 
L 25.32±2.82 20.10±3.14 23.58±3.24 26.28±3.80 
M 2.20±0.32 2.10±0.30 2.20±0.28 2.25±0.22 
E 1.00±0.00  1.0±0.20 1.0±0.13 1.00±0.11 
B 0 0 0 0 
ESR(mm) 1±00 1±00 1±00 1±00 
PCV 46.23±2.25 45.41±2.16 45.14±3.04 45.52±3.41 
Values are mean of 6 animals ± S.E.M. (Dunnett's test). nsP>0.05. 
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    Table 4.3.6. Effect of treatment with Hingu Chooranam biochemical parameters. 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Total Bilirubin 
(mg/dL) 
0.211±0.05 0.214±0.06 0.213±0.05 0.215±0.06 
D. Bilirubin (mg/dL) 0.1±0.04 0.1±0.05 0.1±0.04 0.1±0.05
ALP (U/L) 286.30±10.12 274.25±10.26 280.13±10.11 290.21±10.30 
SGOT (U/L) 168.24±6.21 160.67±6.58 156.38±5.80 154.01±5.15 
SGPT(U/L) 45.2±2.30 44.2±3.24 45.00±2.50 46.22±3.10 
Total Protein(g/dl) 10.00±1.23 9.88±0.31 9.02±0.20 9.14±0.30 
Albumin(g/dl) 3.22±0.25 3.12±0.29 3.40±0.33 3.42±0.14 
Globulin(g/dl) 6.00±0.28 5.72±0.28 4.84±0.26* 4.80±0.25* 
Values are mean of 6 animals ± S.E.M. (Dunnett's test). *P<0.05; Vs. Control  
       Table-4.3.7 RFT 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Urea (mg/dL) 55.00±1.42 54.11±2.00 55.00±2.04 54.10±1.88 
Creatinine (mg/dL) 0.75±0.05 0.74±0.05 0.75±0.06 0.74±0.05 
Uric acid (mg/dL) 1.7±0.16 1.6±0.15 1.6±0.12 1.6±0.15 
Na m.mol 142.70±5.42 141.8±5.02 141.10±4.32 141.10±4.08 
K m.mol 20.10±2.88 19.40±1.62 20.20±1.42 20.14±2.00 
Cl m.mol 102.00±4.68 100.11±5.32 99.28±4.28 101.00±5.11 
Values are mean of 6 animals ± S.E.M. (Dunnett's test). nsP>0.05. 
                                              Table-4.3.8. Lipid Profile 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Total cholestrol(mg/dL) 42.55±2.52 41.46±2.40 40.54±3.05 41.00±3.02 
HDL(mg/dL) 13.20±1.32 13.24±1.70 13.12±2.30 13.18±2.23
LDL(mg/dL) 43.11±2.35 44.52±3.00 44.12±3.28 43.40±3.25 
VLDL(mg/dl) 16.20±1.28 15.22±1.30 16.00±1.42 15.41±1.20 
Triglycerides (mg/dl) 86.20±2.02 85.62±2.22 86.00±2.21 87.24±2.32 
TC/HDL ratio (g/dl) 3.50±0.25 3.40±0.24 3.37±0.33 3.45±0.28 
Blood glucose(mg/dl) 125.22±4.75 126.02±4.29 126.32±5.00 125.12±4.52 
Values are mean of 6 animals ± S.E.M. (Dunnett's test). nsP>0.05. 
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                                               Table-4.3.9 Urine Analysis 
Parameters Control 100 mg/kg 200 mg/kg 400 mg/kg 
Colour Yellow Yellow Yellow Yellow 
Transparency Clear Slightly turbid cloudy Slightly turbid 
Specific gravity 1.010 1.010 1.010 1.010 
PH >7.2 >8.0 >8.0 >9.0 
Protein Nil 3+ 3+ 3+ 
Glucose Nil Nil Nil Nil 
Bilirubin -ve -ve -ve -ve 
Ketones -ve +ve +ve +ve 
Blood Absent Absent Absent Absent 
Urobilinogen Normal Abnormal Abnormal Abnormal 
Pus cells 0-cells/HPF 1-cell/HPF 2-cells/HPF 1-cell/HPF 
RBCs Nil Nil 0-1cells/HPF Nil 
Epithelial cells Nil 1-cell/HPF Nil 1-cell/HPF 
Crystals Nil Nil Nil Nil 
Casts Nil Nil Nil Nil 
Others Bacteria seen Bacteria seen Bacteria seen Bacteria seen 
 
Table 4.3.10. Effect of oral administration of a Hingu Chooranam on organ weigh 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Liver (g) 5.24±0.14 5.25±0.12 4.26±0.14** 4.12±0.15** 
Heart (g) 0.61±0.04 0.60±0.05 0.57±0.04 0.59±0.04 
Lung (g) 1.47±0.16 1.48±0.14 1.46±0.13 1.50±0.11 
Spleen (g) 0.63±0.05 0.65±0.04 0.64±0.04 0.62±0.05 
Ovary (g) 1.65±0.14 1.70±0.16 1.67±0.15 1.71±0.15 
Testes (g) 1.45±0.14 1.46±0.12 1.45±0.15 1.47±0.14 
Brain (g) 1.54±0.16 1.52±0.12 1.56±0.12 1.54±0.15 
Kidney (g) 0.72±0.04 0.71±0.04 0.72±0.04 0.71±0.05 
Stomach (g) 1.34±0.14 1.35±0.11 1.34±0.15 1.33±0.10 
Values are mean of 6 animals ± S.E.M. (Dunnet's test). **P<0.01 Vs control 
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HISTOPATHALOGICAL FEATURES 
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4.4. PHARMACOLOGICAL STUDY: 
Antiulcer property of Hingu  chooranam: 
Results and discussion:  
 Peptic ulcer disease is a serious gastrointestinal disorder that requires a well 
targeted therapeutic strategy. A number of drugs including proton pump inhibitors and 
H2 receptor antagonists are available for the treatment of peptic ulcer, but clinical 
evaluation of these drugs has shown incidence of relapses, side effects, and drug 
interactions. This has been the rationale for the development of new antiulcer drugs and 
the search for novel molecules has been extended to herbal drugs that offer better 
protection and decreased relapse. This study revealed a significant anti-ulcer effect of 
Hingu Chooranam in experimental animals induced by a non-steroidal drug, Aspirin.  
 Synthetic NSAIDs like aspirin cause mucosal damage by interfering with 
prostaglandin synthesis, increasing acid secretion and back diffusion of H+ ions. Aspirin 
is a potent inhibitor of prostaglandin biosynthesis. Prostaglandins are known to play an 
important role in maintaining mucosal integrity. Under our experimental conditions, 
different doses of Hingu Chooranam altered the gastric mucosal lesions compared to the 
control. Anti-inflammatory drug Aspirin administered in toxic doses (200mg/kg), 
produce visible gastric ulcers in animals.  
 An Increase in certain endogenous prostaglandins can enhance gastric mucosal 
resistance to ulcerogenic agents. The mechanisms involved in prostaglandin action are 
multiple, including stimulation of mucus and bicarbonate output, gastric mucosal blood 
flow, decreasing gastric motility, increasing the release of endogenous mediators of 
gastric injury vasoactive amines and leucotrienes and stimulation of cellular growth and 
repair. Although in most of the cases the etiology of the ulcers is unknown, it is generally 
accepted that they are a result of an imbalance between aggressive factors and the 
maintenance of mucosal integrity through endogenous defensive mechanisms.  
 In our investigation, the effect of the Hingu Chooranam on prostaglandin 
biosynthesis was not evaluated, but an increase in resistance to the necrotizing effect of 
Aspirin was noted. Hingu Chooranam is one of the siddha drug used in the present study 
to evaluate the anti-ulcerogenic potency in aspirin induced ulcers in rats. From the results 
obtained, it was observed that, there was decrease in percent of incidence of ulcer and 
ulcer index in a dose dependent manner when compared with control group. So it was 
considered that the Hingu Chooranam has significantly decreased the ulceration in 
Aspirin induced ulcers in rats. 
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4.5. CLINICAL ASSESMENT 
                 Table: 4.5.1 IMPROVEMENTS IN SIGNS AND SYMPTOMS 
SL. 
NO 
SIGNS AND 
SYMPTOMS 
NO. OF PATIENTS 
BT AT IMP. IMPROVEMENT 
(%) 
1 Epigastric pain 50 4 46 92 
2 Heart burn 46 3 43 93 
3 Water brash 35 7 28 80 
4 Regurgitation 44 6 38 86 
5 Nausea 38 4 34 89 
6 Vomiting 19 6 13 68 
7 bdominal distension 32 6 26 81 
 
 
Inference: 
Among 50 patients, 
• 45 out of 50 patients were relieved from Epigastric pain. 
• 43 out of 47 patients were relieved from heart burn. 
• 29 out of 37 patients were relieved from Water brash 
• 39 out of 45 patients were relieved from regurgitation. 
• 34 out of 39 patients were relieved from nausea. 
• 12 out of 18 patients were relieved from vomiting. 
• 24 out of 30 patients were relieved from abdominal distension.  
• 23 out of 28 patients were relieved from Constipation 
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STATISTICAL ANALYSIS 
PAIRED “t” TEST RESULT: 
P value and statistical significance:  
 The two-tailed P value is less than 0.0001 
 By conventional criteria, this difference is considered to be extremely statistically significant.  
Confidence interval: 
 The mean of Group One minus Group Two equals 5.14 
 95% confidence interval of this difference: From 3.79 to 6.50  
Intermediate values used in calculations: 
 t = 9.2952 
 df = 6 
 standard error of difference = 0.553  
Table: 4.5.3 
 Sign & 
Symptoms 
Mean S.D. S.E.M 
Before Treatment 7 37.71 10.40 3.93 
After Treatement 7 32.57 11.361 4.28 
 
 
 From the table we calculated the descriptive statistic like Mean, S.D & S.E.M of 
Mean for the improvement score before and after treatment 
“t” Table: 4.5.4 
t-Table S.D “t” Value “p” Value 
Pre vs Post 0.553 9.2952 0.0001 
The two-tailed P value is lessthan 0.0001 
By conventional criteria, this difference is considered to be extremely statistically 
significant.  
Result and discussion: 
 Improvements of signs and symptoms by statistical analysis shows the two tailed 
“p” value equals 0.0001, by conventional criteria, this difference is considered to be 
extremely statistically significant. From the above results p < 0.05, it shows the 
improvement in the subjective parameters produced by Hingu  chooranam statistically 
significant. 
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                                                   6. CONCLUSION 
The trial drug Hingu chooranam is selected from the classical siddha literature 
Sarabendhirar vadhya muraigal- Gunmaroga sigichai by for the evaluation of safety and 
efficacy of Peptic Ulcer Disease. 
The trial drug was  identified and authenticated by the gunapadam experts. 
 The drug is easily available. Then  preparation and preservation of the drug is 
easy and also economical. 
 The literary reviews along with Phytochemical, chemical constituents, supports 
the efficient activity of the drug, Standardisation of the drug was done by physico 
chemical analysis. 
Hingu chooranam is a herbo mineral drug which contains 8 drugs. In the siddha 
literature “ Gunapadam mooligai and thaadhu vaguppu” all drugs are indicated for 
Gunmam 
Tannins are used in peptic ulcer disease  because of their astringent properties. 
These properties are due to the fact that tannins react with the tissue proteins . In peptic 
ulcers, this tannin-protein complex layer protects the stomach by promoting greater 
resistance to chemical and mechanical injury or irritation.  Tannins present antioxidant 
activity, promote tissue repair, exhibit anti Helicobacter pylori effects, and also involved 
in gastrointestinal tract anti-inflammatory processes.   
The presence of Triterpenes, Steroids, Anthraquinine, Saponin and Coumarin in 
Hingu chooranam is most effective for peptic ulcer disease .Because of these promote 
anti –ulcer activity. 
Zinc is extremely important in ulcers, irritable bowel syndrome, 
yeast infections, colitis, and many other digestive problems. 
 The trial drug was subjected to  pharmacological, clinical studies were analysed  
that the trial drug has potent Anti Ulcer activity. 
The clinical study showed improvement in the symptoms like epigatric pain, heart 
burn, epigatsric tenderness, nausea and vomiting, abdominal discomfort, loss of appetite, 
constipation etc. The results were found to be good in 72% of patients, satisfatory in 10% 
of patients , moderate in 14% of patients and poor in 4% of patients. Statistical analysis 
shows p value < 0.05 which is considered very statistically significant. 
No adverse effects were produced during the entire clinical study. 
From the above observation, I conclude that the Hingu chooranam is most 
effective for Peptic ulcer disease ( Gunmam ). 
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7. SUMMARY 
 Herbo- mineral drug Hingu chooranam was prepared as per Sasthrik method and 
evaluate the Anti – ulcer activity, and to prove its efficacy and safety in peptic ulcer 
disease.  
Hingu chooranam is a herbo mineral drug which contains 8 drugs. In the siddha 
literature “ Gunapadam mooligai and thaadhu vaguppu” all drugs are indicated for 
Gunmam 
The Hingu chooranam was subjected to various process of  like  phytochemical, 
chemical and physico-chemical analysis to report the creditability of drug 
 The physico chemical analysis expressed the presence of calcium, potassium, 
magnisum, zinc, Iron which is known well for its ulcer curing property. 
The pharmacological analysis showed that the drug has got significant Anti ulcer 
activity. 
The clinical study showed improvement in the symptoms like epigatric pain, heart 
burn, epigatsric tenderness, nausea and vomiting, abdominal discomfort, loss of appetite, 
constipation etc. The results were found to be good in 72% of patients, satisfatory in 10% 
of patients , moderate in 14% of patients and poor in 4% of patients. Statistical analysis 
shows p value < 0.05 which is considered very statistically significant 
This present study suggests that Hingu  Chooranam has the remarkable medicinal 
value against the disease Peptic ulcer without any adverse effect. 
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1.       DEPARTMENT OF POST GRATUATE GUNAPADAM BRANCH,  
GOVERNMENT SIDDHA MEDICAL COLLEGE,  
CHENNAI ‐ 106. 
ARIGNAR ANNA GOVERNMENT HOSPITAL FOR 
INDIAN MEDICINE AND HOMEOPATHY, ARUMBAKKAM, 
CHENNAI ‐ 106. 
OPEN CLINICAL TRAIL PHASE II B 
ANTI MICROBIAL ACTIVITY OF 
“ILAVU VER CHOORANAM” 
FORM II 
1. Centre :  
2. Code no  :      Level of study: OPD/IPD 
3. Name of the patient  :  
4. Address  : 
     
    
5. Age :   :   sex: Male  Female   
6. Educational Status  :  
7. Occupation  :  
8. Income  :  
9. Religion  : H M CH  S 
10. Marital Status  : 
     11. Date of Admission     : 
     12. Date of Discharge     : 
     13Diagnosis     : 
PERSONAL HISTORY: 
11. Food habits  : Veg Non Veg Veg/Egg 
12. Addiction  : None Smoking Snuff 
    Ganja Alcohol Opium 
13. Sleep  : Good Distributed Insomnia 
14. Presence of anxiety  : Yes No 
15. Naadi  : Vatham  Pitham Kapam        Thontham 
FAMILY HISTORY: 
1. Hypertension  : Yes  NO  
2. Diabetes mellitus  : Yes  NO 
3. Tuberculosis  : Yes  NO 
4. IHD/MI/MS/AS  : Yes  NO 
5. If any other disease specify  : Yes   NO 
 
   
PRESENTING SYMPTOMS: 
        Yes     No   Duration (WEEKS) 
1. Excessive watery discharge : 
2. Yellowish discharge : 
3. Muco purulent discharge : 
4. Foul smell : 
5. Irritation on genitalia : 
6. Itching in vulva : 
7. Lower abdominal pain : 
8. Low back pain : 
9. Dysuria : 
10. Weakness : 
11. Indigestion : 
12. Headache : 
13. If any other disease :  
HISTORY OF PRESENT ILLNESS: 
1. Excessive watery discharge  : 
2. Yellowish discharge  : 
3. Muco purulent discharge  :  
4. Foul smell  : 
5. Irritation on genitalia  : 
6. Itching in vulva  : 
7. Lower abdominal pain  : 
8. Low back pain  : 
9. Dysuria  : 
10. Weakness  : 
11. Indigestion  : 
12. Headache  : 
13. Constipation 
14. Vertigo  : 
15. Burning micturation 
16. Weight loss  : 
17. Black patches under the eyes  : 
18. If any other disease   
PAST HISTORY: 
1. Date of diagnosis  : 
2. Duration of disease  :           months/years 
3. Source of any infection  : 
4. Gastrointestinal bleeding   : Yes    No If Yes, when? 
5. Cancer(GI tract)  : Yes    No 
6. Cancer(other organs)  : Yes    No       
7. Sedentary life style  : Yes    No        
8. Achlorhydria  : Yes    No      
9. Tumours in stomach  : Yes    No     
10. Tuberculosis (GI tract)  : Yes    No        
11. Diabetes  : Yes    No   
12. Nephritis  : Yes    No  
13. Syphilis  : Yes    No 
14. AIDS  : Yes    No  
15. Pt.underwent any surgery  : Yes    No 
16. UTI  : Yes    No  
17. Others  : If Yes , Specify    
HISTORY OF PREVIOUS TREATMENT:  Yes    No 
If yes, give details as follows: 
PHYSICAL EXAMINATION: 
1. Height (cm)  :  
2. Weight (cm)  : 
3. Pulse  : 
4. Blood pressure  : 
5. Temperature  : 
6. RR  :  /minute 
7. Anaemia  :  Present   Absent 
8. Lymphadenopathy  :  Present    Absent 
9. Pigmentation  :  Present   Absent 
PRESENTING SIGNS:     
1. Muco purulent discharge   :  Present    Absent 
2. Foul smell                 Present              Absent           
3. Irritation and itching in vulva      :  Present  Absent 
4. Lower abdominal and backache   :  Present  Absent 
5. Dysuria         :  Present  Absent 
6. Indigestion and constipation             :  Present  Absent 
7. Headache and vertigo   :  Present   Absent 
8. Weakness   :  Present   Absent 
9. Black patches under the eyes   :  Present   Absent 
CLINICAL EVALUATION: 
1. Cardio vascular system  :  Normal    Abnormal  Details   
2. Respiratory system  :  Normal      Abnormal Details 
3. Central nervous system  :  Normal  Abnormal Details 
4. Urogenital system  :  Normal  Abnormal Details 
SIDDHA PARAMETERS: 
1. Naa  :  Normal  Abnormal Details 
2. Niram  :  Normal   Abnormal Details 
3. Mozhi  :  Normal   Abnormal Details 
4. Vizhi  :  Normal  Abnormal Details 
5. Malam  :  Normal  Abnormal Details 
6. Moothiram  :  Normal  Abnormal Details 
7. Sparisam  :  Normal  Abnormal Details 
8. Naadi  :  Normal  Abnormal Details 
RESULT: 
1. GOOD  : 
2. FAIR  : 
3. POOR  : 
4. NO RESPONSE  : 
SIGNATURE OF MEDICAL OFFICER      SIGNATURE OF INVESTIGATOR 
LABORATORY INVESTIGATION AND CLINICAL PARAMETERS 
1. Centre :  
2. Code no  :      Level of study: OPD/IPD 
3. Name of the patient  :  
4. Age :   :   sex: Male  Female   
5. Date and month of assessment    : 
CLINICAL PARAMETERS: 
 Urine: Albumin, Sugar, Deposits. 
 MOTION; Ova ,Cyst  
HAEMOGRAM :Total WBC Count, RBC, Hb, ESR, Vaginal smear, Culture, USG Abdomen 
 
2.       DEPARTMENT OF POST GRATUATE GUNAPADAM BRANCH,  
GOVERNMENT SIDDHA MEDICAL COLLEGE,  
CHENNAI ‐ 106. 
ARIGNAR ANNA GOVERNMENT HOSPITAL FOR 
INDIAN MEDICINE AND HOMEOPATHY, ARUMBAKKAM, 
CHENNAI ‐ 106. 
OPEN CLINICAL TRAIL PHASE II B 
ANTI ULCER ACTIVITY OF 
“HINGU CHOORANAM” 
FORM II 
16. Centre :  
17. Code no  :      Level of study: OPD/IPD 
18. Name of the patient  :  
19. Address  : 
     
    
20. Age :   :   sex: Male  Female   
21. Educational Status  :  
22. Occupation  :  
23. Income  :  
24. Religion  : H M CH  S 
25. Marital Status  : 
     11. Date of Admission     : 
     12. Date of Discharge     : 
     13Diagnosis     : 
PERSONAL HISTORY: 
26. Food habits  : Veg Non Veg Veg/Egg 
27. Addiction  : None Smoking Snuff 
    Ganja Alcohol Opium 
28. Sleep  : Good Distributed Insomnia 
29. Presence of anxiety  : Yes No 
30. Naadi  : Vatham  Pitham Kapam        Thontham 
31. FAMILY HISTORY: 
6. Hypertension  : Yes  NO  
7. Diabetes mellitus  : Yes  NO 
8. Tuberculosis  : Yes  NO 
9. IHD/MI/MS/AS  : Yes  NO 
10. If any other disease specify  : Yes   NO 
PRESENTING SYMPTOMS:                Yes             No   Duration (WEEKS) 
14. Pain : 
15. Vomiting : 
16. Indigestion : 
17. Sore tongue : 
18. Diarrhoea : 
19. Constipation : 
20. Haematemesis : 
21. Loss of appetite : 
22. Thirst : 
23. Dysphasia : 
24. Flatulence : 
25. Heart-burn : 
26. If any other disease :  
HISTORY OF PRESENT ILLNESS: 
19. Pain  : 
20. Vomiting  : 
21. Indigestion  :  
22. Sore tongue  : 
23. Diarrhoea  : 
24. Constipation  : 
25. Haematemesis  : 
26. Loss of appetite  : 
27. Thirst  : 
28. Dysphasia  : 
29. Flatulence  : 
30. Heart-burn  : 
31. Bloating & abdominal fullness : 
32. Water brash  : 
33. Nausea and copious vomiting: 
34. Weight loss  : 
35. Melena  : 
36. If any other disease   
PAST HISTORY: 
18. Date of diagnosis  : 
19. Duration of disease  :           months/years 
20. Source of any infection  : 
21. Gastrointestinal bleeding   : Yes    No If Yes, when? 
22. Cancer(GI tract)  : Yes    No 
23. Cancer(other organs)  : Yes    No       
24. Sedentary life style  : Yes    No        
25. Achlorhydria  : Yes    No      
26. Tumours in stomach  : Yes    No     
27. Tuberculosis (GI tract)  : Yes    No        
28. Diabetes  : Yes    No   
29. Nephritis  : Yes    No  
30. Syphilis  : Yes    No 
31. AIDS  : Yes    No  
32. Pt.underwent any surgery  : Yes    No 
33. UTI  : Yes    No  
34. Others  : If Yes , Specify    
HISTORY OF PREVIOUS TREATMENT:  Yes    No 
If yes, give details as follows: 
PHYSICAL EXAMINATION: 
10. Height (cm)  :  
11. Weight (cm)  : 
12. Pulse  : 
13. Blood pressure  : 
14. Temperature  : 
15. RR  :  /minute 
16. Anaemia  :  Present   Absent 
17. Lymphadenopathy  :  Present    Absent 
18. Pigmentation  :  Present   Absent 
PRESENTING SIGNS:     
10. Bloating and abdominal fullness    :  Present  Absent 
11. Water brash  (Rush of saliva after 
 an episode of Regurgitation to  
Dilute the Acid in oesophagus)     :  Present  Absent 
12. Nausea and copious vomiting      :  Present  Absent 
13. Loss of appetite and weight loss    :  Present  Absent 
14. Haematmesis         :  Present  Absent 
15. Melena(tarry, foul-smelling faces 
 due to oxidized iron from  
Haemoglobin)         :  Present  Absent 
16. Fatigue   :  Present   Absent 
17. Heartburn   :  Present   Absent 
18. Hunger   :  Present   Absent 
CLINICAL EVALUATION: 
5. Cardio vascular system  :  Normal    Abnormal  Details   
6. Respiratory system  :  Normal      Abnormal Details 
7. Central nervous system  :  Normal  Abnormal Details 
8. Urogenital system  :  Normal  Abnormal Details 
SIDDHA PARAMETERS: 
9. Naa  :  Normal  Abnormal Details 
10. Niram  :  Normal   Abnormal Details 
11. Mozhi  :  Normal   Abnormal Details 
12. Vizhi  :  Normal  Abnormal Details 
13. Malam  :  Normal  Abnormal Details 
14. Moothiram  :  Normal  Abnormal Details 
15. Sparisam  :  Normal  Abnormal Details 
16. Naadi  :  Normal  Abnormal Details 
 
 
 
 
RESULT: 
5. GOOD  : 
6. FAIR  : 
7. POOR  : 
8. NO RESPONSE  : 
SIGNATURE OF MEDICAL OFFICER      SIGNATURE OF INVESTIGATOR 
LABORATORY INVESTIGATION AND CLINICAL PARAMETERS 
5. Centre :  
6. Code no  :      Level of study: OPD/IPD 
7. Name of the patient  :  
8. Age :   :   sex: Male  Female   
5. Date and month of assessment    : 
CLINICAL PARAMETERS: 
 Urine: Albumin, Sugar, Deposits. 
 MOTION; Ova ,Cyst  
HAEMOGRAM :Total WBC Count, RBC, Hb, ESR, Barium meal,Endoscopy,Ultra sound 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                     
                                                                                                                                            








